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Abstract 
Psoriasis is a skin condition characterised by raised, red, scaling patches that cover the 
body to varying degrees, with a prevalence of 1-3% in Caucasian populations. There is 
evidence that sufferers hospitalised for treatment of their psoriasis are more depressed 
and more anxious than controls (e.g. Fava et al, 1980; Lyketsos et al, 1985), but con-
flicting evidence about whether psoriasis outpatients are also more depressed and 
anxious. The research presented in this thesis examined depression and anxiety in a 
group of psoriasis outpatients and found statistically significantly higher depression and 
anxiety levels than in a group of matched controls. The relationship over time between 
area of coverage of psoriasis, depression and anxiety was examined in another group of 
psoriasis outpatients. Using multiple regression analysis, change in area of coverage 
between two assessments was a significant predictor of depression and anxiety at the 
second assessment, once levels at the first assessment had been accounted for. Self-
esteem was also examined in this way and was found to be significantly related to 
psoriasis area of coverage, where worsening psoriasis was associated with a lowering of 
self-esteem. There were statistically significant differences between males and females. 
Pain had not previously been examined systematically in psoriasis outpatients, but was 
higher than pain in matched controls in the first study reported in this thesis. Conse-
quently the quality of pain was examined further, and found not only to be significantly 
related to psoriasis area of coverage, but also was described in terms which suggested a 
distinct character to psoriasis pain. Fluctuations in sleep quality were also found to be 
significantly associated with psoriasis area of coverage. 
Visual assessment of psoriasis area of coverage was shown to be unreliable, so a 
computer program (SKINMAP) was developed to allow psoriasis lesions to be mapped 
onto a computer which then calculates area of coverage. SKINMAP estimates were 
shown to be statistically significantly more accurate and reliable than visual estimates. 
Informal conversations with psoriasis sufferers suggested that they held firm views 
about their condition which often did not coincide with medical views. Lay beliefs 
about psoriasis in a group of sufferers were therefore investigated in detail. Sufferers 
showed quite high levels of knowledge about the condition, but the nature of some 
common misconceptions was investigated through the use of semi-structured inter-
views, and the results highlighted the need for better patient education. 
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Chapter One 
Introduction and Literature Review 
Chapter One: Introduction 
1.1 Introduction 
The aim of the research presented in this thesis is threefold. First, to examine the link 
between disease severity and mood in psoriasis sufferers; in particular, to assess depres-
sion, anxiety and self-esteem and to determine whether they vary as the area of cover-
age of psoriasis fluctuates. Second, to develop and validate a computer-aided assess-
ment technique for determining the area of coverage of psoriasis. And third, to examine 
sufferers' beliefs and knowledge about psoriasis, their perceptions of the nature of their 
disease and its treatment, and their expectations for its likely prognosis. 
1.2 Psoriasis as a physical illness 
Psoriasis is a skin condition characterised by discoid, raised, red, scaly patches. Until 
the early nineteenth century psoriasis was taken to be a form of leprosy: even when 
Robert Willan in 1809 described for the first time different manifestations of psoriasis, 
he did not define them in terms of a disease completely separate from leprosy. It was 
not until 1841 (Farber, 1991) that psoriasis was described as a disease sui generis. 
1.2.1 Clinical features 
The psoriatic lesion is sharply defined (i.e. with no gradual change from unaffected to 
affected skin) and may vary from pinpoint size to several inches in diameter. Lesions 
tend to be asymmetrically distributed on the body in the early stages of the condition 
but the pattern becomes more symmetrical as the disease progresses (Farber & Nail, 
1974): in extreme cases it may completely cover the whole body (erythrodermicpsoria-
sis). The outline shape of large lesions is polycyclic, indicative of the fact that small 
lesions tend to expand and combine to form larger plaques. Typically, the patient 
presents with some areas of the body affected and some areas clear. The most common-
ly affected areas are the elbows, knees, and scalp (Lomholt, 1963). 
There are three common types of psoriasis. They are quite different in appearance, but 
possess the common features of erythema, thickening and scaling. Different manifesta-
tions may be present at the same time in one patient, although this is uncommon, and 
different manifestations may appear at different times during a patient's life: even 
within one episode, clinical signs tend to vary considerably as the disease progresses 
(Mier & van de Kerkhof, 1986). 
Different manifestations of psoriasis are characterised by the size and distribution of the 
lesions. I f they are small and widely distributed, the condition is diagnosed guttate 
psoriasis, whereas i f the typical lesion is larger (coin size to palm size), the diagnosis is 
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chronic plaque psoriasis. I f the lesions are characterised by pustules, the label pustular 
psoriasis is appropriate. Other manifestations exist, but their prevalence is low. The 
most common form is chronic plaque psoriasis which accounts for approximately 90% 
of adult psoriasis cases (Mier & van de Kerkhof, 1986). 
Psoriasis also often affects the nails with pitting and brown discolouration. There are no 
significant differences in the degree to which nails are affected between different 
manifestations of the condition (Calvert, Smith & Well; 1963). Joints may be affected 
{psoriatic arthropathy), and may even be affected in the absence of any cutaneous 
manifestation. Psoriasis of the nails is much more prevalent (Wright, 1957) in patients 
with psoriatic arthropathy (87%) than in patients with only cutaneous involvement 
(15-18%). 
Once the patient has psoriasis, its course is variable and may last from a few weeks to 
several decades. Farber & Nail (1983), for example, summarise the data in five studies 
which looked at length of suffering and the number and duration of remissions. These 
data are presented in Table 1.1. About half the patients reported at least one period of 
remission at some point. 
TABLE 1.1 Reported time since onset of psoriasis, and the frequency and duration of 
remissions in five studies 
Location Time since % reporting Mean length of 
onset (years) remission remission (months) 
Denmark 19 55 35 
United States 17 41 46 
Sri Lanka 8 46 22 
Hong Kong 7 36 9 
Kuwait 7 42 18 
To summarise, psoriasis is a skin condition which may take various forms and cover 
different parts of the body: it may also affect the nails and joints. Once a person has 
psoriasis it may last for many years, but patients can experience remissions during its 
course. 
1.2.2 Epidemioiogy 
While several studies have attempted to assess the prevalence of psoriasis in other 
countries, only one (Rea et al, 1976) has focussed specifically on Britain. Rea and his 
colleagues found a point prevalence of 1.58% in a random sample of 1056 individuals 
3 
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Figure 1.1 Estimated psoriasis prevaience rates and 95% confidence intervals 
5 
8 c 
0) 
03 
> 
1056 3892 10576 
Sample Size 
10984 38670 
in North Lambeth, London. This is broadly in line with point prevalence figures report-
ed for other primarily Caucasian countries. For example, Braathen, Botten & Bjerkedal 
(1989) reported a prevalence of 1.41% in Norway, Hellgren (1967), in an extensive 
epidemiological study in Sweden found a prevalence for definite psoriasis of 1.44%, 
while Lomholt (1964) in the Faroe Islands reported a prevalence of 2.84%. Brandrup 
and Green (1981) found a prevalence of 3.73% in a random sample of Danes, but this 
was a lifetime, rather than a point prevalence. These prevalence estimates are shown 
graphically with their 95% confidence intervals in Figure 1.1. 
Al l point estimates would therefore put the prevalence of psoriasis in Caucasian popula-
tions at between 1% and 3%; one lifetime prevalence rate was 3.7%. 
The data for prevalence rates by sex, however, are less clear. Most general texts on 
dermatology (e.g. Rook, Wilkinson & Ebling, 1986) or psoriasis (e.g. Mier & van de 
Kerkhof, 1986) suggest that there is no difference between the prevalence in men and in 
women. Examination of the data does not wholly support this. 
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The data for the five studies are shown in Table 1.2. We can compare the differences 
between the proportions - the so-called effect sizes denoted d' - which is approximately 
distributed as %^  with k-1 degrees of freedom, where k is the number of studies (Rosen-
thal, 1984). 
TABLE 1.2 Prevalence of psoriasis by sex, reported in five epidemiological studies. 
Males Females 
Country N Psoriatic Prevalence N Psoriatic Prevalence 
England - - .0258 - . .0077 
Denmark 1916 80 .0418 1976 65 .0329 
Norway 5122 70 .0137 5454 79 .0145 
Faroe Islands 5536 158 .0285 5448 154 .0283 
Sweden 20569 473 .0230 19002 285 .0150 
The value for is 13.91 with df=4, which is significant at the 0.003 level. The results 
are therefore significantly heterogeneous and cannot be pooled for an overall analysis. 
Examination of the rates in Table 1.2 however shows that epidemiological studies 
generally find more men with psoriasis than women. This is not a consulting effect (i.e. 
it is not simply that more males consult doctors for psoriasis) since the data comes from 
epidemiological studies sampling general populations, not from clinical records. Indeed, 
Hellgren (1967) found that psoriasis was more prevalent in males in all geographical 
areas even when age and occupational status had been controlled for. 
To summarise, therefore, the point prevalence of psoriasis is between 1% and 3% in 
Caucasian population, and the prevalence for males is slightly higher than for females. 
1.3 Psoriasis as a psychosomatic illness 
Psoriasis is often classified as a psychosomatic illness (e.g. Blake, 1987; Dorfman & 
Cristofar, 1985). I f it is to be referred to in these terms some definition of the concept of 
a psychosomatic illness must be provided. 
Some physical illnesses appear to be more susceptible to psychological influences than 
others, and the term "psychosomatic" can be used to describe them. The term "psycho-
somatic illness" refers to those conditions in which emotional or psychological factors 
lead to somatic reactions: the term does not apply when psychological reactions are 
caused by illness (Whitlock, 1976). This definition includes cases where emotional 
factors help cause a physical condition, as well as where they influence the course of a 
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condition. There is one important caveat: the term psychosomatic does not apply when 
emotional disturbance and physical condition simply co-exist. A causal link, or at least 
a suspected causal link is necessary for denoting a physical illness as "psychosomatic". 
1.3.1 Psychosomatic skin diseases 
Over the past four or five decades definitions of what constitutes a psychosomatic skin 
disease have changed. Alexander (1943), for example, developed a classification system 
which attributed to specific conditions, specific emotional disturbances. However, this 
so-called "specificity hypothesis" has now been largely superseded: partly because 
Alexander's (and other's) work tended to rely on psychoanalytic case studies in which 
there were seldom adequate controls, and partly because the conception of a multifac-
toral origin to disease in general has tended to move medical thinking away from 
searching for unidimensional causes for conditions. Several other authors, notably 
Wittkower & Russell (1953) and Obermayer (1955) attempted to devise classification 
systems that would delimit the extent to which psychological factors influenced the 
onset and course of cutaneous diseases. A more general approach is usually taken today. 
Rook, Wilkinson & Ebling (1972), for example, have distilled a wide range of classifi-
cation systems into five categories: 
1) Conditions exclusively emotional in origin - e.g. dermatitis artefacta. 
2) Conditions of other origin which are aggravated or perpetuated by self-inflicted 
trauma, e.g. acne excoree. 
3) Conditions which are provoked or perpetuated by demonstrable psychosomatic 
factors, e.g. hyperhidrosis. 
4) Conditions in which psychological factors are frequently implicated as predisposing 
or perpetuating factors, e.g. urticaria. 
5) Conditions which are sometimes influenced by psychological factors, e.g. vitiligo. 
These distinctions are primarily concerned with the extent to which psychological 
factors influence the onset or course of a cutaneous condition. They are merely a classi-
fication system: they do not add anything to our understanding of the underlying 
mechanisms of disease pathology or perpetuation. Nevertheless, they do serve to high-
light the fact that different skin conditions can be affected in different ways by emo-
tional factors. Psoriasis falls into either category 4 or 5 of this classification system. 
1.4 Psychiatric morbidity and psoriasis 
Hughes, Barraclough, Hamblin & White (1983) set out to discover whether patients 
attending a dermatology clinic showed a higher prevalence of psychiatric disorder than 
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the general population. They administered the 30-item General Health Questionnaire 
(GHQ-30) to 196 outpatients and 40 in-patients, chosen consecutively from new refer-
rals. A cutoff point of 5 was used to indicate a possible "case", and those individuals 
who attained this score were given the Wakefield Self-Assessment Depression Scale 
(WSADS), and interviewed about their perceptions of the relationship between psychiat-
ric symptoms and their skin condition. The cutoff point on the WSADS for probable 
depression is 14. 
Thirty percent of the outpatient group exceeded the GHQ-30 cutoff score, as did 60% of 
the in-patients. Of these, 49% of the outpatients and 54% of the in-patients scored 
above the cutoff point on the WSADS. The numbers of males and females that are repre-
sented in these figures were not reported. The authors compared these results with those 
of Goldberg (1976) who reported 11% of 213 individuals taken from the general popu-
lation and 30% of 365 General Practice patients scoring above the cutoff point. Thus, 
the dermatology outpatients had similar scores to those of general practice outpatients, 
and both dermatology and general practice outpatient groups scored higher than figures 
reported for the general population. However, more dermatology in-patients in Hughes' 
et al study scored above the cutoff point than has been found in studies using samples 
of general medical in-patients (e.g. McGuire et al, 1974, found 33% of 230 general 
medical in-patients could be classified as cases). 
This study is of particular interest because the authors also examine how the psychiatric 
symptoms and skin diseases might be linked by reference to four categories of psycho-
somatic influence, as follows: 
1) Self-reports of psychiatric symptoms pre-dating or exacerbating the skin condition 
were found in 28% of the probable cases. The authors note that these patients did not 
have any particular subset of illnesses. It is not possible to conclude from this sort of 
data that the psychiatric problem precipitated changes in the skin condition. A 
prospective methodology together with clinical assessment of psychiatric symptoms 
would be required to detect a true temporal relationship. 
2) The second possibility that the authors examined was a psychiatric disorder whose 
symptoms are in the form of skin lesions. Three of the "cases" fell into this category: 
two with hypochondriacal preoccupation with trivial lesions and one with dermatitis 
artefacta (self-mutilation). 
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3) The hypothesis that the stigma of having unsightly lesions on exposed parts of the 
body might lead to psychiatric problems was addressed by examining the type and 
location of the skin condition. Forty seven patients had conditions which affected the 
face or hands, and of these, 70% scored above the cutoff point on the GHQ-30. With 
the exception of dermatitis artefacta, the chronic conditions which affected wide-
spread areas of the body (e.g. psoriasis) or conditions which affected only the visible 
parts of the body (e.g. alopecia) showed the highest GHQ-30 scores (see Table 1.3). 
Tabie 1.3 GHQ scores reported by Hughes et al (1983) for a range of si<in conditions 
Condition N %GHQ>5 Mean GHQ 
Dermatitis artefacta 1 100 20 
Alopecia 4 75 12 
Widespread lesions present 
for > 6 weeks (e.g. psoriasis) 
125 46 7 
No lesion (e.g. pruritus) 11 27 3 
Small non-malignant single lesions 63 14 3 
Small malignant single lesions 23 8 2 
Widespread lesions present 
for < 6 weeks 
7 0 2 
Systemic lymphoma 2 0 3 
4) One further possibility was examined: that drugs used to treat the skin condition may 
also cause psychiatric effects. Steroids, for example, used topically for skin condi-
tions can have psychiatric side-effects i f used in high doses (Lewis & Smith, 1983). 
The patients on high-dose steroids in this study did score above the GHQ-30 cutoff 
point more often than others, but this is probably confounded by the fact that high 
dose steroids were being used by those patients with the most severe skin conditions. 
This study by Hughes et al has therefore suggested that there are more dermatology 
outpatients exceeding the level set for possible cases on the GHQ-30 than are found in 
the general population. It has also suggested that those conditions which are chronic or 
visible in normal situations, tend to contribute to greater numbers of cases. 
Wessely & Lewis (1989), while accepting the broad findings of Hughes et al, suggest 
that the impact on a patient's life is more important in predicting psychiatric morbidity 
than the location or severity of skin lesions. They used two measures of psychiatric 
8 
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morbidity: the GHQ-12 (cutoff point 2), and the Clinical Interview Schedule (CIS - cutoff 
point 13). In 160 subjects from a sample of 173 consecutive outpatients, they found 
40% cases defined by CIS scores, with women scoring non-significantly higher than 
men (mean for males 12.1, females 13.4). The GHQ-12 revealed 43% cases. While the 
authors do not give any indication of the numbers of subjects suffering from individual 
conditions (11 skin conditions were represented in the group), they note that no signifi-
cant difference was found on CIS scores between illnesses. This is interesting in the 
light of Hughes' findings (above). Wessely & Lewis's sample comprised individuals 
with warts, single lesions and naevi, as well as conditions more widespread, chronic and 
visible, such as psoriasis, alopecia and acne. Hughes' findings would suggest that there 
should be more cases in this latter group than in the former. Wessely & Lewis did find, 
however, that area of coverage on exposed regions of the body was positively correlated 
with a self-report measure of how much impact the skin condition had on patients lives, 
as was time since onset, but not total area of coverage. This "impact" measure was in 
turn highly correlated with the CIS scores. 
Wessely & Lewis suggest, therefore, that any psychiatric morbidity in dermatology 
patients is of a general nature and due more to the perceived impact on the patients 
lives, in terms of the behaviour modification that is entailed, than to the location or dis-
tribution of the lesions, or to the specific condition. The fact remains, however, that 
those conditions which were reported to have the highest impact on the patients' lives 
were more likely to be chronic conditions with more visible lesions. 
To summarise, studies which assess the prevalence of psychiatric morbidity in derma-
tology patients have found higher levels of cases than in the general population. The 
rate is much higher in hospitalised dermatology patients whose rates are in turn higher 
than in hospitalised general medical patients. 
1.5 Psychological variables associated with psoriasis 
Investigations into the psychological concomitants of psoriasis fall broadly into two 
areas: 1) studies which have assessed effects of psoriasis on patients' lives in general, 
and 2) studies which have attempted to quantify specific psychological variables. 
Within these categories, different researchers have employed varying methods and 
while many of the results overlap, it is useful in the first instance to examine them in 
their individual categories. 
Chapter One: Introduction 
1.5.1 Reported effects of psoriasis on the patient's life 
Jobling (1976) surveyed 291 members of the British Psoriasis Association by postal 
questionnaire regarding their psoriasis. Multiple answers to each question were allowed 
and the questions were open-ended, not multi-choice. Eighty four percent said that one 
of the worst things about having psoriasis was establishing social contacts and relation-
ships, while 25% reported the worst aspect to be suffering embarrassment and shame 
about their condition. Sixteen percent were very concerned about being stared at by 
other people, and 20% felt the worst aspect of psoriasis was having to wear particular 
types of clothing in order to cover affected areas. The problem of bias arising from 
restricting the sample to members of the psoriasis association cannot be overlooked 
when interpreting these results, but it seems clear that the appearance of the condition 
and the reactions it elicits from other people are major concerns. 
Approaching this idea from a slightly different perspective, Baughman & Sobel (1970) 
set out to devise a self-report measure of psoriasis severity. They had psoriasis sufferers 
and dermatologists rate on a seven point scale 50 features of psoriasis according to the 
degree to which each feature "indicates the severity of this disease". Selecting 23 of the 
items for their final scale, they found that, while dermatologists ranked "Embarrassment 
over appearance" as the least important indicator of severity, the patients ranked it the 
most important. 
Stankler (1981) extending Jobling's line of enquiry to a more representative sample 
questioned 100 consecutive outpatients about what they considered the worst aspect of 
psoriasis. Again with an open-ended question, 87% of his sample reported that the 
worst aspect of psoriasis was feeling embarrassed about the condition, particularly 
when it affected visible parts of the body, or regions that became visible under certain 
circumstances (e.g. sports or work). Males reported largely the same problems as 
females. This was in contrast to the findings of a previous study by Roenigk & Roenigk 
(1978) who had reported significant differences between males and females in the 
degree to which their "relations with the same sex" were affected and the degree to 
which they were affected by "worry and stress", with females reporting more problems 
than males. 
Noting that much of the research into the social consequences of psoriasis (and skin 
disease in general) had been "presented in an anecdotal and unstructured way", Jowett 
& Ryan (1985) interviewed 100 outpatients (at their own homes) about the conse-
quences and experiences with their skin condition. Their sample comprised 32% with 
eczema, 38% with psoriasis and 30% with acne, and in each group the condition affect-
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ed either the hands or the face in 84%, 83% and 81% of cases respectively. One crite-
rion for inclusion in the sample was a time since onset of twelve months or longer. The 
mean time since onset in the psoriasis group was 13 years. 
Jowett & Ryan asked sufferers what they thought was the worst aspect of having pso-
riasis, and reported that "the majority" said it was embarrassment caused by the appear-
ance of the lesions, together with awareness of other peoples' reactions. Furthermore, 
while 38% reported experiencing no difficulty at work through their psoriasis, 15% did 
say they felt that their employment opportunities were limited because they had psoria-
sis, and 44% reported that they had experienced functional difficulties at work because 
of their condition. Four subjects suffering from psoriasis or eczema said they had had to 
leave their job because of their condition, and others reported that chemicals at work 
irritated their lesions. 
Their interview schedule also included systematic inquiries about the negative emotions 
that patients felt because of their condition. Not only did psoriasis sufferers think that, 
in general, embarrassment was the worst aspect of psoriasis, 89% of them reported 
actually feeling embarrassment or guilt because of their condition. 
These findings were broadly supported by Dooley & Finlay (1990) in 35 psoriasis 
outpatients using repertory grid technique. In comparison with a control group of 28 
other dermatology outpatients and a further group of 29 members of the general popula-
tion, they found that the psoriasis group was least well socially adjusted on their embar-
rassment construct (a low score for social adjustment on this construct corresponded to 
a high level of embarrassment in social situations) with a mean score of 89.2, compared 
to a mean of 106.8 for the other dermatology group and 96.8 for the non-dermatology 
controls. The difference between groups was significant, but this was accounted for by 
the difference between the psoriasis group and the dermatology controls. Further, when 
these results were analysed by sex, there was no difference between males in the three 
groups, but females reported more embarrassment in social situations than either control 
group: again the significant difference was between the psoriasis group and dermatolo-
gy controls. 
Taken together, these studies suggest that psoriasis sufferers are highly embarrassed by 
their condition, and those feelings of embarrassment may be heightened in social situa-
tions. They may also experience impairment in their relationships with other people, 
and a minority feel that their employment chances are limited because of their psoriasis. 
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Given the existence of these feelings of embarrassment, guilt and shame, it is pertinent 
to enquire how psoriasis affects the self-esteem of sufferers, and some limited research 
has attempted to examine this area. However, Wells and Marwell (1976) have demon-
strated that self-esteem research has been hampered by inadequate definition, so this 
must be clarified before examining the findings that relate specifically to psoriasis. 
1.5.2 Self-esteem 
In research on self esteem the view most commonly accepted has, until recentiy, result-
ed in the measurement of self esteem as a global construct (e.g. Rosenberg, 1965): and 
because of this relatively unsophisticated view, the development of measuring instru-
ments has been largely unsatisfactory (Bingham, 1983; Marx & Winne, 1980; Watkins, 
1978). Over recent years however, self-esteem has more usefully been conceptualised 
as several different dimensions (Fleming & Courtney, 1984; Marsh & Shavelson, 1985; 
Robson, 1988), and measuring instruments now tend to reflect these dimensions, while 
stUl retaining an assessment of global self esteem. 
Building on his comprehensive review of the literature (Robson, 1988), Robson (1989) 
has defined self esteem in a way which overcomes some of the shortcomings of the 
"conceptually primitive" definitions previously employed. He combined the work of 
Rosenberg (1965), who concentrated on the relationship of self esteem to the sense of 
personal worthiness held by an individual, the evaluation of their appearance, and their 
level of social confidence, with that of Coopersmith (1967), who highlighted the impor-
tance to self esteem of feelings of competence and power, and Beck (1967), who noted 
that the way an individual interprets events partly determines the view the individual 
has of the self. 
Following Robson then, self-esteem in the present study is defined as: 
The sense of contentment and self acceptance that results from a person's appraisal of 
their own worth, significance, attractiveness, competence and abihty to satisfy their 
aspirations. 
(Robson, 1988, p. 13) 
The important theoretical advance in this conceptualisation is that the concept of global 
self-esteem is retained while the individual components of which it is comprised are 
also recognised. Marsh & Shavelson (1985) and Marsh (1986) have suggested that self-
esteem ought to be measured as a situation-specific variable: one's self-esteem only has 
relevance as a concept i f the situational factors are taken into account. Thus, Marsh's 
approach has been to develop a measure of self esteem that inquires about feelings in a 
range of specific situations. The problem with this approach is defining sufficient 
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numbers of situations about which to inquire. A self-esteem instrument following 
Marsh's conception would require a large number of questions, and the notion of self-
esteem as a global measure would be lost. 
1.5.2.1 Self-esteem and psoriasis 
In one of the most thorough investigations into the effects of psoriasis on the sufferer, 
Ginsburg & Link (1989) examined feelings of stigmatisation associated with the condi-
tion. They defined stigma as "a biologic or social mark that sets a person off from 
others, is discrediting, and disrupts interactions with others", and devised a question-
naire to evaluate feelings of stigmatisation. Following administration to 100 adult pso-
riasis sufferers, factor analysis revealed six main dimensions of the stigma experience: 
anticipation of rejection (fear of how others might react to the condition), feeling flawed 
(feelings of weakness and dirtiness), sensitivity to others' opinions (reactions to actual 
behaviour of others), guilt and shame (falling short of one's ideal image, guilt over 
passing psoriasis to children), positive attitudes (taking a positive view of the conse-
quences of the condition), and secretiveness (attempting to conceal the condition). One 
overall category was also identified and labelled psoriasis-related despair, which 
composed items that loaded on all factors. 
Age at onset was a significant predictor of all factors except feeling flawed: the 
direction of prediction was the same in all cases (i.e. the older the patient was when 
the condition first appeared, the lower the patient's score). Also, the longer a 
patient had had psoriasis the less guilt and shame they exhibited and the less secre-
tive they were. The best predictor of feelings of stigmatisation among disease 
symptoms was the extent of bleeding, but interestingly neither area of coverage 
nor visibility of the lesions accounted for any significant amount of variance. 
Ginsburg & Link note that, for each of their stigma factors, the predictors they 
identified accounted for between 11 and 30% of the variance, and suggest there-
fore that other processes are involved in coping with feelings of stigmatisation, 
such as learnt coping strategies or social support networks. 
This paper on feelings of stigmatisation in psoriasis has considerable bearing on self 
esteem. Many of the questions in their instrument coincide with those appearing on self 
esteem measures. For example, the question with the highest loading on the factor 
anticipation of rejection was "When my psoriasis improves after intensive treatment, I 
feel much better about myself. Self-evaluative statements such as this link closely with 
the concepts of self esteem: 46% of their sample strongly agreed with this item. 
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To summarise, studies which have investigated how psoriasis sufferers feel about their 
condition and how it affects their relationships with other people have found that they 
report feeling very embarrassed and guilty about their appearance, and report some 
reduction in opportunity and interpersonal contact because of their condition. Feelings 
of stigmatisation are apparent in psoriasis sufferers, which are related to the age at onset 
and the time since onset of the condition, and the amount of bleeding involved. 
These findings can be related to more theoretical conceptions of psychopathology. 
Following the work of Lewinsohn's group, (e.g. Lewinsohn, 1974), several studies have 
suggested that symptoms of depression are more likely to occur in individuals who do 
not have access to social situations where they can receive positive reinforcement (e.g. 
Brown & Harris, 1978). This applies to individuals with stigmatising marks. Goffman 
(1968) hypothesised that the non-stigmatised will tend to avoid entering long-term rela-
tions with stigmatised individuals because they tend to be associated with the same 
negative social connotations. Empirically, this has been examined by Kleck, Ono & 
Hastorf (1966) who found that in face-to-face interactions with stigmatised individuals 
(the stigma in this case was a bogus left-leg amputation) subjects tended to terminate 
interactions significantly quicker than when interacting with a non-stigmatised individ-
ual. 
This would tend to suggest that one consequence of feeling stigmatised for dermatology 
patients may be raised levels of depression brought about by decreased positive inter-
personal contact, and a subsequent lack of positive reinforcement. Depression in psoria-
sis sufferers is reviewed below. 
1.5.3 Depression 
The term depression has come to mean different things in different contexts. To the 
psychiatrist or clinical psychologist depression is a generic term which can be subclassi-
fied into specific conditions with clearly defined criteria and symptomatology. To the 
general practitioner, the word depression may have a somewhat less stringent definition, 
and to the patient, depression may simply refer to depressed mood, or feelings of sad-
ness. 
D S M - l l l - R characterises the essential features of depression as either persistent de-
pressed mood, or persistent loss of interest in all (or almost all) activities. Associated 
symptoms are disturbance in appetite (often resulting in deviations from normal 
weight), disturbance in normal sleep patterns, persistent feelings of restlessness or 
slowing down, uncharacteristic fatigue, inappropriate feelings of worthlessness or guilt, 
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reduction in the ability to concentrate, and recurrent thoughts of death or suicide 
(American Psychiatric Association, 1987). DSM-111-R lists chronic physical illness as 
a predisposing factor for a major depressive episode, and further notes that a major 
depressive episode may be "...a psychological reaction to the functional impairment 
associated with a physical illness that does not involve the central nervous system...". 
Psoriasis is a chronic physical illness and as such may predispose sufferers to an in-
creased risk of depression. To assess the magnitude of this increased risk, it is useful 
first to examine rates of depression in the general population and in the physically i l l in 
general. 
1.5.3.1 Depression in the general population 
There is some disagreement on the prevalence of depression in different populations, 
partly because different researchers choose to define depression using different criteria. 
Hall, Beresford & Blow (1987) note that the DSM-l l l classification Organic Affective 
Syndrome which has been used for some research, is inadequate because it excludes 
those individuals whose depression co-exists with other states such as cognitive im-
pairment, yet the criteria for inclusion are broad enough to encompass physical symp-
toms which may parallel those of depression, but which are due to a somatic disorder, 
e.g. weight loss and insomnia. This criticism can also be applied to the preferred as-
sessment instruments for detecting depression, in that they most usually focus on somat-
ic symptoms which may reflect physical conditions rather than dysthymic states. In-
deed, Snaith (1987) pointed out that 42% of items on the Hamilton Depression Scale 
examine physical symptoms that often relate solely to physical Ulness, and noted that 
other rating scales tend to follow the same pattern. He suggests that anhedonia (the 
inability to experience pleasure) is the most central indicator of depression. Problems 
with the measurement of the incidence and prevalence of depression are further com-
pounded because population characteristics tend to vary by geographical location (areas 
with predominantly middle class residents, for example, show lower depression rates 
than those with lower class residents, e.g. Brown & Hartis, 1978). 
With these restrictions in mind, Weissman & Myers (1978), for example, report that 
between 10 and 16% of males and between 20 and 24% of females in a variety of 
general population samples produce high scores on self-report depression measures. 
Classification using the Present State Examination (PSE), however, has suggested lower 
rates: 2.6% males, 6.7% females (Henderson et al 1979); 3.9% males and 7.4% females 
(Wing 1980). 
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1.5.3.2 Depression and physical illness 
Similar problems apply to assessing depression in general medical patients. One re-
viewer noted that estimates of the prevalence of depression in medical patients varied 
between 5% and 58% (Hall, Beresford & Blow, 1987). There is however, evidence that 
depression and physical illness tend to co-exist, particularly when the illness is chronic 
or severe. Stewart, Drake & Winokur (1965), for example, found that 27% of severely 
i l l in-patients were suffering from depression compared with 13% of those diagnosed as 
moderately to mildly i l l . Moffic & Paykel (1975) estimated these prevalence rates to be 
61% and 21% respectively in their sample. 
The relationship between depression and physical illness depends on several factors. 
The physical illness itself may stimulate the body to produce chemicals which affect 
emotional states: excess ACTH secretion by the pituitary gland in Cushing's disease, for 
example, is associated with a high incidence of depression (Smith, Barrish «&; Correa, 
1972). The treatment for a somatic condition may affect emotional states: Schoonover 
(1977), for example, has suggested that steroids may cause depression. The stress of 
day-to-day coping with chronic illness may also affect emotional states. On the other 
hand, depression may also affect the individual's ability to control their disease: de-
pressed mood and concomitant lowering of motivation may affect compliance with 
treatment regimens, which in turn lead to a worsening of the condition. 
To summarise, while estimates vary because of differing definitions, prevalence of 
depression in the physically i l l is higher than in the general population. 
1.5.3.3 Depression and psoriasis 
Several authors have investigated the link between psoriasis and depression. Results 
have been inconsistent, but some important findings have been reported. 
One of the earliest studies that attempted to isolate psychological characteristics of 
psoriasis sufferers administered the Maudsley Personality Inventory (MPI) and the 
Minnesota Multiphasic Personality Inventory (MMPI) to 13 consecutively admitted 
psoriasis in-patients and 13 control in-patients not suffering from chronic skin condi-
tions (Goldsmith, Fisher & Wacks, 1969). Tests were supplemented by a psychiatric 
interview. Psoriasis sufferers did score higher than confrols on the Neuroticism scale of 
the MPI, but both groups were within the range defined as "normal". The results of the 
MMPI were more complex. There was no statistically significant difference between the 
mean depression scores of the two groups, but interestingly the psoriasis group's mean 
(76.5) was above the level usually taken as indicating psychopathology (Anastasi, 
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1988): that is, the scales are standardised to have a mean of 50 and a standard deviation 
of 10 (usually referred to as T-scores), and a cutoff point of mean plus two standard 
deviations is used. The control group's mean was below this cutoff point (66.9). 
There was, however, a statistically significant difference between groups on the Hyste-
ria scale (psoriatic mean 71.2, control 60.5) and the Psychasthenia scale (69.5, 55.6). 
Hysteria, in the context of the MMPI scale, refers to a preoccupation with physical 
symptoms, but usually associated with a marked lack of depression or anxiety. Psychas-
thenia on the other hand is taken to be associated with low self-esteem, which would 
tend to support the depression scores. 
The MMPI was also used (in combination with the California Personality Inventory -
CPI) by Gilbert, Rodgers & Roenigk (1973) on a slightly larger sample of hospitalised 
psoriasis patients. Fifty consecutive in-patients were compared with two control groups: 
15 psoriasis outpatients and 15 dermatology in-patients not suffering from psoriasis. No 
statistically significant differences were found between the groups on the MMPI, al-
though the hospitalised groups scored slighdy higher than the outpatients on all scales. 
The authors explained the discrepancy between their findings and those of Goldsmith et 
al in terms of a larger sample size. This is not altogether convincing. It is equally possi-
ble that the samples were not comparable. Indeed, while little data are reported on the 
composition of Gilbert's psoriasis in-patient sample (the numbers of males and females 
are not given, for example), it is noted that three of the group were in fact clear of 
psoriasis and hospitalised only for liver biopsies (following methotrexate therapy). 
Gilbert's CPI results suggested that the hospitalised psoriasis patients exhibit lower 
social comfort, confidence, enthusiasm and commitment than the outpatients and the 
non-psoriasis in-patients. They interpret this as resulting in "sustained emotional ten-
sion" which may be associated with secondary psychological problems. They do not 
enlarge on these alleged problems. 
This area was examined further by Fava et al (1980) in their study of psychological 
distress in patients suffering from psoriasis, urticaria and fungal infections. Once again 
using in-patients (n=20 in each group), Fava et al used the 30-item Kellner-Sheffield 
Symptom Rating Test (SRT) to detect depression, anxiety, somatisation and inadequacy. 
They found a significant difference in total SRT scores between the psoriasis group 
(mean 18.5) and the fungal infection (11.0) group, and between the urticaria group 
(22.3) and the fungal infection group. The fungal infection group scored close to the 
reported cultural mean of 11.9. On the subscale that measures depression, the psoriasis 
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group had a mean of 0.52, the urticaria group 0.72, and the fungal infections group 
0.28. The difference between the groups was statistically significant. These findings 
suggest that hospitalised psoriasis patients have raised levels of depression which are 
not matched by patients with dermatologic conditions that are not thought to have a 
"psychosomatic" associations. 
Lyketsos et al (1985) also used urticaria (n=28) as a control condition for psoriasis 
(n=26), and included alopecia as a third condition (n=26): all groups were again in-
patients, as were a group of "non-psychosomatic" controls (n=38). Using the States of 
Anxiety and Depression Scale (SADS) they found that the psoriasis group scored very 
significantiy higher than the non-psychosomatic controls on depression (psoriasis mean 
5.7, control mean 0.4). Furthermore, they found 73% occurrence of "simple depres-
sion" on the Present State Examination in the psoriasis group, compared with 18% in 
the control group. These data suggest that psoriasis in in-patients is associated with 
raised levels of depression. 
Perhaps of more interest though, are the findings of Hardy & Cotterill (1982) who 
examined depression in a small sample of dysmorphophobics and psoriasis outpatients, 
rather than those hospitalised for their condition. Unfortunately their sample of dysmor-
phophobics comprised mostiy women (twelve out of fourteen), and their psoriasis group 
and a control group drawn from the general population were matched for sex. Further, 
one member of the psoriasis group was in fact hospitalised for psoriasis therapy. Never-
theless, Hardy & Cotterill found significant differences between groups on the Beck 
Depression Inventory (BDI). The dysmorphophobic group had the highest depression 
scores (mean 15.4), followed by the psoriasis group (9.1) and the controls (3.9). The 
psoriasis group's mean BDI score of 9.1 is borderline for minimal/mild depression (a 
cutoff score of 10 can be taken as the lower limit for probable mild depression; Beck, 
Steer & Garbin, 1988). This would suggest that psoriasis sufferers not hospitalised for 
their condition may have raised, but not clinically severe levels of depression. 
None of the studies reported above have examined the severity of psoriasis as an inde-
pendent variable. Gupta et al (1991) have examined the link between depression and 
psoriasis in more detail. This study has certain advantages over the many others in that 
it was a prospective study, evaluating symptoms of depression and disease severity over 
a period of a few weeks (the mean stay in hospital was 23.1 days), and in the Gupta 
study psoriasis was the only condition examined. It does, however have some limita-
tions. The sample was drawn from a hospitalised population, who might be expected to 
have raised levels of depression whatever their condition (e.g. McGuire et al, 1974). 
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Further, it is not reported how the measure of psoriasis severity, percent Total Body 
Surface Area covered, was arrived at (this point wi l l be discussed in more detail in 
Chapter 2). 
Nevertheless, Gupta's findings are interesting. He split 95 in-patients into three groups 
by the degree of response to therapy: low, moderate, and high. The changes in scores on 
the Carroll Rating Scale for Depression are given in Table 1.4. While there was no sta-
tistically significant difference between the pre-treatment levels of depression, there 
was a significant difference between the post-treatment scores. So while depression was 
not related to pre-treatment severity, it was related to the degree to which the psoriasis 
cleared. Gupta does not report the location of lesions (i.e. whether or not they fall 
mainly on visible areas), but the likelihood is that the psoriasis would be fairly genera-
lised to warrant hospitalisation. These findings suggest that depression may be more 
easy to detect in patients with severe psoriasis than in those whose condition is relative-
ly mild. 
T A B L E 1.4 Change in depression scores with change in psoriasis severity. Scores 
given are means and standard deviations (from Gupta etal, 1991) 
Effectiveness of Treatment Initial depression scores Change in depression scores 
Low 13.2 (±10.5) 3.6 (±5.8) 
Medium 13.6 (±7.7) 4.5 (±4.3) 
High 15.1 (±7.9) 7.6 (±7.2) 
More recently Price, Mottahedin & Mayo (1991) have investigated the effects of stress 
reduction techniques on the course of psoriasis and on depression, anxiety (see below) 
and self-esteem. One group of 11 subjects attended eight therapy sessions, another 
group of 12 patients acted as controls. They were assessed three times for levels of 
anxiety and depression on the Hospital Anxiety and Depression Scale (HADS) and for 
self-esteem using an eight-item scale devised by O'Malley & Bachman (1979). The first 
assessment was prior to any group sessions, the second after an 8 week course of group 
therapy, and the third at a six month follow-up. Psoriasis severity was rated on a visual 
analogue scale completed by the patient and the dermatologist. The patients in this 
study on the whole scored low on the depression scale of the HADS, but there was a 
decrease in depression scores in the therapy group from 4.0 to 3.1 which was not 
matched in the conti-ol group (4.1 to 4.8). 
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To summarise, in general psoriasis inpatients have raised levels of depression, but the 
evidence for raised levels of depression in psoriasis outpatients is inconclusive, and the 
depression reported does not reach clinical levels. Two studies have shown that that the 
level of depression tends to vary as the disease varies. 
1.5.4 Anxiety 
Anxiety is a normal emotional reaction to everyday stimuli. It is not the presence or 
absence of anxiety reactions per se that is clinically important, rather it is the severity of 
those reactions and the frequency of their occurrence that is of interest. 
Izard (1972) proposes that anxiety can be thought of as a combination of emotions; the 
fundamental emotion of fear, plus two or more of distress, shame, anger and interest-
excitement. In Izard's formulation, anxiety is composed of three components: neuro-
physiological, behavioural-expressive, and subjective. The neurophysiological compo-
nent is indicated by the physical changes that accompany anxiety: raised heart rate and 
blood pressure, for example. The expressive component is made up of the overt beha-
vioural changes that accompany anxiety, such as pacing and agitation. The subjective 
component refers to psychological distress that can occur in the form of thinking uncon-
trollable tiioughts and imagining terrifying scenes. 
Cognitive theorists (e.g. Lazarus & Averill, 1972) suggest that anxiety occurs only once 
a situation has been cognitively appraised as threatening in some way. Izard does not 
accept this position, pointing out that cognition is itself influenced by emotional states, 
and that the assertion of the primacy of cognition as antecedent to anxiety does not take 
into account the interaction between feelings and rational appraisal. 
Epstein (1972) has reviewed the various conceptions of the nature of anxiety and dis-
tinguishes three different causes. Primary overstimulisation leads to anxiety when the 
individual's limit of tolerance to a stimulus is exceeded. Epstein proposes that this limit 
is biologically determined and is independent of other environmental factors such as 
cognitive appraisal. His second class of causes of anxiety, cognitive incongruity, refers 
to the situation where the individual is not able to integrate a situation into their particu-
lar schema of the world, and his third, response unavailability, refers to those situations 
where a response to a stimulus cannot be effected - because the response is not in the 
individual's repertoire, for example, or the object producing the anxiety is unknown to 
the individual. These three categories are causes of state anxiety. 
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1.5.4.1 State and trait anxiety 
A distinction can be made between feelings of anxiety that are transitory and the under-
lying predisposition to experience anxiety. Cattell & Scheier (1960) have termed these 
two factors state and trait anxiety respectively, although Spielberger (1966) is generally 
credited with popularising the terms and was responsible for developing the State Trait 
Anxiety Liventory for their measurement. 
Spielberger's theory of Trait-State Anxiety can be summarised as follows (Spielberger, 
1972). An individual will experience a state anxiety reaction ("A-state") when con-
fronted with a situation that is appraised as threatening. This reaction wUl be perceived 
as unpleasant, be proportional to the perceived amount of threat, and persist as long as 
the situation is perceived as threatening. Defence mechanisms, either behavioural or 
psychological, will be initiated in the presence of A-state, and may develop into specific 
coping mechanisms which reduce A-state. Further, individuals who are high in trait 
anxiety (A-trait) wi l l perceive A-state provoking situations as more threatening than 
those low in A-trait. This predisposition can be thought of as learned, building on prior 
(particularly childhood) experiences. 
State anxiety is characterised by heightened psychological arousal, observable physio-
logical reactions such as sweating or trembling, internal physiological reactions such as 
raised heart rate, blood pressure, breathing and gastrointestinal changes, and gross 
motor behaviour such as "freezing" or agitation. In short, by those universally accepted 
symptoms of the typical anxiety reaction. 
Trait anxiety on the other hand is somewhat more problematic. Spielberger conceptua-
lises trait anxiety as an individual's latent predisposition to perceive a wide variety of 
situations as threatening and to react to those threats with anxiety symptoms. Spielber-
ger therefore regards the person as most important. Other theorists (e.g. Endler, 1975) 
propose that the situations which evoke anxiety responses are more useful descriptors 
of trait anxiety, and argue that a composite of specific state anxiety provoking situations 
provides a more useful indication of trait anxiety. This does not appear to be a particu-
larly useful approach since the range of anxiety-producing situations is so large. Spiel-
berger's conception of a general trait offers more generalisable hypotheses. 
For the purposes of this research state anxiety will refer to the transitory, observable (or 
reported) symptoms of anxiety experienced in specific situations; trait anxiety, follow-
ing Spielberger, will refer to a latent predisposition to experience state anxiety. Appro-
priate measures of state and trait anxiety will be discussed in chapter three. 
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1.5.4.2 Cognitive and somatic anxiety components 
Building on the notion that anxiety is not a unitary phenomenon, several authors have 
argued that anxiety tends to present primarily in one of two different ways for different 
people (e.g. Buss, 1962; Steptoe & Kearsley, 1990), and that the primary type of anxie-
ty presentation might properly be explored as the most effective target for therapy 
(Lazarus, 1973). To this end, it has become useful to distinguish between feelings of 
anxiety which can best be termed cognitive, and those which can be termed somatic. 
These two distinctions correspond broadly to Izard's subjective component on the one 
hand and his neurophysiological and behavioural-expressive components on the other. 
Hamilton (1959) identified two components of anxiety reactions by factor analysis, 
which he termed psychic and somatic, and Barratt (1972) reports the results of his item 
analyses of questions on anxiety measuring instruments as two clusters: one represent-
ing the awareness of somatic changes and the other representing the awareness of 
unpleasant feelings. These two facets of anxiety symptoms can be interpreted in terms 
of the broader theory of "individual response stereotypy" proposed by Lacey & Lacey 
(1958), who demonstrated that individuals tend to respond to different stressors with 
consistent and stereotypic physiological arousal symptoms. 
To summarise, anxiety is not a unitary phenomenon. The transient emotions and physio-
logical reactions associated with anxiety can be termed state anxiety, while the latent 
predisposition to experience state anxiety in a range of situations can be termed trait 
anxiety. Individuals report responding to anxiety provoking situations with symptoms 
which can be described as primarily cognitive and those which can be described as 
primarily somatic. 
1.5.4.3 Anxiety and psoriasis 
Fava et al (1980) used the Anxiety subscale of the Kellner-Sheffield Symptom Rating 
Test (SRT) with hospitalised psoriasis patients. On the subscale that measures anxiety, 
the psoriasis group had a mean of 0.76, the urticaria group 0.91, and the fungal infec-
tions group 0.48. The difference between the groups was statistically significant. Simi-
larly, in the Lyketsos et al (1985) study (see above) the psoriasis group scored very sig-
nificanUy higher than the non-psychosomatic controls on the anxiety scale of the SADS 
(psoriasis mean 7.1, control 0.8) - once again the sample was drawn from inpatients. 
Price et a/ (1991), using the HADS, found that the patients on the whole scored moder-
ately high on the Anxiety scale of the HADS. Price et al point out that 26% of the pa-
tients could be categorised as definite cases of anxiety on HADS criteria (mean psoriasis 
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therapy group 8.9, psoriasis controls 9.2). Examining the trend in anxiety scores over 
time, those authors showed that anxiety in the therapy group decreased, and at six 
months differed significantiy from the control group. They also note that psoriasis in the 
therapy group appeared to clear more than the control group, but this was not statistical-
ly significant. However, the measure of disease severity was, as the authors point out, 
extremely crude, which may obscure any trend here. 
Using the depression-anxiety subscale of the Structured and Scaled Interview to Assess 
Maladjustment, Baughman & Sobel (1977) categorised 15% of psoriasis patients 
(n=48) as having minimal anxiety, 12% as mild and 6% as moderate. They did not 
attempt to relate these ratings to the disease severity, but in a prospective study of stress 
and psoriasis, Gaston et al (1987) employed as one of their measures the Psychological 
Distress subscale of the Psychological Adjustment to Illness Scale, which measures 
anxiety and depression. Using a time-series design with five patients, the authors found 
a significant correlation between psoriasis severity (measuring the scalp only) and 
psychological distress. 
To summarise, most researchers have reported that both in- and outpatient psoriasis 
sufferers have raised anxiety levels. Two studies have shown that anxiety is related to 
change in the severity of psoriasis, but in one of those the method of measuring severity 
was crude, and in the other only the scalp was assessed. 
1.6 Conclusions and hypotheses. 
Both Hughes et al (1983) and Wessely & Lewis (1989) found high prevalence of psy-
chiatric "cases" in dermatology outpatients, but neither of those authors examined rates 
specific to psoriasis. The first hypothesis to be examined in the study reported in Chap-
ter 3 is therefore that more psoriasis outpatients will present as "cases" than controls. 
Patients reports about their psoriasis indicate that they feel very embarrassed about visi-
ble lesions and that they feel this effects their social and work experiences. Studies 
which have examined depression in psoriasis patients have for the most part concentrat-
ed on those hospitalised for their condition and have consequentiy found levels above 
those in the general population, but have also found that psoriasis in-patients tend to be 
more depressed than general medical in-patients. Those few studies which have used 
psoriasis outpatients have provided inconclusive evidence about whether they are more 
depressed than controls. Those that have found raised levels have found that they have 
not reached standard criteria for clinical depression. Psoriasis in-patients appear to have 
unusually high levels of depression, yet only two studies have attempted to link depres-
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sion levels to disease severity (Gupta et al, 1991; Price et al, 1991). Gupta used in-pa-
tients as his subject group, all of whom had severe psoriasis, and it has not yet been 
demonstrated in an out-patient sample whether this link still holds for less severe pso-
riasis. This is the second general aim of the research reported in the following chapters. 
Closely linked to levels of depression are levels of self-esteem. Psoriasis sufferers 
report severe embarrassment over their condition, as well as feelings of shame and guilt. 
The results of Ginsburg & Link (1989) suggested that psoriasis sufferers may have low 
self-esteem, which varies with the length of time they have had the condition. However, 
while Ginsburg's results were suggestive of low self-esteem, their work was primarily 
concerned with feelings of stigmatisation, and no other research has addressed specifi-
cally the question of whether or not self-esteem is affected in psoriasis. This, then, is the 
third general aim of the current study. There is limited evidence that psoriasis outpa-
tients are more anxious than controls, and the studies which have attempted to ascertain 
whether anxiety varies with the severity of the condition do not use adequate means of 
assessing severity. Confumation of the relationship between disease severity and anxie-
ty is the fourth general aim of this research. 
In summary, levels of depression, anxiety and self-esteem are to be assessed, together 
with the severity of the condition. It is hypothesised that more severe psoriasis will be 
associated with higher levels of depression and anxiety, and lower levels of self esteem. 
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2.1 Introduction 
To examine any relationship between psychological variables and the severity of pso-
riasis a reliable and valid means of assessing severity must be used. The first part of this 
chapter reviews the existing means of assessing psoriasis severity. The second part of 
this chapter describes the development of a computer program to give an objective 
means of recording and assessing psoriasis severity, and reports on its validity and reli-
ability. 
2.2 Psoriasis severity 
The "severity" of psoriasis is a nebulous concept whose definition is dependent upon 
the purpose of the investigation. The dermatologist may be interested in primary clini-
cal signs such as thickening, scaling and erythema and how these change as the disease 
progresses. Researchers whose interests lie in the genetic control of lesion positioning 
information (e.g. Goudie, Spence & Sconthorne, 1980) may be less interested in clinical 
signs but more interested in the distribution of psoriasis lesions over the body, while 
psychologists interested in the effect of psoriasis on psychological variables may re-
quire a measure of psoriasis severity that focuses primarily on the area of coverage, or 
on the area of coverage on visible body regions. The patient, on the other hand, may 
regard pain and discomfort, or feelings of embarrassment associated with the appear-
ance of the condition as the most important indicators of severity (e.g. Baughman & 
Sobel, 1970). 
These different standpoints lead in practice to different assessment strategies and the 
use of a range of technical aids. In a study of the assessment strategies used by derma-
tologists, Marks and his colleagues (1989) undertook a survey of all published papers 
which reported a clinical assessment of psoriasis in the British Journal of Dermatology, 
Clinical and Experimental Dermatology, Archives of Dermatology, and the Journal of 
the American Academy of Dermatology for the years 1985 and 1986. In the thirty 
papers they reviewed, they confirmed that a wide variety of techniques were being 
used, measuring a range of different features. These fall broadly into two categories: 
assessment of clinical signs, and assessment of area of coverage. 
2.2.1 Assessment of clinical signs 
Mechanical and electronic aids are available for assessing clinical signs, but they can be 
expensive and unwieldy to use, and have not always been shown to provide valid and 
reliable results. 
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Reddening (erythema) can be assessed by matching skin colour to standard colour 
patches, but as yet no standard colour grading has been defined, making comparisons 
between studies difficult. Another method which has been refined recentiy for dermato-
logical use is refiectance spectrophotometry. Diffey, Oliver and Farr (1984) have de-
signed a relatively compact instrument capable of measuring reddening, which pro-
duces an "erythema index" with a reported coefficient of variation of 3% when used 
repeatedly on a single site. While the accuracy of this instrument is impressive, it is not 
yet commercially available, requires specialist training to operate, and although its size 
is more acceptable than previous instruments (e.g. that described by Wan, Parrish & 
Jaenicke, 1983), it is still too cumbersome for use outside the hospital environment. 
Scaling (desquamation) has been measured in a variety of ways, none of which are 
entirely satisfactory. One method is to cover a lesion with sticky tape then pull the tape 
off. The scales stripped away can then be assessed: either visually or by weight. Clearly 
this is quite unpleasant for the patient and the resulting figures are difficult to evaluate. 
A more accurate method has been developed by Marshall & Marks (1983) using densi-
tometric assessments of macro photographs of skin lesions. While they have shown that 
scaling can be assessed by this method, it does suffer from the drawbacks of requiring 
specialist equipment, trained operators, and standardised lighting conditions, and the 
results are not available until the photographs have been processed and densitometrical-
ly analysed. 
Thickening of the skin can be measured accurately by high resolution ultrasound (e.g. 
Tan, Marks & Payne, 1981) or by "pinch" callipers (e.g. Dykes, Frances & Marks, 
1976). Ultrasound equipment is very expensive and cumbersome, but measurement 
with callipers is relatively easy and quick for large lesions. However, callipers are diff i-
cult to use on small lesions because the skin needs to be folded at 180°; psoriasis lesions 
are often small, making this technique unsuitable. 
Because of the drawbacks of these techniques, most clinicians have tended to rely on 
visual ratings of clinical signs on three-, five- or seven-point scales. I f the purpose of 
estimation is to evaluate subtie changes in the skin brought about by the application of 
different treatments, this approach may not be appropriate. However, for a general 
measure of disease severity, rating erythema, scaling and thickness as mild, moderate or 
severe (for example) does provide adequate assessment. 
While not a primary clinical feature of psoriasis, itch (pruritus) is sometimes assessed as 
part of a measure of severity, and mechanical instruments are available for the indirect 
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measurement of itch through the measurement of scratching. Summerfield and Welch 
(1980) have used a wrist-watch type meter for measuring scratch, and Felix & Shuster 
(1975) developed a bed that purported to measure scratching by measuring limb 
movement. Part of the problem with these measuring techniques is that limb move-
ments may not in reality correlate with scratching nor, in turn, with itch. Generally, 
those researchers who have assessed pruritus in psoriasis patients have relied on self-
report measures. 
Ten papers attempted to assess reddening by visual estimation on scales ranging from 
three points to seven points. Scaling and thickening were assessed on three- to nine-
point scales in eleven papers. The authors note that only two articles made any attempt 
to operationalise reddening or scaling. Itch was assessed on similar scales in four stud-
ies. 
To summarise, the clinical signs of erythema, scaling and thickening can be assessed 
accurately in principle, but Marks' review of the literature has shown that in practice, if 
they are assessed at all, a simple rating scale is used. It may be possible to relate scratch 
to the symptom of pruritus, but this may not give reliable results. Pruritus is most often 
assessed by patient self-report. 
2.2.2 Area of coverage 
In Marks' review, while all included some form of assessment of area of coverage, only 
nine out of the thirty studies assessed the total percentage of the body covered by pso-
riasis: the remainder assessed coverage at between one and seven sites. In general, 
techniques for the assessment of the area of psoriasis lesions fall into three categories: 
patients' descriptions, physical measurement, and visual estimation. 
Patients' verbal descriptions provide an estimate of psoriasis coverage which may be 
used when the specific extent of psoriasis is not required but the distinction "present" or 
"not present" is important, but they are inherentiy inaccurate. Patients may not be able 
to see their psoriasis, and indeed may not be aware that they have any psoriasis at all on 
hidden parts of the body, particularly i f they are not treating the psoriasis themselves. 
Methods are available for the physical measurement of skin lesions. An indkect meas-
ure of area of coverage that has been used involves the researcher tracing lesions onto 
clear f i lm then measuring the traced areas. While this does provide quite accurate 
information, it is very time consuming and unpleasant for the patient. A similar tech-
nique is to draw the psoriasis on standard templates, then to measure the area from these 
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templates (e.g. Farber & Nail 1968, 1974). This is most often used in hospital settings 
to keep records of disease progress. Instruments which measure directly the dimensions 
of skin lesions are available (e.g. callipers or stylus tracking), but are time-consuming in 
use and unpleasant for the patient. One accurate method of measuring the area of cover-
age of skin lesions is planimetry: computerised digital image analysis. Photographs of 
affected body parts are projected onto an image analyser digitising tablet and the result-
ing data gives information on the area covered by psoriasis (e.g. Marks et al, 1989). The 
major problem with planimetry for dermatological assessment is that subjects must be 
photographed under standardised lighting conditions, which is seldom practical outside 
the hospital environment. 
To summarise, area of coverage can be measured by a variety of means, but available 
methods are either inherentiy inaccurate or impractical outside the hospital environ-
ment. 
The most widely used method of estimating the area of coverage of psoriasis is visual 
assessment by the clinician. Most often this takes the form of simply looking at the 
affected area and estimating a percentage coverage. However, two variations on this 
approach are sometimes used. Wallace (1951) suggested a strategy using the "Rules of 
Nine" procedure, whereby visual estimates of coverage are made on different body 
regions, which in turn are taken to represent fixed percentages of the total body area. 
The head and each arm are each taken to represent 9% of the total body area respective-
ly, while the torso front and back, and each leg represent respectively 18%. The genital 
area represents 1%. Estimates for each area are combined to give a total body coverage 
figure. Another estimation strategy uses the premise that the hand approximates 1% of 
the body area. Coverage estimates are made by assessing lesion size against hand size 
(e.g. Stem et al, 1986). Marks' study has demonstrated that these estimation strategies 
are seldom, i f ever, used in practice, and they still require the rater to assign numerical 
values to lesion areas. This is the heart of the problem of area estimation in psoriasis. 
2.3 General evidence for problems with visual area estimation 
Regardless of the strategy used, there are certain problems inherent in area estimation 
which suggest that visual ratings are likely to be inaccurate. Psoriasis lesions are most 
often discoid or of polycyclic outline due to expansion of several lesions to form one 
large plaque, and the evidence reviewed below suggests that raters are not able to 
estimate accurately the true area of disks. This is supported by further evidence, also 
reviewed below, that in a clinical situation, estimation of the area of coverage of psoria-
sis, even by trained dermatologists, does not provide reliable results. 
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23.1 Psychological evidence for problems with visual area estimation 
A great deal of research has been undertaken in the field of cartography on the percep-
tion of the area of disks used as map symbols, a problem directiy analogous to estimat-
ing the area of psoriasis lesions on the body. Much of the work can be traced back to 
Stevens (1957), and to Fechner before him (1877, quoted in Stevens, 1957), and starts 
from the observation that perceived area (in general, but also disk area in particular) is 
proportional to true area raised to some power. In Stevens' terms: 
where *F is the perceived area, S is the true area, k is some constant appropriate to the 
scale of measurement, and n is the power coefficient. This leads in practical terms to the 
assumption that true area can be calculated from estimated area i f only the appropriate 
power coefficient is known. It is from here that the cartographic literature proceeds, 
with several studies attempting to discover a power coefficient associated with judg-
ments of disk area. Several studies have reported empirically derived power coefficients 
for disk area estimation and these are reported in Table 2.1. 
Table 2.1 Power coefficients derived by empirical studies into the reiationship 
between perceived and true stimulus size using circles or 6\sks. 
Source Power Coefficient 
Ekman, Lindman & William-Olsson (1961) 0.80 
Ekman, Bergstrom & Kuennapas (1956) 0.86 
Flannery (1971) 0.87 
Crawford (1971) 0.91 
Ekman & Junge (1961) 0.98 
Ekman &Junge (1961) 0.99 
Ekman & Junge (1961) 1.05 
MacDonald-Ross (1977) in an extensive review of techniques for the visual presenta-
tion of data suggested that these coefficients represent "quite good agreement, consider-
ing all the problems that beset the researcher" (p.373). However, when they are trans-
lated into predicted estimates of frue area over an appropriate range, the difference be-
tween the functions is quite pronounced (Figure 2.1), and even the mid-range coeffi-
cients do not give comparable results at larger true areas. Therefore, in the absence a 
reliable, universal power coefficient linking perceived area to true area, it is not possible 
simply to apply a correction calculation to estimates of disk area in general. 
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Figure 2.1 Plots of the relationship between perceived size and stimulus size at a 
range of empirically derived power functions (n). 
100 
80 
3 60 
N 
i 
40 
o 
Q. 
20 
n=1.05^.^ 
n=0.99 / 
/ . / 'n=0 .98 
-^.•'^ n=0.91 
n=0.87 
•;-'-n£0.86 
...-••••••n=0.80 
• ^ . - -
20 40 60 
Stimulus Size (Units) 
80 100 
There is further evidence from cartography to suggest that perception of disk area may 
be problematic. Meihoefer (1969) presented untrained subjects with a range of circles of 
differing sizes distributed at random on a white page, and asked them to estimate the 
area of each circle relative to a standard circle. His results suggested that while subjects 
indicated that they thought their estimates were precise, in fact they were quite poor at 
estimating areas, particularly if the circles were relatively similar in size. Further, larger 
area variations were required for subjects to perceive differences between larger circles 
than smaller ones. Perhaps more importantiy, the estimate errors were distributed over a 
wide range and did not follow any pattern of under- or over-estimation. Meihoefer does 
not offer any measure of the distribution of his data, but his plots of responses to the six 
test areas do indeed show wide variation. 
These results were subsequentiy replicated by Meihoefer (1973) for filled circles 
(disks), but in an important extension of his work he showed that even though subjects 
were not able to estimate absolute area accurately, they were able to match one disk 
size to another. That is, when subjects were required to choose matching circles, they 
accurately chose circles that matched standard legends. Meihoefer evaluated perform-
ance on this task by plotting errors of estimation, and his plots confirm that almost all 
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the estimation errors were close to zero. Unfortunately, Meihoefer does not report his 
raw data and does not analyse these errors statistically other than reporting a mean and 
mode error of zero, but notes that "these results are so strikingly conclusive that statisti-
cal analysis of these tests would be redundant" (p.78), and that 95% of his sample 
perceived matched circle sizes correctly. 
One question that arises from this research is whether a more precise correction coeffi-
cient can be obtained i f subjects are trained in estimating area and given suitable feed-
back about their errors. This was examined by Olson (1975), who compared subjects 
estimates of relative circle areas before and after training on labelled pairs of circles. 
His results were interesting and inconclusive. While the power coefficient before train-
ing was 0.71, after training it rose to 0.97, which represents a clear improvement and a 
final coefficient quite close to unity. However, while the power coefficient (which was 
based on the median ratings) did improve, the distribution of estimates (reflected in the 
interquartile ranges) appeared to worsen after practice, and for half the circles the range 
of estimates increased after practice. Olson concluded that practice does not, therefore 
improve the precision of estimated area of coverage. 
To summarise, psychological theory (e.g. Stevens, 1957) predicts that perceived circle 
or disk area will be related to true area by a power function, but empirical evidence has 
failed to ascertain a reliable power coefficient to allow corrections to area estimations to 
be made in circle and disk studies. While the median estimate of area better approxi-
mates the true area after practice, the spread of estimates actually increases after prac-
tice. 
There is reason to suggest, therefore, that estimates of area of coverage of psoriasis 
(which presents as disks on the body) are unlikely to be either consistent or accurate. 
2.3.2 Direct evidence for problems with visual area estimation in psoriasis studies 
In order to ascertain whether trained clinicians were able to assess area of coverage in 
psoriasis accurately and consistently, Marks et al (1989) investigated area estimation in 
a more practical setting. They chose to examine the relationship between assessed area 
of coverage and true area of coverage on colour transparencies of psoriasis patients. By 
adopting this strategy they were able to obtain a planimetric assessment of the actual 
area that was covered on the transparency and compare that with clinicians' estimates of 
the area of psoriasis on the transparency. They compared the assessments by four expe-
rienced clinicians of the area of coverage of psoriasis on ten patients, both against the 
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planimetric values and against each other. The results for the assessed percentage of the 
area involved and the planimetric assessments are summarised in Table A2.1 (Appendix 
1). Marks et al do not report planimetry and estimates for individual transparencies; 
rather they report figures for body regions, which are composites of several transparen-
cies ("Legs", for example is a composite of two transparencies - front and back). 
Marks et al chose to analyse their data using Friedman two-way analysis of variance in 
order to avoid assumptions of homogeneity of variance and normality of scores. Their 
analysis showed the rank ordering of area of coverage by each clinician to be signifi-
cantly different (p<0.001). They also tested whether clinicians varied in the amounts by 
which their estimates differed from the true (planimetric) values, i.e. in difference 
scores. Again, they used a non-parametric statistic (Kruskal-Wallis) and found a signifi-
cant difference between raters. However, parametric statistics supply more useful statis-
tical information, since it is the size of errors that is more important than the ranking of 
estimates. 
The data were reanalysed by the author using GLIM 3.77 to produce regression models 
for each clinician: the results are presented in Table 2.2. The estimated area and plani-
metric values are plotted in Figure 2.2, together with the regression lines for each clini-
cian. 
Table 2.2 Coefficients and residual errors from regressing estimated area on 
planimetric area for 4 clinicians assessing 25 body regions. The t-test for 
the intercept tests for a significant difference from zero; the t-test for the 
slope tests for a significant difference from 1 . 
Clinician Intercept S.E. t sig Slope S.E. t sig Residual SS 
1 1.87 1.50 1.25 - 1.074 0.074 1.00 - 755.8 
2 9.79 2.37 4.13 <0.001 1.12 0.12 1.03 - 1897.4 
3 -0.42 0.93 -0.45 - 0.79 0.046 -4.60 <0.001 291.1 
4 1.78 1.26 1.41 _ 0.94 0.062 -0.96 - 540.0 
The question is how each clinician performs in estimating area of coverage. This can be 
divided into two issues: how accurate are the mean estimates from each clinician, and 
how large are the errors around the mean? 
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Figure 2.2 Regression of estimated area of coverage on planimetric values for 
four clinicians (original data from Marks etal, 1989). 
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Mean accuracy was determined by regressing the estimated area on the planimetric area 
for each clinician. The regression line is unbiased even though the data are not normally 
distributed with constant variance. From the regression coefficients for each rater given 
in Table 2.2 it can be seen that the intercept for clinician 2 is significantiy greater than 
zero. Al l slopes are clearly significantly different from zero, but the slope for clinician 3 
is also significantiy different from unity. The other slope coefficients are not significant-
ly different from unity. Thus, of the four clinicians tested in Marks' study, one tended to 
overestimate by about 10%, one tended to underestimate larger areas, and the other two 
estimated area quite accurately. The mean intercept for all clinicians is 3.25 (SD 4.48), 
the mean slope is 0.98 (0.15). The regression lines for the four clinicians are plotted 
together in Figure 2.3 as deviation from planimetry against planimetric value. 
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Figure 2.3 Regression of difference between estimate and pianimetry on planimetric 
value for eacii of four clinicians (original data from Marks et al, 1989). 
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A measure of the variability of each clinician's estimations is the residual sum of 
squares (RSS) around the regression lines. These are presented in Table 2.2 and it can 
be seen that there are considerable differences between clinicians. Taking the extremes, 
the RSS for clinician 2 is 6.5 times greater than the RSS for clinician 3. Without ^55 
values from other studies, it is not possible to ascertain whether these values represent 
good or poor responses. However, given the wide range, it can be seen that individual 
clinicians do vary considerably in the precision of their estimates. 
Inspection of the plots in Figure 2.2 suggests that the variance of estimates is not equal 
at all planimetric levels. Appropriate transformations require that the variance be pro-
portional to the mean, and examination of coefficients of variation should reveal no 
systematic trends i f this is the case. The coefficients of variation are plotted against 
mean estimate in Figure 2.4, and it can be seen that this is not the case with Marks' 
data. Thus, since the variance of estimates is neither constant nor proportional to the 
mean estimate, no simple transformation is appropriate for these data. 
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Figure 2.4 Coefficients of variation for each body region plotted against mean 
estimate of area of coverage (original data from iVIarlcs ef a/, 1989). 
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To summarise, from Marks' data it cannot be concluded that clinicians are able to 
estimate area of coverage of psoriasis accurately - only two out of four clinicians were 
able to produce estimates that did not differ systematically from the true values. Further, 
there is no consistent pattern to the spread of estimation errors, suggesting that raters are 
not precise in their estimates. So, psychological and cartographic evidence suggests 
strongly that the perception of disk area is not accurate when subjects are required to 
assign values, but that individuals can reliably match one patch to another. Direct 
evidence shows that dermatologists do not rate area of coverage of psoriasis either 
accurately or consistently. Thus, before area of coverage in psoriasis can be used as an 
independent variable, a more valid and reliable means of assessing area of coverage 
must be found. 
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2.4 Computer aided visual assessment 
Based on the evidence (above) that stimulus disks can be matched accurately to tem-
plate disks, it was decided to write a computer program which would allow representa-
tion of psoriasis lesions on a V D U showing pictures of body regions. The program, 
rather than the rater, could then calculate the area of coverage of those patches, thus 
avoiding the estimation stage of area of coverage assessment. A computer was chosen 
for this task for several reasons. First, while accurate methods of assessing area of 
coverage are available - e.g. planimetry (see above) - they require specialist equipment 
which is not generally available. Marks (1985) and Marks et al (1989) have urged 
researchers to use the same or comparable measures of psoriasis severity (of which area 
of coverage is a major component) so as to facilitate comparison of results between 
studies. In keeping with the spirit of this request, planimetry was rejected as a general 
means of assessing area of coverage in favour of a computer-based method. This also 
guided decisions about the type of computer the program would support. At the time the 
program was written, the most popular P C configuration comprised an 8086 (or at best 
80286) processor, C G A graphics adaptor and 5 1/4 inch floppy disk drives. The program 
was therefore written to best use this configuration. 
The second reason for choosing a computer for assessing mapped areas was that its use 
requires no specialist skills, other than basic familiarity with P C operation. Thus, 
minimal instruction or training are necessary for any researcher or clinician to use the 
program in their work. The third reason relates to more pragmatic concerns about data 
collection in general. Collecting information directly onto a computer removes two 
stages from the data collection and analysis process: data coding and data entry. Both of 
these stages, apart from being time consuming, increase the possibility of introducing 
errors. Their avoidance removes this possibility. 
The development and validation of the computer program - to be called S K I N M A P - is 
described below. 
2.4.1 Outline of the SKINMAP computer program 
The purpose of S K I N M A P is to facilitate accurate assessment of the area of coverage of 
skin lesions in general, and those in psoriasis in particular. The program was designed 
so that the computer draws body shapes on the screen then allows the user to position 
representations of psoriasis (or any other skin lesion) in appropriate places on the 
screen. The computer then calculates the area of coverage based on pixel areas and 
stores this to disk. Since clinical signs can be an important part of assessing disease 
severity in psoriasis, S K I N M A P was designed also to allow recording of assessments 
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made by either visual rating or by electronic measurement, of other disease-characteris-
tic features such as reddening, thickening and scaling. Provision was made for S K I N M A P 
to combine these diverse assessments into a single "severity" figure (for example, the 
P A S I score proposed by Fredriksson and Pettersson, 1978), with the exact calculations 
specifiable by the user. This program was conceived such that it could be used in a 
variety of clinical and research settings, so a further section of the program was de-
veloped to facilitate clinical comparisons of disease progress which allows visual pre-
sentations of previous assessments simultaneously on the screen. 
In short, while the immediate purpose of S K I N M A P was to assess area of coverage in 
psoriasis sufferers, it was designed to be a general purpose assessment tool for dermato-
logical use. 
2.4.2 SKINMAP program development 
Since the research presented in this thesis was to involve assessing psoriasis patients in 
then- own homes, it was essential that S K I N M A P be able to run on a portable "lap-top" 
computer. This immediately imposed certain restrictions on the design of the program. 
First, the update time on available LCD-based screens at the time the program was writ-
ten was relatively slow, so screen modifications needed to be kept to a minimum. 
Second, disk storage was limited, so saving screens as "bit-mapped" images was not 
feasible, and third, disk access was slow and consumed a relatively large amount of 
power, so for efficient operation and reasonably long battery life, disk access needed to 
be kept to a minimum. These were the guiding factors in program development. 
S K I N M A P was written in Turbo Prolog® and Assembly Language (for reasons of copy-
right protection a program listing is not appended). Turbo Prolog was chosen as the 
main programming language for two reasons. First, it has well developed and powerful 
external database functions which facilitate rapid and safe storage and retrieval of data. 
Second, it has advanced graphics capabilities built into the language as standard predi-
cates. It does have the disadvantage of producing executable code with a high program 
overhead, so executable programs tend to be very large in Turbo Prolog, but this was 
acceptable in the light of the considerable advantages it offers. In the first developmen-
tal version of S K I N M A P , all operations were executed through Turbo Prolog predicates. 
After testing however, it became clear that some operations were simply too slow, so in 
the second version (used throughout this thesis) those functions were replace with 
Assembly Language routines - counting a screen full of pixels, for example. The graph-
ics mode selected by S K I N M A P is 640 x 200 pixels in either C G A or E G A A ' G A mode, 
depending on which adaptor it detects. There is no significant visible difference be-
tween the adaptors at this resolution. 
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2.4.3 Representation of body regions 
A variety of body representations were tried in order to find the most useful way of 
displaying different regions. The first set used in version 1 of S K I N M A P comprised 
highly stylised line drawings using a minimum of straight lines to outline a filled 
polygon - which formed the body shape. Contours were added to the body regions with 
straight lines. While this approach did facilitate very rapid drawing of the regions onto 
the L C D screen, they tended to look too artificial and "mechanical". Consequently in 
version 2, line drawings from biological textbooks were converted into filled polygons, 
again with contours represented by straight lines. The areas represented were arms 
(front and back), hands (front and back), legs and feet (front and back), torso (front and 
back) and face. Androgynous shapes were chosen to avoid the necessity of duplicating 
body regions for males and females. An example of a typical body region (with psoria-
sis patches drawn) is shown in Figure 2.5. 
2.4.4 Representation of psoriasis lesions 
Psoriasis lesions are represented by filled ellipses which can be varied in size and 
moved over the body region by use of a mouse or the cursor keys. Large psoriasis 
patches tend to be polycyclic, and these can be built up from smaller ellipses. 
2.4.5 Method of operation 
Before any mapping can be performed, the patient's identifier (which may be their 
name, but for the sake of confidentiality may be some other alphanumeric identifier), 
date of birth, and sex must be entered. Within the database, each patient is uniquely 
identified by a composite of their identifier, date of birth and sex. If a previous record 
for the patient exists, the new record is appended to the database chain associated with 
that patient, i f not, a new database chain is created. The first screen of S K I N M A P allows 
the user to chose between a) drawing, b) viewing a patient's previous records, or c) 
outputting the data in a specified format. 
a) Drawing 
Body regions are presented sequentially on the screen. Al l body regions are presented 
for all patients to avoid the possibility of missing any. Psoriasis lesions are then mapped 
by the user onto the region: their size can be changed, and they can be erased if neces-
sary. Once the psoriasis has been mapped, the user signals the program to calculate the 
area of coverage, which is stored together with the coordinates and size of each ellipse. 
The next screen contains the identical body region onto which the mapped lesions have 
been redrawn, and here there is the option of superimposing blank patches to remove 
certain areas from the area calculations. In this way, a coverage figure can be obtained 
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for individual areas of the body (lower arms only, for example) which may be used to 
evaluate area of coverage on visible regions, for example. Finally, S K I N M A P checks 
whether a user-defined program exists and executes it (to prompt for ratings of any 
clinical features, for example, or to interface with external measuring equipment). The 
data collected are stored with the area assessments. This process is repeated for each of 
the body regions. An example of a mapped region is shown in Figure 2.5, together with 
an example of a blanked equivalent in Figure 2.6. 
Once all regions have been assessed, S K I N M A P runs another subsidiary program (if it 
exists) designed to allow the user to create extensions to the data collected, such as 
general comments, or to interface with other measuring instruments. Finally, the exter-
nal database is updated and the opening menu represented. The patch locations and 
sizes, and all other data are stored in a temporary file at the end of each regional as-
sessment. Should the program be terminated abnormally (through power failure, for 
example), S K I N M A P rebuilds the representation at the start of the next session and gives 
the opportunity to save permanently or abandon the assessment. 
b) Viewing Previous Records 
The history option from the main menu presents paired mappings of body regions, 
together with a summary of the area of coverage of that region and the number of 
patches. It is possible to step through all previous assessments to view changes in the 
disease coverage over time. A sample of the history screen is shown in Figure 2.7. 
c) Output of Data 
This option writes the database to an A S C I I file in user-defmed format. Thus, any or all 
of the recorded areas and patch locations, as well as the extra data obtained from the 
subsidiary programs can be output in a format suitable for input to a statistics package. 
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Figure 2.5 SKINMAP main drawing screen. The example shows a body region with 
a range of patches mapped. 
L^ase Resune Next Abandon • ! Block Read Bl 
Figure 2.6 Example of the same SKINMAP body region with selected areas blanked. 
Erase Resune Next Abandon Block Read B 
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Figure 2.7 SKINMAP history option screen. The example shows assessments 
made on the same subject on two occasions. 
Previous First Last Region* Region- End 
• tX / f t 
ASSESSMENT I OF 2 
Date of s e s s i o n ; 13 MAR 92 
Tine of s e s s i o n ; 00;02 
Nunber of p a t c h e s ; 127 
Coyerage ( t h i s r e g i o n ) ; 7,1 7. 
FINAL ASSESSMENT 
Date of s e s s i o n ; IG MAR 92 
Tine of s e s s i o n ; 05;57 
Nunber of pa tches ; 38 
Coverage ( t h i s r e g i o n ) ; 1,8 Z 
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2.5 Validation of S K I N M A P 
Before S K I N M A P could be used in practice, it was important to be sure that it did indeed 
produce estimates of the area of coverage of psoriasis that were better than simple 
visual estimation. A validity study was therefore undertaken to assess how estimates 
made by S K I N M A P compare with estimates made by visual assessment. 
2.5.1 Introduction 
Two groups of eight subjects were required to estimate the area of coverage of psoriasis 
on a series of eighteen colour transparencies. The first group used SKINMAP, the second 
made a visual estimation. 
2.5.2 Subjects 
Sixteen subjects were recruited for this study from a range of occupational and educa-
tional backgrounds. There were nine females and seven males, the mean age was 29 
years ( S D 16). None had any formal experience in estimating areas and none had any 
specific computing experience, although all had used computers before. None of the 
subjects were medically trained. Al l the subjects had seen psoriasis before, but none had 
ever suffered from it nor had any close relation who suffered from it. None reported any 
visual impairments not corrected by spectacles. 
2.5.3 Transparencies 
A set of eighteen colour transparencies was used drawn from the full set of 66 used by 
Marks et al (1989). It was necessary to use a subset of those transparencies because 
planimetric data was not readily available for the full 66. The planimetrically assessed 
areas of coverage ranged from 0.25% to 47.63% (Table 2.3). 
Table 2.3 Planimetric assessment of the area of coverage of psoriasis on a set of 18 
colour transparencies drawn from a full set of 66 used by Marias ef a/(1989). 
Slide Coverage (%) Slide Coverage (%) 
10 0.25 17 21.68 
5 0.31 11 22.56 
2 0.62 4 25.08 
9 2.18 15 27.84 
3 2.38 14 30.38 
18 7.59 7 33.37 
1 8.78 8 35.77 
6 13.52 13 39.38 
16 14.06 12 47.63 
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2.5 A Equipment 
For the purpose of this study S K I N M A P was run on an Amstrad 1512 computer with twin 
5 1/4 inch floppy disk drives, and monochrome monitor with C G A graphics adapter. 
This represents a minimum standard of computer hardware necessary for SKINMAP. A 
mouse was used for all drawing operations. Transparencies were projected using a 
Kodak Carousel projector and back-projection screen. 
2.5.5 Procedure. 
Subjects were recruited in pairs then one of each pair was randomly allocated to a group 
by drawing numbers out of a hat, the other member of the pair was assigned to the other 
group giving eight subjects per group. Both groups were shown four transparencies to 
familiarise themselves with the condition to be assessed. These transparencies were 
chosen to be typical of the nature and range of psoriasis in the experimental transparen-
cies. 
None of the subjects in the computer assessment group had any experience with S K I N -
M A P . At the start of the session the program was explained to them, and they were taken 
through each stage of its operation. Each of the subjects was allowed as much time as 
they required to familiarise themselves with the program's operation. Subjects were told 
they would be shown a series of eighteen transparencies and asked either to map the 
psoriasis as accurately as they could onto the computer screen, or to estimate the per-
centage of the body region that was covered by psoriasis, depending upon to which 
group they were assigned. Results were recorded either directly by S K I N M A P in the 
computer aided assessment group ( S K I N M A P group) or by hand in the visual estimation 
group (visual group). The time taken to assess each transparency was also recorded. 
A l l subjects were tested in the same room. Use of the the computer requires some 
ambient light so artificial room lighting was kept on and daylight excluded. The 35mm 
colour transparencies were back-projected to give a maximum image height of 24 
inches and were viewed from approximately 48 inches, although subjects were advised 
to adopt the most comfortable viewing distance. Slides were presented in random order. 
2.5.6 Results 
All subjects in both groups completed all the assessments, giving a full set of data for 
each of the 18 transparencies. The mean ratings ( ± S D ) for each transparency for visual 
estimation are presented in Figure 2.8 and for S K I N M A P estimation in Figure 2.9. 
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Figure 2.8 Visual estimates of area of coverage on 18 transparencies. 
Plot shows mean ± SD 
to 50 
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10 20 30 
Planimetry Value (%) 
Figure 2.9 SKINMAP estimates of area of coverage on 18 transparencies. 
Plot shows mean ± SD 
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T3 
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Table 2.4 shows the intercepts and slopes of the regression of estimated area on plani-
metric assessment for each subject. These regression lines are plotted in Figure 2.10 
(visual group) and Figure 2.11 ( S K I N M A P group). 
Table 2.4 Coefficients and residual errors from regressing estimated area on 
planimetric area for16 subjects assessing 18 transparencies. The t-test for 
the intercept tests for a significant difference from zero; the t-test for the 
slope tests for a significant difference from 1 . 
Subject Intercept S.E. t sig Slope S.E. t sig Residual SS 
SKINMAP group 
1 1.27 2.89 0.44 - 0.98 0.12 -0.17 - 926 
2 0.44 2.42 0.18 - 0.92 0.10 -0.80 - 647 
3 5.46 2.73 2.00 - 1.01 0.12 0.08 - 824 
4 0.65 1.51 0.43 - 0.88 0.06 -2.00 - 253 
5 1.47 2.72 0.54 - 1.06 0.12 0.50 - 819 
6 2.85 1.80 1.58 - 0.95 0.08 -0.63 - 358 
7 4.72 2.06 2.29 - 0.91 0.09 -1.00 - 472 
8 3.41 1.92 1.78 - 0.97 0.08 -0.38 - 407 
Visual group 
9 1.08 1.83 0.59 - 1.15 0.08 1.87 - 371 
10 -3.50 2.77 -1.26 - 1.11 0.12 0.92 - 854 
11 4.26 3.11 1.37 - 1.25 0.13 1.92 - 1072 
12 2.93 4.13 0.71 - 1.42 0.18 2.33 - 1895 
13 2.44 2.21 1.10 - 1.61 0.09 6.78 0.001 540 
14 0.78 1.90 0.41 - 0.66 0.08 -4.25 0.05 401 
15 -0.47 4.16 -0.11 - 1.46 0.18 2.26 - • 1920 
16 0.49 2.42 0.20 - 0.99 0.10 -0.10 - 651 
The mean intercept for the visual group was 1.00 ( S D 2.37) and for the SKINMAP group 
was 2.53 (1.89): there is no significant difference between these values {t=\A, #=14). 
The mean slope for the visual group is 1.21 (0.30) and the mean slope for the S K I N M A P 
group is 0.96 (0.058). 
For this measure a simple t-iest is not appropriate because the variances are not equal in 
each group. Therefore, calculating / and applying the Welch-Satterthwaite approxima-
tion for calculating df (Howell, 1987) gives t' =2.315 on 8 degrees of freedom, which 
is significant at the 0.05 level. Thus, the slopes are significantly different; however, in 
neither group is the slope significantly different from unity. 
The difference in slopes can be better visualised i f they are considered as devia-
tions from the planimetric values, and these are plotted in Figures 2.12 and 2.13. 
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Figure 2.10 Regression of estimated area on planimetry for 8 raters using visual 
estimation on 18 slides 
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Figure 2.11 Regression of assessed area on pianimetry for 8 raters using SKINMAP 
on 18 slides 
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Figure 2.12 Regression of deviation from planimetry on pianimetric values for 8 
raters using visual estimation 
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Figure 2.13 Regression of deviation from pianimetry on pianimetric values for 8 
raters using SKiNMAP 
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Figure 2.14 Coefficient of variation plotted against mean estimate for visual 
estimation and SKINMAP assessment of area on 18 transparencies. 
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The coefficients of variation for different levels of psoriasis coverage are plotted against 
mean estimate for each group in Figure 2.14. Inspection of this plot suggests that the 
visual group are less consistent in their estimates than the S K I N M A P group, and indicates 
that variances are not proportional to means: no single summary statistic is appropriate. 
In general, the residual sums of squares around the regression lines in the visual group 
are larger than in the S K I N M A P group, as can be seen in Table 2.4. The largest RSS in 
the S K I N M A P group is 926, while the largest RSS in the visual group is 1920. 
To summarise, the mean intercepts for the regression of estimated area on planimetric 
value for visual estimation and S K I N M A P assessment are not significantly different from 
each other. There was significant difference between mean slopes, though neither dif-
fered significantly from unity. When these slopes are plotted as deviations form pla-
nimetry, the wide variations in the visual group can be seen. 
2.6 Discussion 
As with Marks' group of clinicians (above), estimates of larger areas by both the visual 
group and the S K I N M A P group tend to become more consistent as the true area increases 
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(that is, the coefficients of variation decrease), but this means that simple transforma-
tions cannot be applied to either set of data. It can also be seen however, that while the 
use of SKINMAP does not affect the fact that the variance of estimates of larger areas is 
relatively smaller than that of smaller areas (once the mean estimate has been taken into 
account), assessments by different subjects using SKINMAP will be closer to one another 
than by subjects estimating visually. 
Examination of Table 2.4 reveals that the majority (6 out of 8) of subjects in the visual 
group tended to over-estimate larger areas (that is, the slope of the regression line was 
above 1), while the majority (again 6 out of 8) of SKINMAP assessments tended to slight-
ly underestimate larger areas. 
2.7 Conclusions. 
Visual estimation of area of coverage is not accurate. Studies which have examined the 
perception of disk areas have shown that a simple "correction factor" does not work. 
Psoriasis lesions are discoid, thus visual estimation of area of coverage may not be 
accurate. Empirical evidence using a group of clinicians supports this. However, carto-
graphic evidence suggests that individuals can match one disk with another accurately, 
even though they may not be able to assign an area value. A computer program, 
SKINMAP has been developed which allows patches to be positioned on body represen-
tations. The key task for the user, therefore, is to match disks rather than estimate areas 
- which is done by the program itself. Validation of SKINMAP shows it to produce more 
accurate and consistent area estimations when compared with planimetrically assessed 
transparencies of psoriasis. 
The results presented in this chapter show that SKINMAP produces estimates of psoriasis 
coverage which give significantly more reliable information about area of coverage 
than existing methods, and SKINMAP will therefore be used to assess area of coverage as 
an independent variable in the remainder of the research reported in this thesis. 
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Cross-sectional Investigation of Psychological Variables 
in Psoriasis Out-patients and Controls 
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3.1 Introduction. 
The studies reviewed in Chapter 1 suggest that psoriasis sufferers hospitalised for their 
condition are more depressed and anxious than controls groups, but the situation regard-
ing psoriasis out-patients is less clear. For example, Hardy & Cotterill (1982) found 
psoriasis out-patients to be borderline depressed on the BDI, while Price et al (1991) 
found their groups scoring well within normal limits on the depression scale of the 
HADS. Price et al also found high anxiety scores in psoriasis outpatients. The main 
problem in evaluating the psychological state of psoriasis outpatients is the dearth of 
suitable studies: as noted in Chapter 1, most of the work with outpatients has used 
informal data collection techniques, or has not used adequate controls. Further, while 
anecdotal evidence suggests that psoriasis sufferers do not regard themselves as " i l l " 
(e.g. Stankler 1981), they are, nevertheless, acutely aware of their physical symptoms 
(e.g. Jobling, 1976; Jowett & Ryan, 1985). 
Much of the research on psychological problems associated with psoriasis reviewed in 
Chapter 1 has used hospital inpatients, but these account for only a small proportion of 
people who have psoriasis. Examination of the psychological state of psoriasis sufferers 
in general should involve a wider sampling frame of psoriasis sufferers in the communi-
ty, so outpatients were used as the population from which the samples for the present 
research were drawn. This also means that any raised levels of anxiety will not be sim-
ply a consequence of hospitalisation. Derived from the general hypotheses summarised 
in Chapter 1, the specific aims of the present study are 1) to ascertain whether psoriasis 
outpatients have higher levels of depression and anxiety, and lower levels of self-es-
teem, than controls, 2) to ascertain whether psoriasis outpatients are more likely to be 
psychiatric "cases" than controls, 3) to assess their health status, and 4) if there are dif-
ferences between psoriasis sufferers and controls on these variables, to examine rela-
tionships between them and age at onset, time since onset, and severity of psoriasis. 
3.2 Design 
The design of this study was cross-sectional, examining psychological variables in two 
matched groups. One group comprised psoriasis sufferers and the other, matched con-
trols with no psoriasis and no other skin condition. 
3.3 Subjects 
Ethical permission was obtained from the North Durham Ethics Committee (Ref. 
EC275/90) to recruit subjects for the psoriasis group from the patient index at Drybum 
Hospital, Durham. Outpatients over 16 years of age who had attended for treatment in 
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the years 1987 and 1988 were included in the initial sampling frame. However, because 
of possible conflict with other research projects, the Consultant Dermatologist stipulat-
ed that patients currently undergoing treatment could not be included. 
3.4 Procedure 
A letter was sent to each patient explaining the outline of the study and asking them to 
participate, together with a stamped, return envelope and a reply slip to be completed by 
the patient. If no reply had been received within four weeks a further letter was sent. A 
group of individuals not suffering from any skin condition was also recruited to be 
matched with the psoriasis group on age, sex, marital status and social class. This group 
was drawn from names and addresses of acquaintances provided by the psoriasis group. 
Since the two groups were to be matched, this technique has several advantages. 
Friends of subjects are more likely to be in the same social class, be of the same marital 
status and be of approximately the same age. Although this could not be guaranteed, it 
does increase the chances of obtaining samples who can be matched (O'Hara, 1989). 
Upon receipt of the reply form, those subjects who agreed to participate were contacted 
by telephone, or by letter if they gave no telephone number, and a time arranged for a 
visit at their own homes. This location was chosen for several reasons. First, since one 
of the measures was to be state anxiety (that is, how anxious the subject is at the present 
time) it was felt that a familiar environment was more desirable than a hospital or 
University location. Second, since the groups comprised individuals with a wide age 
range living over a large geographical area, asking respondents to visit a single location 
may have caused problems associated with mobility or cost and consequently may have 
influenced response rates. Third, while the psoriasis group may have been quite moti-
vated to participate in the study and been prepared to travel, the control group had less 
reason to participate and could not realistically be expected to travel. 
In the psoriasis group, the severity of the condition was assessed using SKINMAP, and 
the age at onset of psoriasis recorded. Psoriasis on visible regions of the body was 
assessed, that is, arms, legs, hands and face. The coverage figures for individual body 
regions were combined to give a total figure. The remainder of the assessments were 
identical in both groups, comprising the questionnaires described below. The psoriasis 
group were also encouraged to talk informally about their condition and its effects on 
their lives. 
54 
Chapter Three: Cross-sectional Investigation 
3.5 Questionnaires 
Demographic variables 
Date of birth, age and sex were recorded for all subjects, together with marital status 
(defined as a categorical variable with two levels: married, or living with a partner; 
single, or not living with a partner) and social class as defined by the Office of Popula-
tion Censuses and Surveys Classification of Occupations (1980). Social class was 
assessed on the occupation of the main wage-earner. If no occupant of the household 
was employed, previous occupation was used: all subjects were classified in this way. 
Depression 
The Centre for Epidemiological Studies Depression Scale (CES-D) used in this study 
was designed for assessing levels of depressive symptomatology in general populations, 
with the emphasis on the affective component of depression. It was not designed to 
measure the severity of already diagnosed depression, nor was it intended to provide 
clinical diagnosis of depression, although subsequent research has shown that applica-
tion of an appropriate cutoff point to the scores does allow prediction of cases (Myers & 
Weissman, 1980). It is a 20 item structured interview or self-report questionnaire which 
returns a single score representing the level of depressive symptoms during the week 
prior to administration. 
Each item is scored from 0 to 3, thus the theoretical range of scores is 0-60, where 
higher scores represent a larger number of symptoms reported, weighted by the fre-
quency with which they have occurred during the specified time period. Radloff (1977) 
gives distribution data of CES-D scores for four populations and quotes a mean CES-D 
score in "normal" populations of between 7.9 and 9.3. In a psychiatric population this 
mean was 24.4. The distribution of scores is positively skewed in the normal population 
and approximately normally distributed in the psychiatric patient population. In a 
thorough and exhaustive validation of the CES-D, Husaini, Neff & Harrington (1979) 
demonstrated that a score of >17 provided the most appropriate cutoff point for "possi-
ble depression" and >23 for "probable depression". 
Araiety 
The instrument for assessing anxiety in the present study was chosen on conceptual 
grounds. Spielberger's distinction between State and Trait anxiety has been discussed in 
Chapter 1. Spielberger and his associates (Spielberger, Gorsuch & Lushene, 1970) have 
developed and validated the State Trait Anxiety Inventory (STAI) for the assessment of 
these two factors, and this was used in the present study. They showed a median test-
retest correlation of 0.7 for the trait anxiety scale but a test-retest correlation of only 
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0.33 for the state anxiety scale. This is to be expected since the state scale measures 
anxiety levels which are expected to fluctuate over time. The trait scale gave a median 
Cronbach's acoefficient of 0.93 while the median for the state scale was 0.90 in a range 
of populations. This indicates that the questionnaire exhibits very high internal consist-
ency. The authors also provide ample evidence that the scales correlate well with other 
anxiety measuring instruments. 
It was also noted in Chapter 1 that anxiety can be conceptualised as comprising two 
distinct components: cognitive and somatic, and that analysis of individual response 
patterns has been useful in understanding the nature of anxiety reactions. Schwartz, 
Davidson & Goleman (1978) have developed the Cognitive Somatic Anxiety Question-
naire (CSAQ) which has subsequently been validated in a number of populations (e.g. 
Delmonte & Ryan, 1983; Tamaren et at, 1985; Crits-Cristoph, 1986; DeGood & Tait, 
1987; Heimberg et al, 1987; Freedlan & Carney, 1988) and shown to discriminate these 
two components well. This questionnaire was used in the present study to examine the 
component nature of the anxiety experience. 
Psychiatric morbidity 
The literature review presented in Chapter 1 has suggested that more visible dermato-
logic conditions in general appear to be associated with a higher proportion of probable 
psychiatric "cases" (Hughes et al, 1983; Wessely & Lewis, 1989). The General Health 
Questionnaire (GHQ - Goldberg, 1976) was designed to identify possible and probable 
"cases" in a variety of populations. It returns an overall score which can be evaluated 
against cutoff criteria. The original version comprises 60 questions and scores have 
been shown in a variety of populations to correlate well with the Clinical Interview 
Schedule and the Present State Examination (correlations ranged from 0.76 to 0.80, 
Goldberg, 1976). The scaled version of the GHQ containing 28 items has been de-
veloped specifically for situations where more information is needed than a simple 
severity score to identify cases, and this instrument was used in the present study to 
examine in more detail the nature of any potential psychiatric problems. A total GHQ 
score is still obtained, but four sub-scale scores can also be calculated: somatic symp-
toms, anxiety and insomnia, social dysfunction, and severe depression. 
Self-esteem 
Robson (1989) has developed a self-report measure of self esteem with high validity 
and reliability. Split half correlation was 0.93 and Cronbach's awas 0.89. Test-retest 
reliability over four weeks showed a correlation of global scores of 0.87 and the global 
score for this instrument correlated 0.85 with the widely used Rosenberg self-repon 
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measure (Rosenberg, 1965), and 0.7 with clinical assessments by a group comprising 
four psychiatrists, three clinical psychologists and two psychotherapists. Since this in-
strument offers more detailed examination of the self-esteem construct than the Rosen-
berg scale, yet without the over-complexity of Marsh's instruments (e.g. Marsh et al, 
1984), this self-report measure of self-esteem was employed in the present study to 
assess both global self-esteem and the relative contribution of individual components. 
Perceptions of illness 
Psoriasis is not generally a life-threatening or physically disabling disease: the main 
impact of the condition is on the sufferers life-styles. An exploratory investigation was 
therefore made of the self-perceptions of illness to see whether they could be related to 
other aspects of psoriasis. 
Hunt a/ (1981) have noted that perceived health status is "a key factor in aspects of 
adjustment to major episodes of illness" and have devised the Nottingham Health Pro-
file (NHP), to measure perceived health status. Hunt, McKenna & McEwen (1989) in 
the manual for the NHP suggest that it can best be described as a "measure of distress in 
the physical, emotional and social domains" and that it is appropriate for use "to moni-
tor changes in the subjective health of chronically ill patients over time" (p4) 
The NHP has six scales measuring energy, pain, sleep, emotional reactions, social isola-
tion, and physical mobility, and has been validated in a number of populations. Hunt et 
al (1980) tested the construct validity of this instrument in a group of elderly people 
with distinct physical illnesses and showed it capable of discriminating different chronic 
illnesses. A further validation study (Hunt et al, 1981), involved administering the NHP 
to a random sample of General Practice patients classified as "attenders" or "non-at-
tenders": the rationale being that perceived health and clinic visits should be highly 
related. The authors found that NHP scores significantly discriminated attenders from 
non-attenders once age and sex had been controlled for. Further studies with the NHP 
using patients with osteoarthrosis (Hunt, McKenna & Williams, 1981) and peripheral 
vascular disease (Hunt et al, 1982) have shown each of the subscales to have acceptable 
reliability coefficients (0.77 to 0.88). 
There is an optional section to the NHP that assesses which areas of the subject's life is 
affected. Hunt McKenna & McEwen (1989) advise that this section should not be used 
when the subject pool is drawn from a wide range of backgrounds: i.e. varying occupa-
tional and marital statuses. Since this is the case with the present group, only the first 
section of the NHP was used in the present study to examine perceived health status. 
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3.6 Results 
The initial letter was sent to 152 psoriasis outpatients. Eighty eight replied, and of 
those, 57 said they would like to participate while 31 declined to take part. Ten letters 
were returned by the Post Office marked "Gone Away" and no further attempts were 
made to contact those patients. One letter was returned because the patient had died. 
Four weeks after the initial mailing, 53 reminder letters were posted. Of those, 13 pa-
tients agreed to participate, 11 declined, 3 were returned marked "Gone Away" and 26 
did not respond. No further attempts were made to contact the non-responders. Thus, 
the overall response rate from letters which reached the patients was was 81%. Of those 
who received letters, 51% agreed to take part, giving 70 subjects in the psoriasis group. 
The initial plan had been to recruit the control group by the same method, but it became 
clear very early on that the response rate from controls was extremely low. Controls 
were therefore telephoned or visited without an initial mailing, which by chance also 
resulted in a group comprising 70 subjects being recruited. 
Age was calliper matched (Cochran, 1983) to ±5 years. That is, a control subject 
matched on age if they were within ±5 years of the psoriasis subject. Employing the 
strict matching criteria of sex, marital status, social class and age (+5 years) forced the 
rejection of 26 pairs of subjects. The matched group therefore comprised 57 subjects in 
each group: 21 pairs of males and 36 pairs of females. The demographic and descriptive 
variables for both groups are summarised in Table 3.1. 
Table 3.1 Demographic and descriptive variables for psoriasis and control groups 
Full Sample 
Psoriasis Control 
Matched Sample 
Psoriasis Control 
Males 26 29 21 21 
Females 44 41 36 36 
Single (%) 16 (23) 15 (21) 14(25) 14(25) 
Social Class 
1 0 0 0 0 
2 14 21 12 12 
3 34 28 27 27 
4 12 12 9 9 
5 10 9 9 9 
Manual 33 30 26 26 
Non-manual 37 40 31 31 
Mean Age in years (SD) 43 (13.2) 41 (15.1) 42(13.9) 41 (14.8) 
Age range in years 17-74 18-70 17-74 18-70 
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There were no missing data for any subject since all the questionnaires were completed 
in the presence of the researcher and checked for errors. 
3.6.1 Psoriasis Group Characteristics 
Within the whole psoriasis group (n=70) the mean age at onset of the condition was 27 
years (SD 17, range 2 to 67 years) and the mean time since onset was 16 years (14, 1 to 
57). In the smaller group of matched subjects, the mean age at onset was the same but 
the mean time since onset was slightly lower at 15 years (13,1 to 52). The mean area of 
coverage for the full psoriasis group was 4.1% (range 0 to 37.8%) and for the matched 
group 3.8% (0 to 37.8%). The distributions were positively skewed and the mean fig-
ures are included for comparison with other studies only. The median area of coverage 
for the full group was 1.4% (SIR 2.36) and for the matched group was also 1.4% (2.49) 
3.6.2 Effects of matching 
To assess the effectiveness of matching, the 57 pairs of subjects were coded by 56 
dummy variables, which were then entered simultaneously into regression analyses for 
each dependent variable in turn. A significant F ratio indicates that a significant propor-
tion of the total variance can be accounted for by the matching. A nonsignificant f-ratio 
indicates that the matching does not account for any significant amount of the total 
variance and implies that the matching process is redundant. 
For those dependent variables where the matching had a significant effect in the whole 
matched sample (n=114), or the male or the female subsamples, all further analyses 
used only the matched pairs. For dependent variables where no matching effect was 
found, all 140 cases were used for further analysis so as to increase statistical power. 
3.6.3 Depression 
The matching explained none of the variance in the scores for this scale so the full 
sample of 140 subjects was used. The scores on the CES-D scale were moderately posi-
tively skewed so a square root transformation was used before t-tests were performed. 
The medians and semi-interquartile ranges are reported in Table 3.2. There was a signif-
icant difference between the control group and the psoriasis group (one-tailed) with the 
psoriasis group reporting more depressive symptoms than controls {t=1.7,p<0.04). 
There was no significant difference between groups in the male or female subsamples 
(Table 3.2) but in both the psoriasis and control groups the females scored higher than 
the males (Figure 3.1). Neither of the group medians reached the cutoff point of >17 
defined as indicating possible depression (see above), but 18 individuals in the psoriasis 
group scored 17 or above, compared with 11 individuals in the control group. 
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TABLE 3.2 Summary of CES-D Depression scores for unmatched psoriasis (n=70) and 
control (n=70) groups. T-test is on square-root transformed scores 
Sample Group Median SIR Range t Sigp< 
All Psoriasis 9.5 6.5 0-38 1.7 0.05 
Controls 6.5 5.0 0-33 
Males Psoriasis 6.5 5.4 0-38 1.3 
Controls 5.0 2.8 0-19 
Female Psoriasis 11.0 8.25 0-37 1.1 
Controls 8.0 6.5 0-33 
Figure 3.1 Depression scores (CES-D) for unmatched psoriasis (n=70) and control 
(n=70)groups 
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In the psoriasis group, none of the variance in depression scores was accounted for by 
any of the psoriasis-specific variables. No significant correlations were found between 
depression scores and age at onset (r=0.073), time since onset (0.094), or area of cover-
age (-0.022). 
3.6.4 Anxiety 
The State Trait Anxiety Inventory was administered such that the State form was 
completed first as recommended by Spielberger et al (1983). This ensures that the scale 
is not influenced by "the emotional climate that may be created if the T-scale is admin-
istered first" (p.4). 
The scores on both the state anxiety scale and the trait anxiety scale of the STAI were 
moderately positively skewed, so a square root transformation was employed on all the 
data. None of the variance between groups was accounted for by the matching variables 
so the full sample of 140 subjects was used in all analyses. There were no significant 
differences between groups on the state anxiety scale for the full group or for males or 
females separately, but there was a significant difference between the full groups for 
trait anxiety (t=1.65, p<0.05, one-tailed), with the psoriasis group scoring higher than 
the control group (Table 3.3). The mean scores and SDs are presented in Figure 3.2. 
There were no significant correlations between trait anxiety scores and age at onset 
(r=0.l\), time since onset (0.15), or area of coverage (0.068). 
TABLE 3.3 Summary of Anxiety Scores (STAI) for unmatched psoriasis (n=70) and 
control (n=70) groups. T-test is on square-root transformed scores 
Sample Group Mean SD Range t Sigp< 
State Anxiety 
All Psoriasis 32 A 10.0 20-58 0.06 -
Controls 32.3 11.2 20-65 
Male Psoriasis 28.5 9.0 20-58 -0.52 -
Controls 29.3 7.5 20-46 
Female Psoriasis 34.3 10.0 20-58 0.25 -
Controls 34.5 12.9 20-65 
Trait Anxiety 
All Psoriasis 37.9 11.0 20-64 1.65 0.05 
Controls 35.0 11.0 20-68 
Male Psoriasis 35.1 11.7 20-64 1.33 -
Controls 31.2 7,7 20-52 
Female Psoriasis 39.5 10.4 20-61 0.94 -
Controls 377 12.1 21-68 
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Figure 3.2 Mean (SD) trait anxiety scores (STAI) for unmatched psoriasis (n=70) and 
control (n=70) groups 
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There were differences in the predicted direction between the psoriasis and control 
groups on both cognitive and somatic anxiety scales of the CSAQ, with the psoriasis 
group scoring higher than the control group (Table 3.4). While these differences were 
not statistically significant within the female subsample, the male psoriasis subsample 
did score significantly higher on both cognitive and somatic scales (Figure 3.3). Area of 
coverage did not account for any significant amount of variance on any of the scales, 
but age at onset significantly predicted somatic anxiety levels (Intercept=17.28, 
Slope=-0.075 (SE 0.033)) as did time since onset (13.86, 0.086 (0.039)). 
There was no difference between groups in the mean ratio of cognitive to somatic 
anxiety symptoms: both group means were 1.03. 
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TABLE 3.4 Summary of CSAQ scores for unmatched psoriasis (n=70) and control 
(n=70) groups 
Sample Group Mean SD Range t Sigp< 
Cognitive Anxiety 
All Psoriasis 15.5 5.8 7-28 1.73 0.05 
Controls 13.8 5.9 7-30 
Male Psoriasis 14.4 5.9 7-28 1.64 0.054 
Controls 12.0 4.9 7-24 
Female Psoriasis 16.2 5.7 7-27 0.85 _ 
Controls 15.1 6.3 7-30 
Somatic Anxiety. 
All Psoriasis 15.3 4.7 7-25 2.00 0.05 
Controls 13.7 4.8 7-31 
Male Psoriasis 14.5 4.5 8-25 2.00 0.05 
Controls 12.3 3.6 7-21 
Female Psoriasis 15.8 4.8 7-25 1.00 _ 
Controls 14.7 5.3 7-31 
Figure 3.3 iVIean (SD) cognitive and somatic anxiety (CSAQ) scores for unmatched 
psoriasis (n=70) and control (n=70) groups. 
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3.6.5 Psychiatric morbidity 
The data from the General Health Questionnaire were very highly positively skewed 
with a large number of zero scores, making parametric analysis inappropriate. Using the 
matched pairs only, and the non-parametric Wilcoxon Signed-Ranks test to assess the 
difference between groups, there were no differences on either the total GHQ score or 
any of the subscales for the whole group or the male or female subsamples. There were 
17 cases above the cutoff point of >5 in both the psoriasis and control groups. The 
psoriasis group median score was 2 (SIR 2.5) and the control group median was 1 
(2.25). 
3.6.6 Self-esteem 
The matching variables did account for a significant amount of variance in the total SEQ 
score and the Value of Existence subscale. Therefore only the matched pairs were used 
in all the analyses of the results from this questionnaire. The means and standard devia-
tions for the total SEQ scores are shown in Table 3.5. There were no significant differ-
ences between the psoriasis and controls groups on this scale. Since no previous re-
search has reported on the components of self-esteem, analysis of the subscales must be 
considered exploratory at this stage and two-tailed significance levels used. The means 
and standard deviations are shown in Table A3.1 (Appendix 4). The only significant 
difference between the groups was on the attractiveness subscale for females (t=2.5, 
p<0.02) where the psoriasis group scored higher than controls (Figure 3.4). 
None of the psoriasis-specific variables accounted for any of the variance in the attrac-
tiveness scores of females or in the full group. 
TABLE 3.5 Summary of total SEQ scores for matched sample (n=114) 
Sample Group Mean SD Range t Sig 
All Controls 136.8 26.8 69-186 0.2 _ 
Psoriasis 137.7 22.2 99-195 
Male Controls 141.8 21.7 105-186 0.3 -
Psoriasis 144.1 20.1 105-195 
Female Controls 133.9 29.3 69-186 0.1 -
Psoriasis 134.1 22.8 99-187 
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Figure 3.4 Mean self-esteem Attractiveness subscaie scores for matched 
psoriasis (n=57) and control (n=57) groups 
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3.6.7 Perceptions of illness. 
Distribution of the Nottingham Health Profile scores deviated considerably from nor-
mal, so Wilcoxon Matched-Pairs Signed Ranks Tests were used to assess any differ-
ences between the groups for the matched samples, in accordance with the recommen-
dations of the test developers (Hunt et al, 1989). It was predicted that subjects would 
report lower subjective health status, so one-tailed tests were used throughout. 
The median scores for each of the scales are shown in Table A3.2 (Appendix 4). There 
were no differences between the full groups, or the male and female subsamples on the 
energy, emotional reactions or physical mobility subscales. While there was no differ-
ence between the full groups on the social isolation subscaie, there was a statistically 
significant difference between the males {Z=-l.77, p<.04) with the psoriasis group 
reporting more social isolation than controls, but this was not reflected in the female 
subsample. The full groups differed on the pain subscaie (Z=-1.84, p<.04) with psoria-
sis subjects reporting more pain, but this was not reflected in the male or female sub-
scale. The sleep subscaie, which assesses sleep problems, showed significant differ-
ences between the full groups {Z=-2.74, p<0.003), the male subsample (Z=-2.45, 
p<0.01), and the female subsample {Z=-I.7,p<0.05). Thus, psoriasis sufferers reported 
more sleep problems than controls. 
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3.7 Discussion. 
The overall response rate of 81% was better than expected. Unfortunately, it was not 
possible to ascertain the reasons for non-response, but it is certainly possible that those 
who chose not to reply, or those who chose to reply but not to participate, represented a 
distinct subgroup of sufferers which may have resulted in some biassing of the results. 
For example, those whose psoriasis was very mild may not have responded because 
they assumed only severe cases were required. Indeed, even though both the initial 
letter and the reminder stressed that all levels of psoriasis were of interest, several of the 
subjects who replied only to the reminder indicated that they had been interested in 
participating on receiving the initial letter, but that their psoriasis was so mild they 
assumed they would be of no use to the study. On the other had, it is equally possible 
that the non-respondents represented individuals who were so upset because of their 
condition that they did not feel they could discuss it with anyone. 
The purpose of the matching was to control for any variance that the matching variables 
might contribute to the total scores. For example, depression has been shown to be 
correlated with social class (e.g. Brown & Harris, 1978), sex (e.g. Weissman & Kler-
man, 1977), and marital status (Radloff, 1975; Gove, 1972), while perceived health 
varies with social class, age and sex (Hunt et al, 1989). Therefore the individuals within 
each group were matched for sex, marital status, social class as defined by the Office of 
Population Censuses and Surveys Classification of Occupations (1980), and age in 
years. Age was calliper matched with a criterion of ±5 years (Cochran, 1983). Eighty-
two percent of the sample matched on these criteria, giving 57 pairs. For the parametric 
analyses, where a significant amount of variance was accounted for by the 56 dummy 
variables coding for the match, all further analyses for that variable were computed 
after the matching variables had been entered. While the whole group of 70 subjects did 
not meet the strict matching requirements, there was no significant difference between 
the two full groups on any of the matching variables. Only the 57 matched pairs were 
used for the non-parametric analyses 
The Centre for Epidemiological Studies Depression Scale (CES-D) was designed to 
assess those symptoms which may cluster together to form a depressive syndrome and 
hence deserve a diagnosis of "depression", but which may also exist as distinct depres-
sive symptoms in the pre-depressed or non-depressed individual. Indeed, it is to be 
expected that most people will exhibit some of the symptoms to a greater or lesser 
extent, and it is only when a cumulative score over all the symptoms is evaluated that a 
decision can be made regarding a probable diagnosis of depression. The CES-D provides 
a continuous score with a theoretical range 0 to 60, where a score of >17 is generally 
used to indicate "possible depression" (Radloff, 1977). 
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While there is some clear evidence that psoriasis sufferers hospitalised for their condi-
tion are more depressed than controls, depression data for psoriasis outpatients is sparse 
(see Chapter 1). Hardy & Cotterill (1982) showed psoriatics more depressed than con-
trols, while Price et al (1991) found no evidence of raised depression levels in their 
sample. In the present study the full psoriasis group and the male and female subgroups 
all scored higher on the CES-D than controls, but only the difference between the full 
groups was significant. Within the two groups, the median depression scores were both 
lower than the cutoff point of >17, but more psoriasis subjects scored above this 
(25.7%) than controls (15.7%). This supports the hypothesis that psoriasis outpatients 
have raised levels of depressive symptoms. 
It was hypothesised that area of coverage would be correlated with depression scores, 
but this was not found to be the case. This is possibly because the levels of coverage 
were quite low, but it may also be the case that psoriasis sufferers are a group who are 
more depressed than controls regardless of the state of their psoriasis. Therefore, while 
no relationship has been found in the present study, no firm conclusions can be drawn 
about the possible link between depression and disease severity since psoriasis area of 
coverage did not encompass a large enough range. A further study, using psoriasis 
sufferers whose condition is more severe is needed to determine whether any relation-
ship between area of coverage and depression exists, and this is reported in Chapter 5. 
As with the depression data, while there is evidence that psoriasis inpatients are more 
anxious than controls, very few studies have examined anxiety levels in outpatients. 
The available evidence reviewed in Chapter 1 led to the hypothesis that sufferers have 
higher levels of anxiety than controls and that these levels are related to disease severi-
ty. In the case of trait anxiety this prediction was confirmed, with the psoriasis group 
scoring on average three points higher than controls, who in turn scored close to the 
reported "normal" mean. This difference between groups is small but statistically sig-
nificant, and supports the hypothesis that having psoriasis leads to anxiety. 
There were no differences between the groups in the case of state anxiety. There may be 
several reasons for this. First, individuals were interviewed in this study in the familiar, 
and presumably relatively unthreatening environment of their own home. Second, the 
psoriasis group was interviewed by a researcher who himself has psoriasis which may 
have minimised the perceived likelihood of feeling negatively evaluated. Indeed, once 
this fact was revealed to the patients, there was a quite noticeable change in attitude, 
from apprehension and hiding of the psoriasis to a more open and inquisitive response. 
The norm cited on the state anxiety scale for male working adults is 35.7 (SD 10.4) and 
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for female working adults is 35.2 (10.6) and on the trait anxiety scale 34.9 (9.2) and 
34.8 (9.2) (Spielberger et al, 1983). Thus, both psoriasis and control groups score below 
average on the state scale and the psoriasis group scores above average on the trait 
scale. 
Again, perhaps because of the low levels of disease severity, no relationship was found 
between disease-specific variables and anxiety. Therefore, psoriasis sufferers are more 
prone to experiencing anxiety than controls, but the association with disease severity 
requires further investigation using subjects with more severe psoriasis to ascertain 
whether raised anxiety can be related to psoriasis severity. This will also be examined in 
Chapter 5. 
However, while the STAI is designed to assess levels of anxiety, the Cognitive-Somatic 
Anxiety Questionnaire (CSAQ) is specifically directed at the manifestation of anxious 
symptoms, and to assessing whether these present primarily through a cognitive chan-
nel, a somatic channel, or both. The results of this study showed that the psoriasis and 
control groups differed in their cognitive manifestations of anxiety (e.g. difficulty in 
concentrating, indecisiveness, anxiety-provoking thoughts and pictures), and somatic 
anxiety (e.g. increased heart rate, tense stomach, perspiration) with the psoriasis group 
scoring higher on both scales. There are at least two ways of interpreting this. Psoriasis 
sufferers may indeed experience more frequent or more intense reactions to anxiety 
than controls. On the other hand, it may be that the CSAQ is simply measuring aware-
ness of symptoms, as in Dooley and Finlay's (1989) study which showed psoriatic 
females to be more conscious of their bodies than controls. In the present study, it was 
hypothesised that reported levels of cognitive and somatic symptoms would be related 
to the severity of the condition but this was found not to be the case. Both scores were, 
however, related to age at onset and time since onset, with earlier age at onset associat-
ed with higher scores and longer since onset associated with higher scores also. 
In respect of psychiatric "cases", the results of the present study do not support the 
findings of Hughes et al (1983) or Wessely & Lewis (1989), both of whom found 
higher numbers of probable "cases" in their samples. This is probably because their 
samples comprised a range of other skin conditions as well as psoriasis, some of which 
are definitely related to psychiatric problems (e.g. dermatitis artefacta). There is no 
evidence therefore from the present research that psoriasis sufferers are more likely to 
be psychiatric "cases" than non-sufferers. 
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The only difference between the groups on the Self Esteem Questionnaire was between 
females for the Attractiveness subscale. Interestingly, the psoriasis females scored sig-
nificantly higher than the controls, suggesting that they considered themselves more at-
tractive than non-sufferers. However, none of the variance in this subscale was account-
ed for by any of the psoriasis specific variables and a further study is therefore needed 
using psoriasis sufferers whose condition is more widespread to confirm that there is no 
relationship between disease severity and scores on this scale. This will be reported in 
Chapters. 
A great deal of information and insight was gained through informal discussions with 
the psoriasis group. Since much of this forms the basis for the next study, the details are 
reported in Chapter 4. However, formal data about perceived health status were avail-
able from the Nottingham Health Profile results. The clearest difference between the 
groups was on the sleep subscale, which assesses sleep problems, where psoriasis suf-
ferers had more problems than non-sufferers. Unfortunately, the NHP was not designed 
to specify exactly what these sleep problems are, so a more detailed sleep questionnaire 
was used in the study described in Chapter 5 to further investigate these findings. 
Pain is not usually thought of as a symptom of psoriasis, yet the two groups differed 
significantly on this NHP subscale, with psoriasis sufferers reporting more pain than 
non-sufferers. Again, the NHP is not designed to quanrify pain, other than giving an 
indication of broad problem areas. However, this finding is interesting and has not 
previously been reported. While it may be that the pain reported on the NHP can be 
accounted for as itch, it may also be the case that some psoriasis sufferers experience 
pain specific to their condition over and above the general discomfort caused by itching 
skin. The study reported in Chapter 5 examines this possibility in more detail and looks 
at qualitative pain description in psoriasis. 
3.8 Conclusions. 
This initial study has shown that while psoriasis outpatients are more depressed and are 
more prone to experience anxiety (which presents through both cognitive and somatic 
channels) than controls, they do not constitute a group which would be classified as 
possible psychiatric "cases" on the General Health Questionnaire. There are differences 
in self-esteem, particularly with respect to self-evaluated attractiveness, and psoriasis 
sufferers have problems with their sleep and problems with pain that have hitherto not 
been considered part of the experience of psoriasis. However, it has not been possible to 
establish any link between disease severity and these factors. This may have been 
because the psoriasis was generally quite mild in the majority of the subjects, but it may 
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also be that psoriasis sufferers are a group who are more anxious and more depressed 
than non-sufferers irrespective of the state of their psoriasis. 
Two areas of further study suggest themselves from these results. First, the nature of 
this study has been cross-sectional, but given that psoriasis is often phasic in its course, 
can the psychological variables examined so far be related to fluctuations in the severity 
of the condition within patients? A prospective study would provide data on levels of 
psychological variables with subjects effectively acting as their own controls, thus base 
levels would be taken into account and change in area of coverage could be related 
directly to change in psychological variables such as depression and anxiety. This will 
be examined in the study reported in Chapter 5. Second, it became clear from informal 
discussions with sufferers in the present study that there is a considerable body of lay 
knowledge about psoriasis that may be instrumental in guiding perceptions about the 
disease and about its probable course. At the time of writing, this knowledge had not 
been examined systematically, and it may be useful in forming a more complete picture 
of the psychological states associated with psoriasis, as well as guiding treatment prac-
tices. Examination of lay beliefs and knowledge about psoriasis is reported in Chapter 4. 
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4.1 Introduction 
In addition to its formal aims, the previous study gave some insight into the worries and 
concerns of the psoriatic population under investigation. In conversation with the suf-
ferers, several areas of concern emerged. Indeed, it became increasingly clear that there 
is a body of lay beliefs about psoriasis, some of which reflect established facts quite 
accurately, but more of which does not. 
The information in the following section was not collected in any standard format, and 
must therefore be interpreted with care. Nonetheless, it is of use in outlining beliefs that 
appear to be common to many of the subjects, and it forms the basis of the interview 
schedule reported later in this chapter, which investigates those beliefs more formally. 
4.2 Findings from informal discussions with psoriasis patients 
First, subjects were unclear as to the actual nature of their condition. Several people 
inquired about a link between skin cancer and psoriasis, while several others sought 
clarification of a link between asthma and psoriasis. Many held to the belief that psoria-
sis may be caused by an allergic reaction, mostly to food or workplace substances. 
None reported that the physiology of psoriasis - exactly what happens to psoriatic skin -
had been explained to them, even at a basic level. Regarding information about the 
probable course of their illness, many indicated that they had been told by their doctors 
that their condition was incurable. This may influence motivation to continue with 
treatment. There was widespread evidence of non-compliance with prescribed treat-
ment, and many of the patients reported having tried a variety of medicaments, all with 
little or no effect, and all with considerable personal discomfort and mess. Reports of 
trying non-medical treatments were given by quite a large proportion of the sample, 
usually in guarded tones to begin with. However, the efficacy of these "alternative" 
treatments was reported with often quite remarkable forcefulness. (One woman insisted 
that St Michael's - and only St Michael's - vegetable oil rubbed on the lesions daily was 
the only effective treatment). Many had tried alternative treatments ranging from 
hypnosis to brewer's yeast. 
Stankler (1981) suggested that it takes about ten years to "come to terms" with having 
psoriasis. The willingness to try often quite inappropriate alternative "cures" can be 
interpreted as an indicator of the strong desire the sufferers have to clear their psoriasis. 
Many expressed anticipation that the treatments they tried would not work, but at the 
same time indicated that they would continue trying anything that stood even the 
remotest chance of effecting relief. 
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While most were aware of some vague genetic link, many, particularly women, showed 
distinct signs of worry about their children "catching" psoriasis from them. It was not 
clear whether they were referring to passing on the disease through a hereditary mecha-
nism, or though infection. 
The majority of sufferers insisted, without prompting, that their psoriasis worsened at 
times of worry. For those who reported a seasonal fluctuation in severity, most indicat-
ed an improvement in the summer. There was no indication of feeling "unclean" or of 
the so-called "leper complex" reported in the literature (e.g. Updike, 1980). 
While the level of satisfaction with the care of specialist clinicians (i.e. the Hospital 
Dermatologists and Nursing staff) was high, CPs (in general, and sometimes by name) 
were often spontaneously and forcefully condemned for their apparent inability to 
prescribe any effective treatments, or more often for their ways of talking to patients. 
In summary then, informal conversations during the previous study suggested that 
patients do not possess basic factual knowledge about their condition, self-medicate 
with varying success, and in general are dissatisfied with their primary health care. 
4.3 The study of lay medical beliefs and knowledge 
There is an extensive body of literature concerned with lay medical and health beliefs, 
and a large number of studies which have attempted to quantify or explain how those 
beliefs relate to knowledge about various medical conditions. Beliefs about illness held 
by individuals guide how they react to their condition and how they manage their treat-
ment so are important in planning care and predicting the course of illnesses. Bishop 
(1987) has argued that people do not respond to disease symptoms per se but rather 
they interpret those symptoms within their own framework before they decide the most 
appropriate course of action to deal with the symptoms - whether to seek medical 
advice, to use medical treatment they already possess, to seek alternative treatment, or 
to do nothing. While noting that the concept of symptom-interpretation is generally 
accepted by other theorists. Bishop argues that the precise attributional processes postu-
lated are generally categorised a priori and reflect more the preconceptions of the re-
searcher than issues important to the patient. In an attempt to overcome these short-
comings. Bishop employed the methodology of multidimensional scaling and cluster 
analysis to evaluate lay conceptions of illness symptoms. 
He found that 'disruption to activities' was one of the most important aspects of illness 
symptoms for both men and women in deciding how severe a condition was. Further, 
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the perceived cause of the symptom was crucial in determining what the patient said 
they would do about it. Interestingly, patients who perceived the cause of a symptom to 
be physical indicated that they would seek medical help, while those who perceived the 
symptom's cause to be psychogenic indicated that they would tend to self-medicate. 
These findings have implications for the present study. Psoriasis sufferers report major 
disruption to theu- everyday activities (e.g. Jobling, 1976; Jowett & Ryan, 1985) which, 
under Bishop's model would suggest that they were likely to perceive their symptoms 
as severe. Furthermore, many patients see worry or stress as the cause of the relapse of 
their symptoms (e.g. Farber & Nail, 1974). Again under Bishop's model this would 
suggest that psoriasis patients are quite likely to self-medicate in preference to seeking 
medical advice. Bishop also reported that when self-care was examined separately, 
although perceived psychogenic symptoms were likely to result in self-medication, the 
level of self-medication was likely to be very low, i.e. symptoms were quite likely not 
to be treated at all. So it may be that the perceived cause of psoriasis symptoms results 
in relatively low levels of treatment compliance. 
Bishop (1991) has extended these ideas to look at how non-sufferers perceive various 
diseases, and more particularly at their wiUingness to interact with individuals who have 
certain diseases. Not surprisingly, he found that diseases perceived as contagious result-
ed in a lower likelihood of interaction than those perceived as non-contagious. As one 
would expect, the true nature of the condition (contagious or not) was completely irrel-
evant: only the perception was important. Bishop also found that people would tend to 
interact more with a person whose disease was perceived as being hereditary than with 
someone whose disease was not perceived as being hereditary (although it must be 
noted that diseases rated as hereditary were also generally rated as not contagious). 
Bishop found however, that the perceived severity of the condition did not predict will-
ingness to interact. Once again this has implications for psoriasis sufferers, whose 
condition is sometimes perceived as contagious but also hereditary. Under Bishops' 
model, lay beliefs about psoriasis, both on the part of sufferers themselves and the 
general public, should result in lower interpersonal contact. This, of course, may be 
compounded, as Strauss (1975) has suggested, by the nature of the treatment of psoria-
sis, in that it is generally intrusive either in looks or in odour. 
Perceptions of illness have been examined in more detail by several authors, and the 
methodologies employed are discussed below. One interesting variation was by Fum-
ham (1989) who examined lay attributions for the cure of various so-called "psychoso-
matic" conditions, one of which was dermatitis. He had subjects rate the importance of 
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a variety of factors in overcoming the specified illnesses. In the case of dermatins, 
subjects believed that the most important influences on overcoming the condition were 
"how embarrassed a person feels about having the problem", "how damaging the prob-
lems is to a person's self-worth and self-esteem", and "how much eliminating the prob-
lem would please others", all of which comprised the factor labelled "social conse-
quences". Since none of his sample were suffering from dermatitis this can be taken to 
represent a general belief about the condition. Psoriasis has been categorised as a 
psychosomatic illness (see Chapter 1) and in the sense that they are both skin conditions 
of broadly similar appearance, it is reasonable to suggest that these beliefs may also 
apply to psoriasis, though this was not examined explicitly by Fumham. 
The acquisition of knowledge and the development of beliefs about a condition from 
the sufferers point of view is not simply a matter of internalising presented information. 
Steptoe et al (1991) have pursued the concept of information seeking as a coping style 
in health related situations and suggest that there are two main types of information-
seeking behaviour: "monitoring" and "blunting" (Miller & Mangan, 1983). "Monitor-
ing" refers to the strategy of requesting and actively searching for information about the 
particular condition, whereas "blunting" refers to the strategy of actively avoiding 
information about the condition. Steptoe & O'Sullivan (1986) found that, while blunters 
said they were satisfied with the information they had about their condition (cancer), 
and thought they had a good understanding of it, when their knowledge was tested, their 
knowledge was actually quite poor. Monitors also thought they had a good understand-
ing of their condition, but in contrast, their knowledge scores were relatively high. 
Steptoe & O'Sullivan interpret this as representing two coping styles. Thus, poor 
knowledge of a medical condition may not reflect the quality of the sources of informa-
tion so much as the willingness to acquire that knowledge. 
While much research has concentrated on doctor-patient communication as a source of 
information for the patient, Frankel, Davison & Smith (1991) argue that patients get 
information from a variety of sources. Thus, they define this "lay epidemiology" as 
arising from informal conversations with peer groups and others in the individual's 
social network, television and magazines and other media productions as well as, and 
along side, medical encounters. These sources guide the knowledge base and belief 
system of the individual. Other authors argue the same point. Helman (1990) for 
example, stresses that the whole of society provides a framework within which illness is 
interpreted and, notes that the medical profession exist within that framework also. 
Thus, traditional 'medical' sources of knowledge stem not only from the concepts 
embodied in the biomedical model of western medicine, but are also interpreted through 
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the "filter" of social knowledge. Helman cites two studies by Elliot-Binns (1973,1986) 
which confirm that knowledge and beliefs about health are drawn from a wide variety 
of sources: 95% of a sample of 1000 GP patients received advice on their condition 
before consulting the doctor, with an average number of sources of advice of 2.3. 
In summary, beliefs about illness affect patients' help-seeking behaviour and the way 
that non-sufferers interact with patients. Beliefs about the factors influencing the cure of 
psychosomatic diseases in the case of dermatitis place "social consequences" as most 
important. The acquisition of knowledge upon which beliefs are based is mediated by 
the coping style adopted by patients, and knowledge is obtained from a wide variety of 
sources, other than doctors and other health-care workers. 
4.3.1 Methodological issues 
There have been many studies which have attempted to measure the knowledge and 
beliefs of patients in a variety of illnesses following differing methodologies. For 
example, the study by Steptoe a/ (1991) referred to above, asked five questions about 
cancer and scored the answers as zero for "don't know", 1 for an incomplete answer 
and 2 for a complete answer. This gave rise to a score between 0 and 10 which was 
used as their measure of knowledge about cancer. While this technique does provide a 
score that can be related to other variables, it does so at the expense of more detailed 
analysis of patient responses. Several other studies provide better examples of method-
ologies used in patient knowledge surveys. 
One widely used instrument is the Test of Patient Knowledge developed by Etzwiler 
(1962) and Collier (Collier and Etzwiler, 1971) which was designed to assess changes 
in knowledge about diabetes following instruction programmes. Although the psycho-
metric properties of this instrument are well documented and impressive (e.g. Garrard et 
al, 1987) there are two problems as far as using this in the present study are concerned. 
First, the questionnaire was explicitly designed for testing knowledge about diabetes 
and is not a general instrument. Second, and perhaps more important, Donovan, Blake 
& Fleming (1989) have noted that the multiple-choice format (used in the Patient 
Knowledge Test) may not in fact measure knowledge in the sense of understanding, but 
rather may measure it only in the restricted sense of recalling certain facts. Many ques-
tionnaires follow this format, perhaps most notably the Kidney Disease Questionnaire 
developed recently by Devins et al (1990), and the Patient Knowledge Questionnaire 
developed for use with rheumatoid arthritis by Hill et a/ (1991). 
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This criticism can also be levelled to some extent at the 51 item questionnaire used by 
Rubinfeld et al (1988) in their large study of Asthma knowledge in Melbourne, Austra-
lia. Their questionnaire required true/false/uncertain responses and was scored such that 
correct answers received a score of 1 while incorrect or uncertain answers received a 
score of zero. Thus, respondents were required only to choose options, not to express 
their own views. There was no further probing to elaborate on where knowledge origi-
nated or on what basis guesses were made. The main purpose of this questionnaire was 
to generate a "knowledge score" which could be used in conjunction with other varia-
bles. Like the two psoriasis knowledge questionnaires discussed below, this approach 
emphasises accuracy but does not examine in any detail the nature of /^accurate knowl-
edge, which is a valuable source of data in evaluating the best sources of information. 
Shevde & Panagopoulos (1991) approached this issue from a slightly different angle in 
their survey of 800 patients' knowledge and attitudes about anesthesia. They inter-
viewed prospective patients with a mixture of Likert scaled and open-ended questions 
in order to elicit a range of information about patients' beliefs. Rather than generating a 
"knowledge score", they concentrated on more descriptive analysis of their data and 
were able to provide more in-depth insights into patient concerns and beliefs. 
This approach was developed further by Donovan & Blake (1992) who used a tape-
recorded semi-structured interview administered in the patients' own homes, which was 
later transcribed and analysed following the principles of grounded theory (Glaser & 
Strauss, 1965). The grounded theory approach involves extracting themes from the data 
by repeated reading, rather than applying a pre-defined conceptual framework. The 
theory, in Glaser & Strauss' terms, is 'grounded' in the data, rather than in the precon-
ceptions of the researcher. Perhaps the most important finding of Donovan & Blake's 
study as far as the present research is concerned, was that almost all the respondents 
expressed a desire for more information about their condition, its treatment, side-effects 
and prognosis. The use of semi-structured interviews for eliciting this type of informa-
tion is common in ethnomethodological research and provides a vehicle through which 
data can be obtained which expresses issues important to the respondent, while retain-
ing the basic structure which is necessary if individuals are to be considered as a group. 
The semi-structured interview (tape recorded and later transcribed) was therefore 
chosen as the most appropriate method for investigating patients' beliefs about psoria-
sis. The structure of the interviews was derived from two sources. The informal conver-
sations with psoriasis sufferers from the study reported in Chapter 3 and outlined earlier 
in the present chapter coupled with previous research on patients beliefs in psoriasis 
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provided a valuable basis for identifying issues of likely concern to patients. Thus, the 
framework was generated primarily by psoriasis patients themselves. Second, Kleinman 
(1980) has proposed the use of what he has termed "explanatory models" which can be 
used as a framework for interpreting patients' (and indeed doctors') beliefs about i l l -
ness. Kleinman stresses that the explanatory model is distinct from a general health 
belief model (which is embedded in local cultures) because it relates specifically to a 
single episode of ill-health: thus one individual may use several independent explanato-
ry models as a framework for different illnesses. The explanatory model is simply a 
categorising system which comprises five areas: etiology, symptoms, pathophysiology, 
course of the illness, and treatment. 
To summarise, while some approaches to the measurement of patient knowledge and 
beliefs have concentrated on generating "knowledge scores", more detailed information 
can be obtained by using semi-structured interviews which allow the respondents to 
express their own views. The structure for the interviews in the present study comes 
from informal discussions with subjects in the previous study, and is guided by the 
general format of the explanatory model proposed by Kleinman (1980). 
4.4 Previous studies of lay knowledge of psoriasis. 
Ray Jobling has written eloquently about the sociological impHcations of having psoria-
sis from a patient's point of view (e.g. Jobling, 1977). He describes what can often be "a 
long career of arduous patienthood" (p73) in terms of the personal adjustment and 
adaptation to chronic psoriasis which can influence every aspect of the patient's life: 
psychological and social, as well as financial. He also notes that the stigma attached to 
psoriasis (either real or imagined) can have effects on significant others in the patients 
environment. For example, bed linen is often stained by psoriasis treaments - hanging 
out this stained linen for all to see can be a cause of embarrassment. Further, Jobling 
implies that the medical profession may subtly use patient knowledge (or rather, lack of 
knowledge) to legitimise their inability to treat the condition. That is to say, they may 
blame failure of the psoriasis to respond on the patient not understanding and following 
treatment instructions rather than on their own inability to prescribe effective treatment. 
Jobling, who is a psoriasis sufferer himself, gives useful descriptions of his own person-
al experiences. However, more generalisable data on the connection between patient 
knowledge and disease state can be obtained by examining experiences reported in a 
wider sample. Only two studies have attempted to examine in a standardised way the 
knowledge that psoriasis sufferers have about their condition. Burton & Thompson 
(1976) examined beliefs about skin conditions in a group of 151 mixed dermatology 
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outpatients, but unfortunately they did not attempt to distinguish the replies of patients 
suffering from different conditions. Their questionnaire was designed to assess what 
patients thought about doctors, the type of treatment they were receiving, and whether 
they had experienced any difficulty in their normal routines because of their condition, 
and did not inquire about beliefs that patients have about the condition itself. On these 
grounds. Burton & Thompson's study is of little value in guiding the current investiga-
tion, although it may be useful in elaboration of Jobling's (1977) assertion that psoriasis 
sufferers' relationships with the medical profession change over time, not only in the 
sense of the patient becoming more active in the understanding of their condition, but 
also in the sense that changing doctors may necessitate a change in ideaology for the 
patient (from a biomedical standpoint, for example, to a "psychologistic" approach). 
Of more value however, is Savin's (1970) earlier attempt to document beliefs about 
psoriasis in a series of 58 sufferers. He instructed them to "Please write down the 
things that you think most important about psoriasis; in particular things that you think 
doctors ought to know about", and found that patients tended to write mostly about the 
worry caused by psoriasis and the self-consciousness and embarrassment that they 
associated with this. A small number of patients (12%) thought that psoriasis could 
spread around the body by an auto-infection mechanism, but only one patient thought 
that other people could "catch" psoriasis. The other main theme of responses was criti-
cism of treatment and treatment-prescribing practices. 
Both of these studies provide limited information on patients' beliefs about psoriasis, 
but also suffer from severe shortcomings. The main problem is that the instructions for 
both studies stated that they were interested in beliefs about the condition that may be 
of interest to doctors, rather than first ascertaining those areas which were of interest to 
the patients. More recently, and after the present study had been undertaken, Lanigan & 
Farber (1990) published results from an investigation of patients' knowledge of psoria-
sis with a sample of 52 psoriasis outpatients compared with 17 other dermatology 
outparients in America, and yet more recently still Lanigan and Lay ton (1991) em-
ployed the same questionnaire with a sample of 108 outpatients in Britain. Their results 
will be discussed in comparison with the present findings later in this chapter. 
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4.5 Study of the beliefs and knowledge of psoriasis outpatients 
Ethical permission for this study was granted by the North Durham Ethics Committee 
(RefEC290/91). 
4.5.1 Subjects 
During the previous study, a note was made when subjects indicated that they would be 
willing to participate in further research. Forty six subjects were identified in this way 
and contacted again. Of those, 37 agreed to participate further and were visited again at 
their own homes. There were 11 males and 26 females; the ratio of males to females is 
not significantly different from that found in the previous study ( x ^ = 0.536) nor is the 
mean age of 43.8 years (SD 14.5) significantly different. 
4.5.2 Procedure 
Based on the issues raised by subjects in the previous study, an interview schedule was 
devised (Appendix 3) comprising both open and closed questions which probed knowl-
edge and beliefs about a range of issues concerned with psoriasis. These fell into four 
main areas corresponding to four of Kleinman's explanatory model categories (above): 
etiology, pathophysiology, course of sickness, and treatment, plus a category of more 
specific knowledge about the condition, and a general area exploring sources of knowl-
edge about psoriasis. The interview schedule was administered by the researcher to each 
of the subjects, and the responses tape recorded and subsequently transcribed. Respond-
ents were encouraged to talk as much as they liked, and where a range of fixed response 
options was available, these were presented to the respondent on a printed card. The 
purpose of the interview was explained to each subject and their consent obtained for 
the session to be recorded prior to the start of the interview. Each subject was asked to 
sign a declaration that they did not object to the interview being taped, provided all 
references that might identify them or others were removed in transcription and the tape 
erased (Appendix 3). A written record of responses was also made at the time of the 
interview for use in the event of a poor recording or equipment failure. The interviews 
lasted between 20 and 45 mins and were transcribed by the researcher. 
4.5.3 Analysis 
Analyses of the interview responses are presented below in the following manner. The 
precise wording of each question is followed by a rationale for formulating a "correct" 
response. Where two question numbers appear together, the second refers to an open-
ended supplementary question. The main purpose of this study was to provide qualita-
tive information on patients beliefs about psoriasis. When the question was closed, the 
numbers of subjects answering in each category are reported. When the question was 
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open, the scripts were content analysed and a summary of the results reported. The 
content analysis procedure (following the recommendations of Krippendorff, 1980), 
involved reading through all the answers to each question and extracting common 
themes. Each answer was then re-read and the frequency of references to each of the 
themes noted. Where other themes became apparent on the second reading, the process 
was repeated for all responses. Scripts were then re-checked against the extracted 
themes. These themes, together with the frequency of occurrence are presented verba-
tim below. 
4.5.4 Results 
Question 1 
What proportion of people in Britain would you estimate are currently suffering from 
psoriasis? 
The point prevalence of psoriasis in Caucasian races is between 1% and 3% (Chapter 1). 
Eight percent of the sample answered that they did not know the prevalence of psoria-
sis. Of those that did indicate a figure, the trend was to overestimate the true prevalence: 
22% of respondents suggested a prevalence of 5% while 60% suggested a prevalence of 
>10% (Figure 4.1). 
Figure 4.1 Respondents estimates of the prevalence of psoriasis in Britain 
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The question which must be answered is where these estimates originate. It may be that 
respondents were aware of another prevalence figure often quoted, that is, the rate of 
presentation at dermatology clinics. There have been several studies which estimated 
the prevalence of psoriasis using patients attending both "free" clinics and private prac-
tice clinics as a sampling frame. Table 4.1 lists the results of "free" hospital and clinic 
studies, and suggests a mean presentation rate of 5.2%. This figure is the percentage of 
patients presenting at dermatology clinics, not true prevalence in the population. 
TABLE 4.1 Prevalence of Psoriasis In Hospltal/Cllnic Studies. 
Country Sample Frequency Source 
Scotland 68,400 4.8% Ratzer(1969) 
Northern Ireland 14,231 5.5% Hall & Burrows (1968) 
Germany 13,075 7.4% Ross (1971) 
Spain 4,600 3.7% Romaguera (1980) 
However, another explanation may be that respondents were simply guessing at a figure 
and not basing their estimate on specific knowledge. Although the answers were chosen 
from options on a card, an analysis of the supplementary language used by respondents 
can clarify the strategies they were employing. Content analysis of the responses re-
vealed 7 distinct patterns (Table 4.2). Response patterns 1 to 5 suggest a guess rather 
than recall, while response pattern 6 suggests recalled figures rather than a guess. 
TABLE 4.2 Frequency of Response Phrases to Question 1. 
Pattern Response Frequency 
1 Definite reason to indicate a guess 6 
2 "I would say..." 15 
3 "I would think..." 2 
4 "Probably..." 4 
5 "Maybe..." 4 
6 "I think its about..." 2 
7 No additional language used 9 
Question 2 & 3 
Do you think psoriasis affects equal numbers of men and women, or do you think one 
sex is affected in greater numbers than the other? 
The epidemiological data analysed in Chapter 1 suggests that psoriasis is more preva-
lent in males than females. Data from hospital and clinic studies presented in Table 4.3 
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show the numbers of males and females presenting with psoriasis, and males do out-
number females, but in 4 hospitals there are more women than men. Unfortunately, the 
authors do not give total numbers of males and females in the population, so no firm 
conclusions can be drawn about true differences. 
The most frequent response to this question (68%) was that men and women suffer in 
equal numbers. However, while 8% thought more men suffered than women and 5% 
had no ideas at all, 19% thought that women are affected in greater numbers than men. 
A supplementary question was asked to ascertain on what grounds any estimate of in-
equality might be based. One respondent had no idea why they thought more women 
suffered than men, while five respondents indicated that they based their estimate on 
personal knowledge of other sufferers. Of the remaining four, two that indicated women 
suffering more than men said they thought it was because women are more anxious than 
men or worry more, while two thought men suffered more than women because men 
are under more stress than women. 
TABLE 4.3 Sex Ratio of Psoriasis in Hospital Presentations. 
Source Total Male (%) Female (%) 
Ratzer 3.323 1917 (58) 1406 (42) 
Ross 963 453 (47) 510 (53) 
Hoede 1,437 833 (58) 604 (42) 
Steinberg 464 251 (54) 213 (46) 
Braun-Falco 536 257 (48) 279 (52) 
Farber 5,600 2562 (46) 3038 (54) 
Powell 406 150 (37) 256 (63) 
Andressen 2,994 1677 (56) 1317 (44) 
TOTAL 15,723 8100 (52) 7623 (48) 
Question 4 & 5 
Do you think children are any more or less likely to develop psoriasis if one of their 
parents already has it? 
Dr B ter Haar (in Mier & van de Kerkhof, 1986) has produced a table of approximate 
risks of getting psoriasis for a given familial occurrence, reprinted here as Table 4.4. 
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Table 4.4 Risk of Psoriasis (IVIier & van de Kerl(hof, 1986). 
Family members with psoriasis Risk % 
Both parents 50 
One parent, one sib 16 
No parents, two sibs 16 
One parent, no sibs 10 
No parents, one sib 7 
Second-degree relatives 4 
Third-degree relatives 1-2 
Dr ter Haar quotes a risk of 10% i f one parent has psoriasis, the correct answer is that 
there is an increased risk i f one or more parent has psoriasis. 
The responses to this question indicate that about 65% believed that psoriasis may be 
hereditary. Of those who answered that they thought children were more likely to get 
psoriasis if one parent already has it (24/37), all gave as the reason that it "runs in fami-
lies" or used the word "hereditary" in their responses. 
Question 6 & 7 
Do you think there are any particular groups of people who get psoriasis more fre-
quently than others? 
Lomholt's (1963) extensive survey of psoriasis in the Faroe Islands found no particular 
occupational groups overrepresented, but Hellgren (1967) did report a comparatively 
high prevalence in people who work with animals or animal products, or people whose 
work brings them into contact with hair (e.g. hairdressers). Hellgren did not, however, 
provide information on the occupational status of these individuals at the time of onset, 
so it is not possible to assess his findings in relation to the present question. Other 
evidence (e.g. Ingram, 1954) would suggest that no occupational or socioeconomic 
group is overrepresented. 
In estimating whether certain groups of people are more likely to get psoriasis, 11% of 
the present sample said they did not know, 57% said no, but 32% did indicate a group 
or groups that they thought were at risk. Suggestions about the nature of these groups 
are presented in Table 4.5 
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Table 4.5 Groups perceived to be at risk of psoriasis 
Group Reason 
Teaching profession - No reason 
People in our zone of the world - No reason 
People who work in dusty places - Drying out of skin 
Cleaners - Allergic reactions 
Unemployed - Worry 
Nervous people - Worry 
Businessmen - Stress 
People in stressful jobs - Stress 
Question 8 & 9 
Do you think psoriasis can be affected by how clean a person is? 
There is no evidence to suggest that psoriasis is directly affected by cleanliness. None 
of the respondents thought psoriasis could be affected by how clean a person is, but one 
did not know. 
Question 10 & 11 
Do you think it's possible for psoriasis to be infectious - that is, under certain circum-
stances can someone else catch psoriasis from you? 
There is no evidence at all that psoriasis is infectious. However, pustular psoriasis is 
characterised by (benign) pus filled papules which might give the impression of co-
existent infection. None of the patients seen in the present study suffered from pustular 
psoriasis, which is relatively uncommon (Mier & van de Kerkhof, 1986). 
The majority (92%) felt that psoriasis was not infectious under any circumstances. Of 
the three people who thought it could be infectious, one said, "When it weeps, when 
you scratch it and it bleeds, I 'd be wary of anybody touching then. But when it's dry, 
I 'd say it's harmless", while another thought it could be infectious if it bleeds too much. 
One said there is a certain type of psoriasis that can be infectious which is quite distinct 
from "the ordinary most common one", which may be a reference to pustular psoriasis. 
Question 12 & 13 
In people who already suffer from psoriasis, do you think it is sometimes possible for 
psoriasis to develop at the site of cuts or scratches? 
Psoriasis may form at the site of skin trauma; an effect generally referred to as the 
Koebner phenomenon (Koebner, 1877) or isomorphic response. Pedace et al (1969) 
demonstrated that the histological and clinical features of psoriasis induced by a 
Koebner reaction are identical to those which occur spontaneously. There is no doubt 
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therefore that the lesion produced by the Koebner phenomenon is psoriasis. Powles et al 
(1990) noted that the epidermis must be damaged before psoriasis lesions will develop. 
The Koebner response appears to be 'all or nothing'; that is, a sufferer either will react 
with a Koebner reaction in all cases of skin trauma, or will not react at all. There is an 
incubation period of several days (Pedace reported a mean of 16.8 days) before the 
psoriatic lesion begins to appear. 
Eyre & Krueger (1982) demonstrated a reverse Koebner phenomenon, by which psoria-
sis lesions cleared following a shave biopsy, and they note that this response too is 'all 
or nothing'. Predicting Koebner reactions was not linked to disease activity, i.e. whether 
or not new plaques are forming, but the authors suggested that susceptibility to the 
Koebner phenomenon changes as the disease progresses. They do not present any 
evidence to support this claim. Out of 24 subjects, they reported 25% with positive 
Koebner reaction and 67% with a positive reverse Koebner reaction, but the two reac-
tions never appeared together in the same patient. 
The respondents in the present study were divided as to whether they thought this reac-
tion could happen. Three said they did not know, but 52% said they thought it could not 
happen while 41% said they thought it could. 
Of those who said they thought it could happen, the reasons given were varied. Of the 
explanations offered, one said that psoriasis bleeds easily, and the bleeding spreads it; 
one thought that the healing process continues too long, transforming a normal scar into 
psoriasis; one respondent thought that open wounds 'attract' psoriasis and another 
thought a wound lets germs in. One respondent said she did not treat any skin trauma 
any more because it was the treatment that brought on the psoriasis. The rest had no 
explanation or said they answered from personal experience. 
Question 14 & 15 
Do you think pregnancy can affect psoriasis at all? 
The literature suggests that there is a tendency for psoriasis to improve during pregnan-
cy, but that this does not happen in every case. Lomholt (1963) reported 38% of 70 
pregnant women experiencing a remission or improvement during their pregnancy, 
while 4% experienced exacerbation. This was replicated by Braun-Falco (1972) who 
reported 40% of 85 improving against 17% worsening, and by Farber & Nail (1974) 
who reported 32% of 1018 improving and 18% worsening. However, in these three 
studies, 57%, 40% and 50% respectively reported no change during pregnancy. None of 
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the authors give figures for controls over the same period, so although this evidence is 
suggestive, it is not possible to conclude that pregnancy and psoriasis are related. 
In the present study, 35% said they did not know whether pregnancy affects psoriasis 
while 19% said it definitely does not affect it. Of the 46% who said pregnancy does 
affect psoriasis, four thought it would make it worse and twelve thought it would make 
it better: one thought it would depend on the individual whether it made it worse or 
better. When questioned on the reason for pregnancy affecting psoriasis the responses 
fall into two categories: physical changes and psychological factors (Table 4.6). 
Table 4.6 Reasons for psoriasis changing during pregnancy. 
Physical Changes: Number 
of responses 
Hormonal changes 6 
'Change in your body' 1 
'Change in your blood' 1 
Extra vitamins in the body 1 
Psychological Factors: 
'The anxiety factor' 1 
Feeling less stressed when pregnant 1 
Not worried about how you look when you are pregnant 1 
Worry that the child will get psoriasis if you have 1 
it bad at the time of birth 
Both 
Pregnancy 'upsets your whole mental attitude or body' 1 
Question 16 & 17 
In general, do you think having psoriasis affects the way people sleep? 
The results of the Nottingham Health Profile - Sleep subscale used in the previous study 
indicated that sleep disturbance is a factor in psoriasis. This has been supported by 
Finlay et al (1990) who found a mean score on the Sickness Impact Profile (Sleep and 
Rest Subscale) of 15.2 in psoriatics compared with 0.25 in healthy controls, indicating 
significantly more sleep problems in psoriasis sufferers. 
The present sample were divided as to whether they thought psoriasis affects sleep. 
Only one respondent had no idea, while 46% said it does not affect sleep and 51% said 
it does. One respondent noted that he slept badly when his psoriasis was bad, but ob-
served that he was usually under stress at those times and could not therefore attribute 
poor sleep to psoriasis alone. Other reasons given for psoriasis affecting sleep were: 
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getting warmed up (3 references); being under stress, worrying more at night, or being 
worried about the psoriasis (9 references); itchiness (14 references). 
Question 18 
Can you tell me what actually happens to the skin in psoriasis? 
It was not expected that the respondents would have precise knowledge of the physio-
logical changes that occur in psoriatic lesions. Is was expected however, that they could 
exhibit some broad grasp of the biological mechanisms. 
Quite a high percentage (35%) of respondents said they had no idea what happens to the 
skin in psoriasis. Of those who thought they knew (n=24), 19 gave an explanation 
which was correct, while 5 gave an explanation which was not correct. Of these five, 
two thought that the skin 'just dried up', a further two thought there was 'too much 
blood' in the plaque area, and one said the skin is 'damaged'. 
Question 19 & 20 
Do you think psoriasis may be an early form of any other disease? 
Arthropathy has been shown to occur in psoriasis patients more frequently than non-
sufferers. Leczinsky (1948) reported 6.8% prevalence of arthritis in psoriatics (n=543) 
compared with 0.7% in the same number of non-psoriatic controls. Other than this 
possible link, psoriasis is not an early form of any other disease. 
The majority of respondents (73%) did not think psoriasis was an early form of any 
other disease. Two said they did not know. Of the 22% who thought it was, one thought 
it might turn into skin cancer, one thought it was an early form of eczema, one that it 
had caused her rheumatism, and five that it was an early form of arthritis. However, 
several respondents indicated that they had previously thought it was an early form of 
another disease, but had subsequently changed their minds. Specifically, two had 
thought it could turn into skin cancer, and a further two that it was an early form of 
arthritis. 
Question 21 
In your opinion, is psoriasis a member of a family' of illnesses? 
This question was included to examine further how sufferers located their condition 
within the spectrum of other illnesses: the particular terminology was used because it 
had been used in the previous study, where several subjects had spontaneously indicat-
ed that they thought psoriasis was as member of a 'family' of illnesses but had not been 
specifically questioned as to the extent or nature of that 'family'. 
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The most important source for associating psoriasis with other conditions is Lindegard 
(1986), who reported on diseases associated with psoriasis in 372 sufferers drawn from 
the Gothenburg Population Cohort Study. Within the ful l group, he found significant 
statistical associations between psoriasis and viral infections, hypertension, alcoholism, 
pneumonia, liver cirrhosis, urticaria, and rheumatoid arthritis. Psoriasis in males was 
associated with iritis and ankylosing spondylitis, while in females it was associated with 
lung cancer, diabetes, obesity, myocardial infarction, and asthma. 
Two respondents indicated that they had no ideas on this question while 19 (51%) said 
they did not think psoriasis was a member of a 'family' of illnesses. Of the remaining 
43%, Table 4.7 lists the frequency of diseases mentioned. 
Table 4.7 Diseases mentioned as members of the same 'family' 
as psoriasis 
Disease No of Responses 
Eczema 11 
Asthma 6 
"Other skin diseases" 5 
Arthritis/Rheumatoid arthritis 3 
"Nerves" 3 
Chicken Pox 2 
Hay fever 2 
Shingles 1 
"Children's rashes" 1 
Question 23 & 24 
Once a person has psoriasis, do you think it's possible that it will ever clear away and 
not come back? 
The answer to this question is problematic, since there are no data on those patients who 
simply do not return to the hospital or GP. Nevertheless, there are data on remissions 
(both spontaneous and following treatment) which suggest that psoriasis may remain 
clear for as long as 54 years (Farber & Nail, 1974). It is likely therefore that some 
patients whose psoriasis goes into remission later in life may remain clear for the rest of 
their lives. 
Only one respondent said they did not know the answer to this question, and only one 
said that it might be possible " i f you can get rid of every last bit". Of the remaining 
95%, many answered in very definite terms that even i f psoriasis could be cleared it 
would not remain cleared. 
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Question 25 & 26 
Are there any sorts of diet that are particularly good for psoriasis? 
Dietary manipulation for psoriasis is not usually a feature of mainstream medical treat-
ments, and psoriasis is not thought to be caused by food allergy. 
The responses to this question were mixed, with 22% saying they did not know whether 
particular sorts of diet were good for psoriasis, 38% saying there were no special diets, 
and 40% saying there were. Of the 15 respondents who said diet could help psoriasis, 
the specific foods are listed in Table 4.8. It should be noted that the respondents were 
only asked whether they had heard of any diets, not whether they had tried them or 
were currently using a diet to treat their psoriasis. 
Table 4.8 Foods claimed by psoriasis sufferers to influence their condition 
(numbers indicate respondents who mentioned each item). 
Foods to avoid: Foods causing allergic reactions: 
Acidic or spicy foods 3 
Citrus fruit 3 Fruit 1 
Oranges 
Vitamin C 
Milk and Dairy produce 2 
Fat and fatty foods 3 
Alcohol 1 
Chocolate 2 Chocolate & 3 
Sweet things 
Tomatoes 1 
Tinned foods 1 
Foods good for psoriasis: Special diets for psoriasis: 
Fish 1 Cod and carrots 1 
Raw vegetables & 2 Rice 1 
Natural foods 
Fresh fruit 2 Low protein 1 
In addition, one respondent noted that healthy eating helps any disease, and one said 
that any change of diet would help psoriasis. 
Question 27 
Are all the ointments prescribed by the doctor for psoriasis really just different 
strengths of the same thing? 
Topical treatments available on prescription are derived from quite different and dis-
tinct pharmacological basic agents, reflected in the categories of Table 4.9, but several 
subjects in the previous study had indicated that they thought treatments were "pretty 
much all the same stuff . 
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In response to this question, the majority (54%) thought that all ointments prescribed by 
the doctor for psoriasis are just different strengths of the same thing. A total of 5 re-
spondents (14%) did not know. 
Question 28 
Respondents were asked to name as many treatments as they could that were available 
from a doctor or from the hospital for psoriasis. The treatments named are listed in 
Table 4.9. The final category of unknown treatments comprises treatments mentioned 
as available from medical sources but which cannot be classified according to the Brit-
ish National Formulary (1990). 
The respondents were also asked to rate how effective they thought each treatment was 
and whether or not they had used it. The ratings were chosen from a prepared card with 
the categories: 
Don't know 
Doesn't work at all 
Works a little 
Works a moderate amount 
Works quite well 
Works very well 
scored from 0 ("Don't know") to 5 ("Works very well"). Of a total of 125 ratings of 
treatments, 16 (12.8%) were made on treatments that subjects had heard about but never 
used. Subjects named a median of 3 treatments each, (range 0 to 12), and had personally 
used at some point a median of 3 treatments each (range 0 to 10). The mean rating for 
treatments that had been used was 3.08 (SD 1.38) and the mean estimate of the effec-
tiveness of treatments that had never been used was 3.75 (1.44). 
Question 29 
Respondents were also asked to name as many treatments as they could that they would 
not get from a doctor or from the hospital. The treatments named are listed in Table 
4.10. Of a total of 75 ratings, 21 (28%) were made on untried treatments. Respondents 
named a median of 2 treatments each (range 0 to 10), and had used a median of 1 treat-
ment (range 0 to 10). The mean rating of effectiveness for treatments that had been tried 
was 2.65 (SD 1.53) and the mean estimated effectiveness of treatments that had not been 
used was 2.52(1.37). 
91 
Chapter Four: Patients' Beliefs and Knowledge 
TABLE 4.9 Treatments for psoriasis reported to be available from medical sources 
STEROIDS 
Bemovate cream or 
Bemovate 1 in 4 
Betnovate scalp 
'Cortisone creams' 
Dermovate 
Diprosalic (ointment 
Eumovate 
Nerisone oily cream 
'Steroid cream' 
'Steroid tablet' 
Stiedex 
Synalar 
No. of subjects who had 
heard of this treatment 
12 
1 
6 
1 
9 
5 
1 
1 
1 
1 
1 
1 
E M O L L I E N T S AND SHAMPOOS 
Oilatum emollient 1 
Poly tar shampoo 3 
'Shampoos' 1 
Sudocrem 1 
Unguentum Merck 1 
P H O T O T H E R A P Y AND 
P H O T O C H E M O T H E R A P Y 
PUVA, 'leg PUVA' 8 
Sunbed, sunlamps, heat treatment 8 
DITHRANOL 
Dithranol 4 
Dithrocream (various percentages) 12 
Psorin 1 
No. of subjects who had 
heard of this treatment 
and had also used it 
12 
1 
6 
1 
8 
5 
1 
1 
1 
1 
1 
1 
4 
12 
1 
Mean Rating 
if treatment 
used 
2.9 
4.0 
3.3 
2.0 
3.3 
2.6 
5.0 
1.0 
2.0 
5.0 
4.0 
5.0 
4.0 
3.0 
4.0 
3.0 
1.0 
Mean Rating 
if treaaneni 
not used 
4.3 
4.2 
4.5 
3.0 
4.0 
4.0 
4.0 
2.0 
TAR PREPARATIONS 
Alphosyl 
Psoriderm cream 
'Tar baths' 
Tar + salicylic acid 
Topical tar treatments 
M I S C E L L A N E O U S 
Acitretin 
Arsenic 
Methotrexate 
Salicylic acid 
Vitamin injections 
UNKNOWN 
'Benelate' 
'Cream with bandages' 
'Hormone cream' 
'Injections' 
'Made up cream' 
'Neodex' 
'Novovate' 
'Pill' 
'Psorex' 
'Sugary medicine' 
'Tablet' 
5 
1 
2 
1 
16 
1 
1 
1 
4 
1 
5 
1 
0 
1 
16 
1 
0 
0 
2 
1 
0 
2.6 
1.0 
5.0 
2.6 
5.0 
3.0 
5.0 
2.3 
5.0 
2.0 
1.0 
3.0 
1.0 
4.0 
3.0 
3.5 
1.0 
4.0 
3.0 
5.0 
4.0 
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TABLE 4.10 Psoriasis treatments reported not to be available from medical sources 
P H O T O T H E R A P Y 
Hospital treatment (inc PUVA) 
Sun lamps 
Sun 
No. of subjects who had 
heard of this treatment 
No, of subjects who had 
heard of this treatment 
and had also used it 
1 
4 
6 
Mean Rating 
if treatment 
used 
4.0 
1.8 
4.5 
Mean Rating 
if treatment 
not used 
4.3 
4.0 
TAR PREPARATIONS 
'Brown sticky bandage' 1 
Coal Tar baths 1 
Coal tar poultices 1 
H E R B A L 
Herbal soap 1 
'Herbal treatment' 2 
Potters No. 143 1 
Potters psoriasis ointment 1 
T O P I C A L PREPARATIONS 
Baby oil, witchhazel & glycerine 1 
E45 cream 4 
E45 bath oil 1 
Hand cream 1 
M & S Vegetable oil 1 
Natural yogurt 2 
Nivea cream 2 
Olive oil 1 
Ponds cocoa butter 1 
Probase 3 1 
'Psoreen' 1 
'Psorigei' 1 
Royal jelly & Bergamot cream 1 
Savlon 1 
Vaseline 2 
Vaseline hand cream 1 
Vaseline Demacare 2 
Whiskey & Olive oil 1 
Zam-buk 1 
Zinc & Castor oil 1 
O R A L MEDICATION 
Cod liver oil capsules 1 
Evening Primrose capsules 3 
Vitamin A 1 
Vitamin B6 1 
Yeast 1 
B A T H ADDITIVES 
Sea Salt 1 
Sea Salt (Dead Sea) 1 
M I S C E L L A N E O U S 
Avoiding spicy food 1 
Dead Sea clinic 6 
'Doctor fish of Kangul' 3 
Faith healer 1 
Hypnotism 2 
Lowering stress levels 1 
Regular sea bathing 2 
1 
0 
0 
1 
4 
1 
1 
1 
2 
2 
1 
1 
1 
1 
1 
1 
1 
2 
1 
2 
1 
1 
1 
1 
0 
1 
6 
3 
0 
2 
1 
2 
1.0 
1.0 
1.0 
4.0 
4.0 
3.0 
3.0 
1.0 
5.0 
1.0 
2.5 
1.0 
2.0 
5.0 
1.0 
1.0 
4.0 
1.0 
3.0 
4.0 
1.0 
3.0 
5.0 
1.0 
1.0 
2.3 
2.0 
2.0 
1.0 
1.0 
5.0 
2.0 
4.5 
3.0 
2.0 
1.0 
3.0 
2.8 
1.7 
1.0 
1.5 
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Question 30 
The respondents were asked to rank seven possible sources of information about psoria-
sis (doctors, newspapers, magazines, television, radio, family and friends, and other 
psoriasis sufferers) in order of which had provided them with most information. The 
number of respondents and number ranking each source first are shown in Table 4.11. 
Table 4.11 Ranking of sources of information about psoriasis. 
Source No. of respondents No. ranking first 
who chose this option 
Doctors 37(100) 11 (29.7) 
Magazines 34(91.9) 9(26.5) 
Other psoriasis sufferers 35 (94.6) 6 (17.1) 
Family and friends 34 (91.9) 5 (14.7) 
Radio 32 (86.4) 3 (9.4) 
Television 32 (86.5) 2 (6.3) 
Newspapers 32 (86.5) 1 (3.1) 
Question 32 
Do you think it would help you to control your condition if you knew more about pso-
riasis? 
Only one person said they did not know whether more knowledge about psoriasis 
would help control their condifion, and 6 said it would not. This leaves (81%) who 
thought extra knowledge would definitely help to control the condition. Content analy-
sis of the reasons given revealed eight distinct concepts, listed in Table 4.12. 
Table 4.12 Content analysis of reasons why more knowledge would help 
control psoriasis. 
To discover what treatments are available 13 
A simple desire to know more 9 
To discover and avoid substances or situations that 4 
might precipitate a relapse 
Knowledge would help allay worry about the condition 4 
To increase the motivation to persist with treatments 4 
To be in a position to predict fluctuations in severity 2 
To help cope with having psoriasis 2 
To be able to give other people correct information 1 
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4.6 Discussion 
The interviews lasted between 15 and 45 minutes per subject and gave a total of 263 
pages of transcript. Al l named references to individuals in the text were removed and all 
tapes erased after transcription and checking. Combining the responses under the head-
ings outlined in section 4.3.1, the main themes are summarised below, and where 
appropriate, comparisons made with the results of Lanigan & Farber's (1990) pilot 
study of psoriasis patients' knowledge, and Lanigan & Layton's (1991) survey. 
4.6.1 Etiology 
Neither Lanigan & Farber nor Lanigan & Layton explicitly inquired about beliefs 
concerning the etiology of psoriasis, but two questions in the present study did (Ques-
tions 4 and 6). Two important points arose from the responses to these questions. First, 
two thirds of respondents were aware that there is a hereditary aspect to psoriasis, and 
second, one third of respondents thought that specific groups of people tend to get 
psoriasis more than others. When probed about the reason why these groups get psoria-
sis more often, half the respondents indicated that it was because they were under a lot 
of stress or experiencing a lot of worry. 
There is considerable evidence to suggest that psoriasis is hereditary. Over the past two 
decades theories about the exact nature of the genetic mechanisms have moved away 
from simple single gene dominant or recessive inheritance towards a multifactoral 
inheritance mechanism which suggests that several genes are required in a certain 
combination for psoriasis to be inherited (e.g. Watson et al, 1972, and especially 
Andressen & Henseler, 1982, quoted in Mier & van de Kerkhof). The subjects in the 
present study seemed quite aware of the hereditary aspects. 
There is, however, less evidence concerning the link between stress and psoriasis, and 
no evidence at all that stress causes psoriasis. Some authors have suggested that stress 
can precipitate relapse or flare of psoriasis (e.g. Seville, 1977,1978,1989; Gaston et al, 
1987) but others dispute this link (most notably Shuster, 1979). The main problem with 
research on stress and psoriasis is that almost all the studies have been retrospective: 
that is, patients have been asked to recall stressful life events over a period of months or 
years, and these events were then associated with psoriasis state (which was often also 
assessed retrospectively by the patient at the same time - e.g. Baughman & Sobel, 
1971). Shuster (1979) argues that anamnestic studies of this sort cannot provide evi-
dence for stress-psoriasis links simply because persistent questioning by the dermatolo-
gist leads patients to the belief that there is a link, and they begin to respond according-
ly. Shuster argues further that continual reinforcement of this view from family mem-
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bers and medial care professionals (and newspaper and magazine anicles, it might be 
added) serves to bias any attempt to evaluate stress levels retrospectively. The prospec-
tive investigation by Gaston et al (1987) employed a more carefully designed method-
ology, but only measured psoriasis on the scalp and used only four subjects. While 
those authors found a significant correlation between stress (measured by the Life 
Experiences Survey) and psoriasis in their sample, they themselves note that their re-
sults cannot be generalised. No definite link has therefore been established between 
stress and psoriasis severity. 
As far the the present research is concerned, regardless of whether or not stress actually 
does influence the course of psoriasis, the mere fact that considerable debate is in 
progress would be sufficient for patients to be aware of the possibility, since this debate 
is reflected not only in scientific journals but also in more popular publications accessi-
ble to a wider audience (e.g. Marks, 1981; and more particularly Gibbons, 1985, which 
contains a chapter entitled "The Stress Factor: Learn to control your tension and your 
psoriasis will improve"). While none of the respondents in the present study said they 
had read these specific publications, much has been written in popular magazines which 
reflect this view. 
To summarise, two thirds of respondents knew that psoriasis can be hereditary and one 
third believed that some groups of people get psoriasis more often than others: especial-
ly those whose lifestyles involve stress or worry. 
4.6.2 Pathophysiology 
In common with those who suffer from other medical condifions (e.g. Rheumatoid 
Arthrifis - Hill et al, 1991) respondents in the present study appeared to be quite poorly 
informed about the actual nature of their condition. While two thirds did think that they 
knew what happens to the skin in psoriasis, the remainder said they had no idea at all 
(Question 18). Of those that did think they knew, 21% gave an explanation which was 
not correct. This figure corresponds to 70% of Lanigan & Farber's sample who an-
swered the negatively worded question that skin cells multiply too slowly in psoriasis 
and 63% who correctly answered the same question in Lanigan and Layton's sample. 
A further question related to pathophysiology both in this study and in Lanigan's ques-
tionnaire and concerned the Koebner phenomenon. It is interesting that over half the 
respondents in the present study thought that psoriasis could not develop at the site of 
damaged skin and 41% thought it could. Two thirds of both Lanigan & Farber's Ameri-
can sample and Lanigan & Layton's UK sample were aware of this phenomenon, while 
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only 8% and 10% respectively thought it could not happen. An important factor in 
managing psoriasis is identification of patients who exhibit Koebner responses. It is 
disturbing to note that 52% thought that skin trauma cannot lead to the formation of 
psoriasis lesions. This may be due to personal experience, that is, those who had not 
experienced Koebner reactions have no reason to suspect that they may occur, but it 
may also be that no causal link had been drawn between skin trauma and psoriasis. 
It has been shown that educating patients about their illness can result in significant 
increases in treatment compliance (e.g. Raven, 1988) and may result in a more encour-
aging prognosis (e.g. Kendall et al, 1979). This lack of basic knowledge is therefore 
cause for concern among health professionals and some steps are being taken to remedy 
it (Reynolds, 1978; Caplan, 1973). This is particularly important where individuals may 
be worried about psoriasis leading onto other diseases. Twenty two percent of respond-
ents in the present study thought that psoriasis was an early form of some other condi-
tion (mostly arthritis, but skin cancer was also mentioned), and this may reflect a 
misunderstanding. For example, one possible side-effect of prolonged PUVA treatment 
can be skin cancer, yet psoriasis per se is not statistically associated with increased 
levels of cancer (Lindelof, 1991). Another factor may be that anti-cancer drugs (e.g. 
methotrexate) are sometimes used to treat psoriasis, which could lead people to link the 
two conditions. It is also possible that knowledge of the existence of psoriatic arthropa-
thy may have led some respondents to believe it to be a progressive process from skin 
pathology to joint problems. 
To summarise, respondents in the present study were quite poorly informed about the 
physical nature of their condition and about half were unaware that skin trauma can lead 
to psoriasis. The idea of psoriasis being an early form of another condition was present, 
most often relating to cancer or arthritis. 
4.6.3 Course of psoriasis 
In common with Lanigan's samples, the current sample did not generally think that 
psoriasis is infectious or spread by autoinfection (Question 10), although one woman 
did explain the Koebner phenomenon in terms of open wounds "letting germs in". 
Some evidence of deeper knowledge of the physiological mechanisms which influence 
the course of psoriasis came from subjects' explanations of why they thought pregnancy 
could affect psoriasis (Question 14). 'Hormonal changes' was the most frequently cited 
explanation, which suggests that some patients may be aware that some authors have 
found peaks of age at onset around puberty and the climacteric (e.g. Gunawardena et al, 
1978; Holgate, 1975), i.e. at times of hormonal changes. 
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It is interesting to note that 95% of respondents thought that psoriasis would never clear 
and stay cleared permanently. This belief may be a reflection of the fact that there is no 
cure for psoriasis. Over 80% of subjects in both Lanigan's samples thought that there 
was no cure for psoriasis and the majority of the remainder were unsure, rather than 
suggesting that there is cure. Thus, even though the data presented by Farber & Nail 
(1974) concerning remissions indicate that extremely long periods clear from psoriasis 
are possible, the vast majority of sufferers do not believe this will happen to them. 
One final question in the present study has bearing on this explanatory model category: 
that is, whether subjects believed acquiring more knowledge about psoriasis would help 
them control their condition (Question 32). Over 80% of subjects said they thought 
more knowledge would help them, and the two most common reasons given were to 
discover what new treatments were available and simply a desire to know more about 
the condition. Interesfingly, Ramsay & O'Reagan (1988) reported that 86% of their 
sample of 104 psoriasis patients thought they would be able to cope better with their 
condifion i f the general public were more knowledgeable about psoriasis, suggesting 
that the general public have relatively littie knowledge about the condition. Indeed, 
Lanigan & Farber's study compared responses of psoriasis sufferers to those of the 
general public and Lanigan & Layton concluded that these responses "demonstrated 
such a low level of knowledge about the condition that it provided no useful informa-
tion". In Jowett & Ryan's (1985) study of dermatology patients' feelings about medical 
care, only 50% said they were satisfied with the information they had been given. 
To summarise, respondents in general did not think their psoriasis would ever clear and 
not return, even though evidence suggests that this is possible, but they did show some 
knowledge of possible hormonal involvement in the course of psoriasis. The majority 
thought more knowledge of psoriasis would help them control their condition. 
4.6.4 Treatment 
Thirteen and a half percent of Lanigan & Farber's sample and only 6.5% of Lanigan & 
Layton's sample of UK psoriasis sufferers thought that specific diets could affect psoria-
sis. In contrast to these findings, 40% of the current sample thought that particular foods 
or specific diets could help psoriasis, although no information was collected on whether 
the respondents had actually tried any particular diet. Jensen (1990) reported 11.6% of 
491 psoriasis outpatients (postal questionnaire) using diet change as 'alternative' thera-
py for psoriasis compared with 18.2% of 424 patients suffering from atopic dermatitis. 
The discrepancy between these findings can be explained by the wording of the ques-
tion. Jensen was interested in whether patients had or were currently using diet change 
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as therapy, while the present study inquired whether subjects thought diet manipulation 
might help psoriasis. In contrast to this, Lanigan & Farber's questionnaire required a 
response to the item "Specific diets may clear psoriasis" while Lanigan & Layton 
changed the wording of this item to "Specific diets may cure psoriasis" (my emphases). 
Given that 87% of their sample agreed that there is no cure for psoriasis and a further 
8% were unsure, it is hardly surprising that such a small number thought diets would 
"cure" psoriasis. 
It had been noted in the previous study that subjects often remarked that they had tried a 
large number of treatments for their psoriasis, and this was examined further in the 
present study. There are a very large number of medical treatments available for psoria-
sis based on a range of basic pharmaceutical agents: the group as a whole mentioned 32 
specific treatments by name and described a further 11 whose name they could not 
remember. However, individual respondents named only a median of three treatments 
that they had heard of, and said they had used only a median of three. 
Respondents estimated the effectiveness of treatments they had never used higher than 
treatments they had used. This reinforces the impression that psoriasis sufferers are 
keen to try almost any treatment and retain some hope that they may find one that 
works better than those they have already tried. This is also reinforced by the apparent 
willingness to try "alternative" medicines. The respondents in the present study could 
name a median of two alternative treatments and had used a median of one, but the 
lower ratings for effectiveness of these treatments suggests that they are not particularly 
effective. Jensen (1990) found that 42.5% of his sample of 506 psoriasis patients had 
used, or were currently using 'alternative' treatments, which compares to 62% of re-
spondents in the present study admitting that they had used alternative treatments at 
some point in the course of the disease. However, this figure should be interpreted with 
care since some of the 'alternative' treatments named in the present study were in fact 
standard medical treatments (e.g. PUVA, coal-tar baths). Wadswoth, Butterfield & 
Blaney (1971) have suggested that about 75% of illness episodes are treated by non-
medical practitioners or by self-medication, and the data from the present sample sup-
ports this. The motivation to seek non-medical therapy may be related to the general 
dissatisfaction with medical treatment noted in the previous study and examined in 
more detail by Jowett & Ryan (1985), who found that only 19% of a sample of 100 
dermatology patients (including psoriasis patients) expressed positive opinions about 
their GPs. 
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To summarise, subjects do tend to use "alternative" treatments, including diet change, 
but report that medical treatment is more effective than non-medical treatment, even 
though the majority think that all medical treatments are based on the same fundamental 
agents. 
4.6.5 General psoriasis knowledge 
Some of the data collected in the present and previous studies does not f i t easily into 
any of Kleinman's explanatory model categories. It does, nevertheless provide useful 
insights into lay perceptions of psoriasis. 
Epidemiology 
Informal discussions with patients had suggested that their estimates of the prevalence 
of psoriasis would be high, and 92% of subjects made some estimate of the prevalence 
of psoriasis by choosing an option from a card. Lanigan & Farber had suggested that 
some of their respondents may have estimated incorrectly because of a fundamental 
misunderstanding of the concept of percentages, so the options of the card for the 
present study were phrased as: 
Don't know 
Less than 1 in 100 
About 2 in 100 
About 5 in 100 
About 10 in 100 
About 15 in 100 
About 20 in 100 
More than 20 in 100 
The modal response was in the 5% category, which may be due to patients being aware 
of hospital or clinic presentation rates rather than true prevalence. However, the analy-
sis of response phraseology would tend to suggest that individuals were simply guess-
ing and were not in fact aware of any figures. Given that these guesses tended to be 
over- rather than under-estimates, it is possible that they were based on the number of 
people that sufferers had come into contact with at dermatology clinics: particularly 
those subjects who had received in-patient or PUVA treatment in the past. Forty six 
percent of Lanigan and Farber's American sample estimated disease prevalence to be 
between 1 and 7%, but the remainder were quite widely inaccurate, ranging from 
0.001% to 75%. Lanigan & Layton found an even wider range of estimates (1-99%), 
which supports their explanation about fundamental misunderstandings of percentages. 
The estimates obtained in the present study were anchored to a minimum of <1% and a 
maximum of >20% and the responses were forced choice rather than free estimates, 
which explains why there is somewhat less variation in the present study than in Lani-
gan & Farber's. Those authors did not report the precise wording of their question, so it 
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is impossible to ascertain whether respondents were instructed to guess if they did not 
know the answer. 
Lanigan & Farber found 66% of their sample reporting that men and women suffer in 
equal numbers, and this compares with 68% in the present study. It is interesting to note 
that the reasons given for any inequality in the present study were based either on 
personal knowledge of other sufferers, or on the assumption that worry or stress causes 
psoriasis and one sex is affected by these factors more than the other. Savin (1970) 
found that half of his patients related psoriasis to worry, and this appears to be a 
commonly held belief. 
To summarise, psoriasis sufferers tend to overestimate the prevalence of psoriasis, think 
that men and women suffer to the same degree, and are generally quite well aware of 
the hereditary nature of the condition. 
4.6.6 Sources of information 
Most of the respondents reported that they had received information about psoriasis 
from all the sources listed. About one third ranked the doctor (which included both GP 
and hospital dermatologist) as their best source of information, which compares with 
72% of Lanigan and Layton's sample and 90% of Lanigan & Farber's sample. This 
supports the findings of Elliot-Binns (1973, 1986) who reported 95% of GP patients 
obtaining information about their condition from a variety of sources, and Frankel 
(1991) who specifically cited television, magazines and other media sources as valuable 
information-providing resources for the lay public. 
4.7 Conclusions 
This study has examined patients knowledge and beliefs about psoriasis through the 
vehicle of a semi-structured interview. Levels of knowledge are broadly comparable to 
those found by Lanigan & Layton (1991), but less comparable to those found by Lani-
gan & Farber (1990). This may be due to the fact that the latter used an American 
sample while subjects in the former were British. 
The findings are of interest on two levels. First they provide valuable information about 
the levels of knowledge that psoriasis sufferers have about their condition and, because 
the methodology allowed respondents to voice their own opinions instead of simply 
choosing options, give a broader picture of how sufferers perceive their condition than 
has been obtained by more restrictive methodologies. The beliefs that sufferers have 
about their condition influence the way they respond to it psychologically, and the way 
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they treat it physically, and investigations of the eflects of psoriasis all too often fail to 
take this into account. Second, the results of this study should be of interest to medical 
practitioners who treat psoriasis sufferers. There is clear evidence that some important 
aspects of the condition are not understood by the sufferers and the results of this study 
can be used to guide information-providing strategies in future. Beliefs about medical 
conditions are influenced by the knowledge patients have about the condition, and 
studies such as this one which evaluate that knowledge help clarify issues of importance 
to sufferers. 
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5.1 Introduction 
The results of the first study reported in Chapter 3, showed that psoriasis sufferers are 
more anxious, have more cognitive and somatic anxiety symptoms, are more depressed, 
differ in levels of self-esteem, have more trouble sleeping and more pain than controls. 
This may indicate that psoriasis sufferers in general have higher levels of these varia-
bles regardless of the state of their psoriasis, but it may also be the case that levels of 
these variables are dependent on how much of the body is affected by psoriasis. This 
question could not be answered with the data obtained in Chapter 1 because the psoria-
sis was very mild. The aims of the present study are first to ascertain whether these 
variables fluctuate within individuals as the severity of psoriasis alters and second, to 
examine in more detail the nature of sleep and pain problems associated with psoriasis. 
5.2 Questionnaires 
The results of the first study showed levels of depression in psoriasis sufferers to be 
significantly higher than in non-sufferers, but not generally high enough for classifica-
tion as a clinical "case". Snaith (1987) has argued that the most appropriate measures of 
depression concentrate on anhedonic symptoms, such as loss of pleasure in everyday 
activities, and avoid symptoms which may coincide with those occurring in somatic 
illness, such as insomnia or excessive weight variation. This argument is particularly 
relevant when people who are physically ill are under investigation, as is the case in the 
present study. 
With this in mind, Zigmond & Snaith (1983) have developed the Hospital Anxiety and 
Depression Scale (HADS) to assess levels of depression and anxiety in physically i l l 
populations. The initial validation used 100 hospital outpatients aged between 16 and 
65 and presenting with a variety of conditions, and the results suggested that scores on 
the HADS identify possible or probable "cases" i f appropriate cutoff points are chosen. 
The range of scores is 0 to 21 for both anxiety and depression (derived from seven 
questions in each category), and Zigmond & Snaith suggest a cutoff point of >8 for a 
borderline or possible "case" and >11 for a probable "case", as assessed by clinical 
interview. Perhaps of more importance for the present study, the authors also demon-
strated that the HADS can be used to measure levels of depression and anxiety which 
they showed correlated with clinical assessments of severity, rather than simply to clas-
sify people as depressed or not depressed, anxious or not anxious. By comparing scores 
on the HADS in a physically i l l group with scores from a sample matched for age and 
sex who were not physically i l l , Zigmond and Snaith were able to demonstrate that 
scores were not contaminated by the presence of physical illness. Finally, since depres-
sion and anxiety tend to co-exist, it is important that any measuring instrument success-
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fully distinguishes the two. Zigmond & Snaith found no significant correlation between 
anxiety scores and scores for depression on the HADS in a subsample of patients who 
exhibited only one of the conditions, as diagnosed by clinical interview. 
Wilkinson & Barczak (1988) have subsequently validated the HADS using ROC analysis 
in a sample of 100 general practice patients, and found a specificity (that is 1 - the false 
positive rate) of 0.86 which is comparable to that found for the GHQ in the same popula-
tion (0.85), and a sensitivity (that is, the true positive rate) of 0.90 compared with 0.77 
for the GHQ. They also noted that the HADS was easier for subjects to complete. Because 
of its ability to measure pre-clinical levels of both depression and anxiety as well as 
identifying cases, coupled with the impressive validity data and acceptability to pa-
tients, the HADS was used in the present study. 
The results of the previous study showed psoriasis sufferers had significantly more 
anxiety symptoms than controls on the Cognitive Somatic Anxiety Questionnaire 
(CSAQ). Validity data for that instrument has already been presented (Chapter 3), and 
the same questionnaire was used in the present study to further examine the relationship 
between anxiety symptom type and psoriasis severity. Self-esteem was assessed with 
the Self-Esteem Questionnaire (Robson, 1989) used in the previous study: validity data 
have already been presented for that instrument (Chapter 3). 
The measurement of sleep quality is problematic because the quality of sleep is neces-
sarily subjective. While it is quite possible to measure some of the more observable 
aspects of sleep: sleep latency, sleep duration, number of awakenings, for example, as 
well as more serious symptoms of sleep pathology, these only form part of sleep quali-
ty. However, there is evidence that these aspects of sleep quality measured by self-
report questionnaires not only correlate quite well with objective measurement (e.g. 
Lewis, 1969) but also with health status (e.g. Belloc & Breslow, 1972; Frederick, 
Frederichs & Clark, 1988). There are several self-report sleep questionnaires available 
but many have not been properly validated, or were designed to assess sleep patterns in 
specific populations. There are, however, two well validated general self-report ques-
tionnaires available. For the purposes of the present research, the Rehabilitation Re-
search Centre Sleep Habit Questionnaire devised by Hyyppa& Kronholm (1987) was 
rejected because, although its statistical properties are acceptable, the translation into 
the English language version is quite crude. The questionnaire chosen was the Pitts-
burgh Sleep Quality Index (PSQI) developed by Buysse and his team at the University 
of Pittsburgh (Buysse et al, 1989). The questionnaire elicits information about sleep 
habits over the preceding month. This timescale was used to discriminate persistent 
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from transient sleep problems. As well as a global sleep quality score in the range 0-21 
(higher scores corresponding to poorer sleep quality), the instrument provides seven 
subscales that examine sleep quality, sleep latency, sleep duration, habitual sleep effi-
ciency, sleep disturbances, use of sleeping medication, and daytime dysfunction. These 
subscales in turn correspond to areas examined in clinical interviews for sleep prob-
lems. Validation studies of the PSQI in populations of "good" and "poor" sleepers, 
depressive s, and individuals suffering from disorders of initiating and maintaining sleep 
and disorders of excessive somnolence revealed a Cronbach's aof 0.83, indicating good 
internal consistency, and test-retest correlation was 0.85 on the global sleep quality 
score, and between 0.65 and 0.84 on the subscale scores. The questionnaire revealed 
different patterns of scores for each of the groups studied, both for the subscales and for 
the global sleep quality score, and thus discriminates "good" and "poor" sleepers, as 
well as depressed patients and patients with diagnosed sleep disorders. The PSQI was 
therefore used in the present study. 
Melzack & Wall (1982) have demonstrated that the measurement of pain is not simply a 
matter of measuring pain intensity. Rather, they suggest that the quality of pain is of as 
much importance as its intensity. Indeed Melzack (1975) wrote: 
To describe pain solely in terms of intensity is like specifying the visual world only in 
terms of light flux without regard to pattern, colour, texture, and the many other dimen-
sions of visual experience, (p.278). 
In an attempt to provide a reliable means for assessing pain quality, Melzack (1975) 
developed the McGill Pain Questionnaire (MPQ) based on work by Melzack & Torger-
son (1971) which identified and categorised lists of verbal descriptors of the pain expe-
rience. This instrument gives information on the quality of pain in three main areas: 
sensory, which contains words to describe how the pain feels, affective, which contains 
words to describe how the pain is interpreted, and evaluative, which offers an overall 
judgment of the pain. There is a further category labelled miscellaneous which includes 
other pain descriptor words not classified in the above categories (although Chapman et 
al, 1985, have noted that these seem to be mostly sensory descriptors), and finally a 
scale labelled present pain intensity which gives a rating of how bad the pain is. Mel-
zack's (1975) original study involved rating of the pain descriptor words so that a scale 
was devised which represents equally spaced ratings. Because of its ability to describe 
the quality of the pain experience, the MPQ was used in the present study. 
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5.3 Subjects 
Part of the problem with the previous study was the generally low level of psoriasis, so 
a group of sufferers whose disease was more severe was required for the present study. 
PUVA therapy (oral doses of 8-methoxypsorlen followed by controlled ultra-violet type 
A exposure) is a relatively expensive, though effective, treatment for psoriasis, and as 
such is usually reserved for those cases where psoriasis does not respond to topical or 
systemic treatment, where these are contraindicated, or where the condition is particu-
larly severe. Thus, in order to obtain a sample whose condition was severe, patients 
undergoing PUVA therapy were taken as the sampling frame for the present study. Over 
a three month period, all patients currently undergoing PUVA therapy at Chester-le-
Street General Hospital were approached by the nursing staff and asked to participate. 
A brief outline of the study was given in writing to the patients and written consent was 
obtained at that time. A total of 35 patients agreed to take part; 54% were females and 
46% males. The mean age was 46 yrs (SD 17.8, range 15-74) and the mean time since 
onset of psoriasis was 23.3 years (14.4, 1-58). 
5.4 Procedure 
Ethical permission was obtained from the North Durham Health Authority Ethics 
committee for this study (ref EC275/90). 
One subject did not provide a telephone number so she was contacted by letter, but the 
remainder were contacted by telephone and a time arranged for them to be visited in 
their own homes. They were each asked to complete the five questionnaires, and a 
record was made of the extent of their psoriasis using SKINMAP. Visits lasted between 
20mins and 1 hour. Subjects were told that the study would involve being seen on two 
occasions, and a further visit was organised twelve weeks later, when the same ques-
tionnaires were completed and a further record of disease severity made. 
Subjects were informed that the study was concerned with how they felt about their 
psoriasis and the general nature of the questionnaires was explained to them. They were 
also asked whether they would mind having their psoriasis recorded on computer. None 
refused: indeed, many expressed interest at what was to them a novel way of recording 
their disease. A record was made of their condition, then they were asked to complete 
the questionnaires. Subjects were not told the precise nature of the variables each ques-
tionnaire examined, but for each questionnaire the instructions were read aloud to the 
subject and they were asked whether they understood the instructions. Any questions 
were answered as fully as possible. There were no objections or difficulties, other than 
considerable deliberation in some cases about the answer which best described how 
they felt. 
107 
Chapter Five: Prospective Investigation 
Minimal debriefing was given at the end of the first session. Those subjects who 
pressed for explanation were asked whether they would mind waiting until after the 
second session for a ful l debriefing. Some subjects asked to see the mapping made of 
their condition, but again they were asked to wait until the end of the second session. 
Al l appeared to accept this. At the end of the second session the subjects were told that 
the study was concerned with examining levels of depression, anxiety, self-esteem, and 
associations between psoriasis and physical problems such as sleep disturbance and 
pain. It was stressed that examining these variables in no way implied that the subject 
was depressed or anxious. I f subjects asked to see the SKINMAP record they were 
shown it. Any questions were answered ful ly . The subjects were urged to consult 
medical advice for answers to questions about treatment, problems controlling psoriasis, 
etc. 
5.5 Analyses 
In the analyses that follow, sex was coded 0 for males and 1 for females. For those 
variables where parametric analysis was appropriate, regression analyses were used us-
ing GLIM 3.77. Al l variables that were not statistically significant were removed unless 
their removal affected the logic of the model. Where a difference between sexes was 
apparent in the slopes of the regression lines, the difference between intercepts for sexes 
was retained in the model regardless of whether or not it's coefficient was significantly 
different from zero. Otherwise, the variable 'sex' was only retained if its coefficient was 
significantly different from zero. Age at onset of psoriasis was not statistically signifi-
cant in any of the analyses. For the sake of clarity, the intermediate steps of the analyses 
are not reported. The results of the analyses are presented in section 5.6, their meaning 
and implications are interpretted in section 5.7. 
5.6 Results. 
All except one of the subjects completed both sets of questionnaires with no missing 
data since the data were checked at the time of the visit and any omissions rectified. 
Unfortunately one subject died between the first and second assessment, so for the 
analyses below, figures quoted for the first assessment are based on 35 subjects and for 
the second on 34. Comparisons between assessments are based on the 34 subjects who 
completed both sets of questionnaires. 
The mean area of coverage was 4.2% (SD 4.7, range 0 to 22.3%) on the first assessment 
and 3.1% (4.0,0 to 18.9%) on the second. It can be seen therefore that the distributions 
are positively skewed and the means and standard deviations are given only for com-
parison with other studies. The median area of coverage at the first assessment was 
2.51% (semi-interquartile range 1.85) and at the second was 1.55% (2.62). The areas of 
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coverage measured on both occasions are plotted in Figure 5.1, where it can be seen 
that for some subjects the disease improved, for some it worsened, and for some there 
was relatively no change. 
Figure 5.1 Area of coverage of psoriasis estimated by SKINIVIAP on two occasions 
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5.6.1 Depression 
Taken individually, the scores for the depression scale of the HADS would suggest that 
on neither occasion was the group a 'depressed' group. Set against a suggested cutoff 
point of >8, the mean score on the first assessment was 3.3 (SD 2.5, range 0 to 10) and 
on the second assessment 3.5 (3.1, 0 to 11). The mean change in depression scores was 
0.2 (3.1, -8 to +10). The scores at the second assessment are particularly skewed. The 
median at the first assessment was 2 (SIR 1.5) and at the second was 2.5 (2.5). Three 
subjects scored above 7 at the first assessment, indicating possible depression, while 
five scored above 7 at the second assessment. 
From the regression analysis summarised in Table 5.1, depression scores at the second 
assessment (time 2) were predicted by area of coverage, by change in area of coverage 
between the first and second assessments, and by time since onset of psoriasis, once the 
starting levels of depression had been taken into account. There was a significant differ-
ence between males and females in the coefficient for change in area of coverage and 
area of coverage at the second assessment. The value for R^ was 0.67. 
The Filliben correlation coefficient (Filliben, 1974), which is a measure of the normali-
ty of residuals, was 0.99. On 26 degrees of freedom, a value for this correlation coeffi-
cient above 0.9590 indicates an acceptable approximation to a normal distribution. 
Table 5.1 Summary of estimates and analysis of variance for the regression of HADS 
depression at time 2 on five predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) -0.55 0.95 -0.58 -
Sex (males=0, females=l) -0.39 1.04 -0.38 -
Depression at time 1 0.52 0.15 3.46 0.01 
Area of coverage at time 2 -0.065 0.12 -0.54 -
Area of coverage at time 2 x Sex 0.48 0.22 2.18 0.05 
Change in area of coverage 0.86 0.20 4.40 0.001 
Change in area of coverage x Sex -0.76 0.24 -3.12 0.01 
Time since onset (years) 0.10 0.028 3.63 0.01 
Analysis of Variance 
Source df SS MS F Sigp< 
Regression 7 215.3 30.76 7.47 0.001 
Residual 26 107.2 4.12 
Total 33 322.5 
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Chronological age is not significantly asociated with depression scores at time 2. 
5.6.2 Anxiety 
The scores for anxiety on the HADS on both occasions were moderately high. On the 
first assessment the mean was 7.6 (SD 4.0, range 0 to 19) and on the second the mean 
was 7.1 (4.1, 0 to 18). The mean change in scores was -0.5 (2.8, -6 to +1). Twelve sub-
jects scored above 7 at the first assessment and the second assessment, while 7 scored 
above 10 at the first assessment compared with 6 at the second. 
The regression model for anxiety scores at time 2 was somewhat less complex than for 
depression because there were no significant differences between sexes. Once the initial 
level of anxiety had been taken into account, the best predictors of anxiety at time 2 
were area of coverage, change in area of coverage since time 1, and time since onset of 
psoriasis. This model fits the data well as evidenced by an value of 0.75 and a Filli-
ben correlation coefficient of 0.99 for the residuals. The regression parameter estimates 
are summarised in Table 5.2 with an analysis of variance. 
Table 5.2 Summary of estimates and analysis of variance for regression of HADS 
Anxiety scores at time 2 on four predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) -1.31 1.17 -1.12 -
Anxiety at time 1 0.88 0.097 8.64 0.001 
Area of coverage at time 2 0.21 0.098 2.14 0.05 
Change in area of coverage 0.53 0.15 3.52 0.01 
Time since onset 0.076 0.027 2.88 0.01 
Analysis of Variance 
Source df 5S MS F Sigp< 
Regression 4 404.61 101.15 21.43 0.0001 
Residual 29 136.92 4.72 
Total 33 541.53 
As with the depression scores, chronological age is not significantly associated with 
anxiety at time 2. 
As far as cognitive and somatic components of the anxiety reaction are concerned, the 
scores on the CSAQ were similar at both assessments. The mean score at the first as-
sessment on the Cognitive subscale was 15.6 (6.4, 7 to 29) and on the second assess-
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ment was 16.1 (8.1, 7 to 35). This compared with 14.7 (4.8, 9 to 23) on the Somatic 
subscale at the first assessment and 14.6 (5.9, 7 to 27) at the second. The mean changes 
in scores were 0.26 (4.9, -8 to -1-12) on the Cognitive scale and -0.12 (4.2, -13 to +8) 
on the Somatic. Neither CSAQ scores nor the ratio of CSAQ scores at time 2 are signifi-
cantly related to any independent variable except levels at time 1. The ratio of cogni-
tive to somatic symptoms was 1.08. 
5.6.3 Self Esteem 
The SEQ gives a total self-esteem score and five subscale scores: contentment, worthi-
ness and personal significance; competence, resilience and control; attractiveness; 
value of existence; and self evaluation. The range of scores for each subscale is 0-7. 
Total SEQ 
The mean total score at the first assessment was 142.7 (20.7, 106 to 200) and at the 
second was 146.8 (24.1, 97 to 191). This produced a mean change of 4.0 (18.0, -57 to 
-1-50). Once the initial total SEQ score had been taken into account, total SEQ at time 2 
was significandy predicted by change in area of coverage, but there was a significant 
difference between males and females (Table 5.3). The value for R^ was 0.71 and the 
Filliben correlation coefficient was 0.99, both of which indicate that the model fits the 
data well. Neither chronological age nor time since onset of psoriasis were significantly 
associated with total SEQ. 
Table 5.3 Summary of estimates and analysis of variance for regression of Total SEQ 
scores at time 2 on four predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) 28.54 19.29 1.48 -
Sex (males=0, females=l) -3.59 5.50 -0.65 -
Total SEQ at time 1 0.85 0.13 6.72 0.001 
Area of Coverage at time 2 -0.93 0.63 -1.48 -
Change in area of coverage -5.90 1.37 -4.33 0.001 
Change in area of coverage x Sex 4.90 1.70 2.89 0.01 
Analysis of Variance 
Source df SS MS F Sigp< 
Regression 5 13649.5 2729.9 13.76 0.001 
Residual 28 5554.5 198.4 
Total 33 19204.0 
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Contentment, worthiness and personal significance 
The mean scores for this subscale were 3.9 (1.2, 1.6 to 6.4) at the first assessment and 
4.3 (1.2, 1.4 to 6.7) at the second. The mean change in scores was 0.4 (1.1, -3.6 to 
-1-2.9). None of the variance in this scale can be accounted or by any of the independent 
variables except the score at time 1. 
Competence, resilience and control. 
The mean scores for this subscale were 5.4 (0.8, 4.0 to 7.0) at the first assessment and 
5.5 (0.8, 3.8 to 7.0) at the second. The mean change in scores was 0.07 (0.7, -12.1 to 
-1-1.5). Once the initial scores had been accounted for, absolute area of coverage, change 
in area of coverage and sex were found to be significant predictors (Table 5.4). With an 
R^ of 0.72 and a Filliben correlation coefficient of 0.99, the model can be seen to fit the 
data very well. 
Table 5.4 Summary of estimates and analysis of variance for regression of Compe-
tence, Resilience and Control SEQ scores at time 2 on four predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) 1.40 0.61 2.28 0.05 
Sex (males=0, females=l) -0.079 0.24 -0.33 -
Competence etc. scores at time 1 0.78 0.11 6.87 0.001 
Area of coverage at time 2 0.0072 0.027 0.26 -
Area of coverage at time 2 x Sex -0.13 0.046 -2.77 0.02 
Change in area of coverage -0.16 0.047 -3.28 0.01 
Change in area of coverage x Sex 0.15 0.059 2.45 0.02 
Analysis of Variance 
Source df SS MS F Sig p< 
Regression 6 16.80 2.80 11.52 0.001 
Residual 27 6.56 0.24 
Total 33 23.36 
Attractiveness 
The mean score for this subscale at the first assessment was 5.2 (0.9, 3.4 to 7.0) and at 
the second 5.3 (0.9, 3.6 to 7.0). The mean change between assessments was 0.01 (0.9, 
-2.2 to 2.4). 
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The the regression model fitted the data somewhat less well with an R^ value of 0.48 
and a Filliben correlation coefficient of 0.98. Time since onset was not a significant 
predictor, but there was a significant difference between sexes for the effect of change 
in area of coverage, the only statistically significant independent variable once starting 
levels at time 1 had been entered into the model (Table 5.5). Chronological age is not 
significantiy associated with attractiveness scores. 
Table 5.5 Summary of estimates and analysis of variance for regression of 
Attractiveness SEQ scores at time 2 on four predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) 2.29 0.72 3.20 0.01 
Sex (males=0, females=l) 0.021 0.25 0.083 -
Attractiveness scores at time 1 0.58 0.14 4.24 0.001 
Area of coverage at time 2 -0.049 0.033 -1.49 -
Change in area of coverage -0.22 0.066 -3.25 0.01 
Change in area of coverage x Sex 0.21 0.083 2.51 0.02 
Analysis of Variance 
Source df SS MS F Sig p< 
Regression 5 12.00 2.40 5.12 0.01 
Residual 28 13.13 0.47 
Total 33 25.13 
Value of existence 
The mean score on this subscale at the first assessment was 5.01 (1.0, 3.2 to 7.0) and at 
the second 4.97 (1.4,1.2 to 7.0). The mean change was -0.04 (1.2, -4.5 to +1.8). There 
are no sex differences in this model (Table 5.6) which is somewhat simpler than the 
others on the self-esteem questionnaire. Only change in area of coverage and time since 
onset are statistically significant once starting scores have been taken into account. The 
value for R^ was 0.58, which suggests a fairly parsimonious model, and the Filliben 
correlation coefficient of 0.98 indicates that the residuals are quite normally distributed. 
Chronological age is not significantiy associated with this subscale. 
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Table 5.6 Summary of estimates and analysis of variance for regression of Value of 
Existence SEQ scores at time 2 on four predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) 0.85 0.84 1.00 -
Subscale score at time 1 0.96 0.17 5.70 0.001 
Area of coverage at time 2 -0.0069 0.042 -0.17 -
Change in area of coverage -0.18 0.055 -3.21 0.01 
Time since onset (years) -0.037 0.012 -3.02 0.01 
Analysis of Variance 
Source df SS MS F Sig p< 
Regression 4 36.33 9.08 10.02 0.001 
Residual 29 26.28 0.91 
Total 33 62.61 
Self evaluation 
The mean score at the first assessment was 4.9 (1.6, 0.5 to 7.0) and at the second 5.1 
(1.5, 0.0 to 7.0) which gives a mean change in self-evaluation scores of 0.09 (1.56, -3.5 
to +5.5). None of the variance in this subscale could be accounted for by any of the 
independent variables and there were no differences between males and females. 
5.6.4 Sleep quality 
The PSQI returns a global sleep quality score and seven subscales. None of the sub-
scales showed any relationship with psoriasis-specific variables. 
Total Sleep Quality Scores. 
The mean total sleep quality score at the first assessment was 5.71 (4.0, 0 to 15) and at 
the second assessment was 5.68 (4.1, 0 to 16). This results in a mean change over as-
sessments of 0.12 (2.6, -7 to -1-6). These data are moderately skewed. The median value 
at the first assessment was 5.0 (3.0) and at the second was 4.5 (2.5). 
The regression model summarised in Table 5.7 is quite complex. Once the starting 
levels have been taken into account, scores on this scale are predicted by change in area 
of coverage and the time since onset of psoriasis, but there is an interaction with sex on 
this variable. The analysis produces an of 0.76, which is high, and the Filliben corre-
lation coefficient was 0.99 which confirms that the residuals are approximately normal-
ly distributed. 
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Table 5.7 Summary of estimates and analysis of variance for regression of Total Sleep 
Quality scores at time 2 on five predictor variables. 
Parameter Estimate SE t Sigp< 
(Constant) -2.42 1.21 -2.00 -
Sex (males=0, females=l) 4.04 1.54 2.62 0.02 
Global PSQI score at time 1 0.85 0.10 8.23 0.001 
Area of coverage at time 2 0.078 0.12 0.68 -
Change in area of coverage 0.24 0.13 1.88 -
Time since onset 0.12 0.045 2.70 0.02 
Time since onset x Sex -0.13 0.062 -2.05 0.05 
Analysis of Variance 
Source df SS MS F Sigp< 
Regression 6 418.33 69.72 14.59 0.001 
Residual 27 129.11 4.78 
Total 33 547.44 
5.6.5 Pain 
The MPQ returns one scale for the rating of pain intensity (Present Pain Intensity - PPI) 
and five scales comprising pain descriptors (Pain Rating Index - PRI - scales of sensory, 
affective, evaluative, miscellaneous, and total). The respondents were instructed to 
assess the pain they may be experiencing from psoriasis, not from any other illness they 
might have. Only the total PRI scale is suitable for regression analysis. The remaining 
four pain rating subscales and the Present Pain Index are therefore analysed by chi-
square. The purpose of this study was to ascertain whether change in severity of the 
condition was related to change in the dependent variables. The subscale data were 
therefore organised as 2 x 3 contingency tables and analysed by chi-square. The two 
columns of the contingency tables correspond to 1) improvement of psoriasis between 
time 1 and time 2, 2) worsening of psoriasis over that period. The rows of the contin-
gency tables correspond to subscale scores which l) improved over assessments, 2) 
which did not change, and 3) which worsened between assessments. The null hypothesis 
in each case was that the distribution of proportions in each cell are due to chance. It 
can be seen that some of the expected frequencies in the contingency tables are rather 
small. Debate about whether small expected frequencies should preclude the use of the 
chi-square test has effectively been resolved by Bradley et al (1979), who showed not 
only that the assumptions underlying correction for continuity in most empirical situa-
tions are untenable, but also that for a nominal a level of 0.05, even with very small 
(fractional) expected frequencies, in practice the actual Type 1 error rate seldom ex-
ceeds 0.06. Those authors advise caution in interpreting exact alevels, but also note that 
these small deviations from the true a level are seldom of much importance. 
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Present Pain Intensity 
At the first assessment the median PPI score was 1 (SIR 1.0) and at the second 0 (0.6). 
Change in PPI scores was not significantly related to change in psoriasis severity 
(X^=2.07, dj^2), but this is not particularly surprising since scores were so low on this 
measure. 
Pain Rating Index - Total. 
The pain rating scales can be combined to form the PRI-T scale. The mean score at the 
first assessment was 8.43 (8.89, 0 to 39) and at the second was 4.35 (5.47, 0 to 20), 
which results in a mean change over assessments of -4.18 (9.72, -37 to +17). These 
distributions are positively skewed. The median rating on this scale was 6 (SIR 4.5) at 
the first assessment and the 2.5 (3.5) at the second. 
Once the starting level of this variable has been taken into account, area of coverage, 
change in area of coverage, and time since onset all predicted PRi-T scores at time 2, and 
there was a significant interaction between time since onset and the sex of the subject. 
The regression estimates and analysis of variance are summarised in Table 5.8. The 
regression model had an R^ value of 0.55 and the residuals were normally distributed 
(Filliben correlation coefficient = 0.97). 
Table 5.8 Summary of estimates and analysis of variance for regression of total pain 
rating index scores at time 2 on five predictor variables. 
Parameter 
(Constant) 
Sex (males=0, females=l) 
PRI-T score at time 1 
Area of coverage at time 2 
Change in area of coverage 
Time since onset 
Time since onset x Sex 
Analysis of Variance 
Source 
Regression 
Residual 
Total 
Estimate SE t Sigp< 
0.66 2.00 0.33 -
7.34 2.89 2.54 0.02 
0.20 0.088 2.30 0.05 
0.24 0.21 1.13 -
0.87 0.25 3.45 0.05 
0.091 0.084 1.09 -
-0.30 O.ll -2.62 0.02 
df SS MS F 
6 542.78 90.46 5.51 
27 442.98 16.41 
33 985.76 
Sigp< 
0.001 
117 
Chapter Five: Prospective Investigation 
Pain Rating Index - Sensory 
The median score on this subscale at the first assessment of 4 (3.0, 0-19) compared 
with 2 (3.0, 0-12) at the second. The value of 12.53 is significant at the 0.02 level 
suggesting that this distribution was unlikely to have occurred by chance. Examination 
of the cell patterns in Table 5.9 reveals that most of the total can be accounted for by 
the cell corresponding to psoriasis worsening and PRI-S increasing. That is, if psoriasis 
worsened between assessments then more, or more severe, pain descriptors were used 
to describe the pain or discomfort associated with psoriasis. 
Table 5.9 Contingency table of psoriasis change and PRi-S change between two 
assessments (expected values in parentheses) 
PRI'S Psoriasis Severity 
Score Improved Worsened 
Increased 2(5.88) 6(2.17) 
No Change 3 (2.21) 0 (0.79) 
Decreased 20(16.91) 3(6.09) 
Pain Rating Index - Affective. 
Although the range of ratings for the affective subscale changed from 0-12 at the first 
assessment to 0-5 at the second, the median ratings stayed the same (0, SIR 0) at both 
assessments. The small number of ratings made in this category (8 at the first assess-
ment and only 4 at the second) make useful analysis impossible. 
Pain Rating Index - Evaluative. 
The median score at the first assessment of 1 (1.0, 0-5) was slighdy higher than at the 
second of 0 (0.5, 0-5). The value for was 10.11 which is significant at the 0.05 level. 
Examinarion of the cell distributions in Table 5.10 reveals that once again the cell 
which contributes most to the total value is where psoriasis worsens between assess-
ments and PRI-E scores increase. Thus, worsening psoriasis is associated with more 
individuals choosing a word in this category (the PRI-E subscale is based on one catego-
ry of descriptor words) or choosing a word with a higher ranking in this category. 
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Table 5.10 Contingency table of psoriasis change and PRI-E change between two 
assessments (expected values in parentheses) 
PRI-E Psoriasis Severity 
Score Improved Worsened 
Increased 0(2.21) 3(0.79) 
No Change 15(14.71) 5(5.29) 
Decreased 10(8.09) 1(2.91) 
Pain Rating Index - Miscellaneous. 
The median scores on this scale stayed the same at both assessments (both zero, SiRs 0.5 
and 0) but the range at the second assessment of 0-3 was narrower than at the first 
(0-7). The value for was 11.01 which is significant at the 0.05 level of significance, 
and once again the cell that accounts for most of this value is where both psoriasis and 
PRI-M ratings worsen between assessments (Table 5.11). 
Table 5.11 Contingency table of psoriasis change and PRI-M change between two 
assessments (expected values in parentheses) 
PRI-E Psoriasis Severity 
Score Improved Worsened 
Increased 0(2.94) 4(1.08) 
No Change 15 (13.24) 3 (4.77) 
Decreased 10(8.82) 2(3.18) 
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5.7 Discussion 
The general reacdon of subjects to the questionnaires and SKINMAP was good: all 
completed the questionnaires, although several subjects missed individual questions, or 
occasionally a whole page. These omissions were rectified immediately, and the sub-
jects indicated that they were simply missed, rather than deliberately avoided. On the 
second assessment, subjects were told that they were not expected to remember their 
original responses to the questionnaires, and asked whether they thought they could 
remember what they had previously written. Al l subjects indicated that they doubted 
they could remember, and given the interval of three months, this seems likely. In any 
event, they were instructed to complete each questionnaire as directed. 
It is possible that administration of SKINMAP prior to completing the questionnaires 
may in principle have influenced the results. However, i f this were the case it would 
have been apparent in the most context-sensitive measure employed - state anxiety. As 
can be seen from the scores on this scale, levels were close to reported norms for con-
trol subjects. It is unlikely therefore that the results reported here were influenced by 
this procedural factor. 
The distribution of areas of coverage at both assessments shown in Figure 5.1 confirms 
that the group in this study did indeed have more severe psoriasis than the group in the 
previous study. Although the mean area of coverage in both studies is quite similar, the 
larger standard deviation in the first study suggests that the distribution of areas of 
coverage was very highly positively skewed. In the present study, while the distribution 
is still positively skewed, more subjects had significant psoriasis (at the first assess-
ment) than before. Nevertheless, the mean total area of coverage of 4.2% is still quite 
low. 
Slightly more females were represented in the sample, but the mean ages for males 
(44.8, SD 17.2) and females (46.8, 18.5) were not significantly different. Similarly, the 
mean time since onset for males (22.0, 14.4) was not significantly different from the 
mean for females (24.3, 14.7). 
5.7.1 Depression and psoriasis severity 
It was not expected that depression scores for the group would reach clinical levels and 
this was confirmed by the results. The mean scores of 3.3 at the first assessment and 3.5 
at the second are both well below the cutoff point of >8 on the HADS. This supports the 
findings of the first study where depression levels were higher than controls but still 
within 'normal' limits. However, as hypothesised, depression scores at the second 
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assessment were significantly associated with change in disease severity (Table 5.1). 
There was a significant interaction with sex, which shows that the relationship between 
depression and disease severity is different for males and females. Regression equations 
for males and females are generated by substituting first the code of 0 (for males), then 
the code of 1 (for females) into the 'sex' variable and interractions in the full model. 
Using the coefficients from Table 5.1, the regression equation for males can therefore 
be expressed as: 
Depj = -0.55 + 0.52xDep, - 0.065xArea2 + 0.86xChange + O.lOxTime since onset 
where Dep, is depression at the first assessment and Dep^ is depression at the second 
assessment (in HADS scores), Area^ is area of coverage at the second assessment (ex-
pressed as percentage body coverage). Change is change in percentage area of coverage 
between the first and the second assessments, and Time since onset is expressed in years. 
For females the regression equation is: 
Depj = -0.94 + 0.52xDep, + 0.415xArea2 + O.lOxChange + O.lOxTime since onset 
It can be seen that, while time since onset of psoriasis has the same effect in both sexes, 
male depression scores are much more strongly related to change in area of coverage 
than female depression scores. Furthermore, for both males and females, the longer the 
individual has been suffering, the greater the depression. With a coefficient of 0.10, this 
means that (keeping all other variables constant) for every 10 years a subject has been 
suffering from psoriasis the model predicts approximately a one point increase in de-
pression scores. This is in contrast to the first study where depression scores were not 
related to time since onset at all. In practical terms this means that, for a given starting 
level of depression, depression in males will vary more than females as their psoriasis 
fluctuates. These fluctuations in depression will tend to be more marked for those who 
have been suffering psoriasis the longest. 
There is a well documented sex difference in prevalence rates for depression, with 
women outnumbering men in the ratio of approximately 2:1 (e.g. Weissman & Kler-
man, 1977). While the numbers of possible cases identified in the present study were 
very small, they do follow a similar pattern (2 females and 1 male at the first assess-
ment, 4 females and 1 male at the second). This is reflected in the median depression 
scores for males and females, where males had a median score at the first assessment of 
2 and a median of 1 at the second assessment, compared to medians of 4 at both as-
sessments for females. This general difference in depression levels may in part explain 
the different models for males and females. The difference in the model lies in the rela-
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tionship between coverage at time 2 and change in coverage between times 1 and 2. 
While it is not possible to tell from the data, one explanation of the different models is 
that lower levels of depression fluctuate as a function of change in area of coverage, 
while higher levels are more sensitive to absolute area of coverage: that is, the differ-
ence is in levels of depression, not between sexes. 
The second point of interest is the relationship between time since onset and change in 
depression scores. Explanation of this phenomenon depends upon the direction of 
causality between depression and psoriasis. I f depressed mood is a consequence of 
psoriatic relapse, change in depression scores at this level may be related to perceptions 
of the likely course of the condition: perceptions which would be reinforced over a 
period of years as the sufferer becomes more aware of phasic fluctuations. If, on the 
other hand, psoriasis relapse is contingent upon prior increase in depression an explana-
tion is less obvious, and requires some external factor to trigger the depression, possibly 
unrelated to psoriasis. Of course, it is also possible that an independent external trigger 
may influence depression and psoriasis activity, and that the two are essentially unrelat-
ed. A prospective study using a time-series design over several months, i f not years, 
would be required to clarify this issue. 
To summarise, depression at the second assessment in females is weakly related to 
change in area of coverage, but strongly related to absolute area of coverage, while in 
males, this pattern is reversed. Time since onset is a significant predictor for males and 
for females. 
5.7.2 Anxiety and psoriasis severity 
The first study showed psoriasis sufferers scoring higher than controls on trait anxiety, 
and higher than the published norms. In the present study, the mean score of 7.6 on the 
HADS at the first assessment and 7.1 at the second show this group to be somewhat less 
anxious than the psoriasis outpatient groups reported by Price et al (1990), who found 
mean scores on the same instrument for all except one group ranging between 8.09 and 
9.17. (Their psychotherapy group at 6 month follow-up scored a mean of 7.0). While 
scores of around 7 are slightly below the cutoff point of >8 for possible clinical anxiety, 
they are nevertheless still quite high. The HADS measures anxiety over the past week, so 
these figures are not likely to be related to anxiety caused by testing. 
In the present study the hypothesis was that anxiety at the second assessment would be 
related to change in disease severity once initial levels of anxiety had been taken into 
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account and this was supported by the data. Unlike depression, there are no significant 
differences between males and females. The R^ value of 0.75 is high, suggesting that the 
simple model is a relatively good representation of the true relationship. From the coef-
ficients summarised in Table 5.2, the model for the relationship between psoriasis and 
anxiety can therefore be expressed as: 
Anx^ = -1.31 + 0.88xAnXj + O-ZlxArea^ + 0.53xChange + 0.076xTinie since onset 
where Anx^ is anxiety at the first assessment and Anx^ anxiety at the second (in HADS 
scores). As with depression, change in anxiety is positively related to change in area of 
coverage, and the time since onset of psoriasis. 
The predominating type of anxiety reaction does not vary at all between assessments 
and is not associated with change in area of coverage for either males or females. The 
ratio of cognitive to somatic symptoms does not change either. This would support the 
concept of an individual response stereotypy (Lacey & Lacey, 1958) that is relatively 
resistant to change which underlies the cognitive/somatic anxiety distinction. The mean 
ratio of cognitive to somatic symptoms is 1.08, which corresponds to a mean ratio of 
1.03 for both psoriasis sufferers and controls in the previous study. However, while the 
ratio of cognitive to somatic symptoms in controls and psoriatics was the same, it 
should be noted that psoriasis sufferers did in fact score higher on both scales than 
controls. The scores found in the present study broadly concur with those found in the 
first study, and confirm that psoriasis sufferers tend to report both more cognitive and 
more somatic symptoms of anxiety when in an anxious situation than controls. 
To summarise, anxiety levels at the second assessment are positively related to change 
in area of coverage, absolute area, and the time since onset of psoriasis. The ratio of 
cognitive to somatic anxiety symptoms reported in anxious situations does not change 
as the severity of the condition varies. 
5.7.3 Self-esteem and psoriasis severity 
Compared with the scores for total self-esteem on this scale in the first study (137.7 for 
the full matched psoriasis group), the scores in the present study were moderately high 
(142.7 and 146.8). This is interesting, given that the group in the first study had relative-
ly mild psoriasis. Indeed, the scores in the present study are higher than those for the 
matched control group previously, and higher than the score of 137 reported for 
"normal controls" by Robson (1989). 
However, of more interest than absolute levels is the change in self-esteem scores that 
occurred between assessments. The mean change was modest (4.0), but when related to 
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disease severity there was a significant relationship between change in area of coverage 
and change in total self-esteem score, and there was a difference between males and 
females in the extent to which this relationship holds. For males, self-esteem rises 
dramatically as psoriasis ameliorates, while for females, although the trend is in the 
same direction, the degree of change is much less pronounced. Using the coefficients 
summarised in Table 5.3, the relationship between self-esteem at the second assessment 
and psoriasis severity for males can therefore be expressed as: 
SEQj = 28.54 + 0.85xSEQj - 0.93xAreaj - 5.90xChange 
while for females the model is: 
SEQ^ = 24.95 + 0.85XSEQ, - 0.93xArea2 - l.OOxChange 
and the value of 0.71 suggests that it fits the data quite well. 
Self-esteem is not related at all to the length of time the individual has been suffering 
from psoriasis. Self-esteem in psoriasis sufferers may therefore be related more to 
general self-perceptions rather than linked to anticipation of the likely progress of the 
disease, and as such relate more directly to disease fluctuarion than to learned re-
sponses. 
Perhaps the most interesting of the SEQ subscale results was that for competence, resil-
ience and control, where change in area of coverage between assessments predicted 
scores at time 2 once the starting levels had been taken into account. Greater changes in 
area of coverage corresponded to greater changes in subscale scores, where the better 
the psoriasis became, the higher the score on this subscale. Scores were significantly 
greater the longer the time since onset of psoriasis. This subscale taps how much control 
respondents feel they have over their lives and its increase as psoriasis decreased sug-
gests that this facet of self-esteem is linked to the effectiveness of the treatment for 
psoriasis: i f psoriasis is ameliorating, subjects feel they have more control over their 
lives. 
The attractiveness subscale produced clear but interesting results. Once starting levels 
of attractiveness had been taken into account, levels at time 2 were significantly pre-
dicted by change in area of coverage: the better the psoriasis became the higher the 
attractiveness score but this was much more pronounced for men than for women. For 
example, for equal starting levels, a 20% decrease in area of coverage for males predicts 
an increase of 4.4 in attractiveness rating, while for females the same change in area of 
coverage predicts only a change of 0.2 in attractiveness rating. Males are therefore more 
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susceptible to change in how attractive they think they are, related to the severity of 
their psoriasis, while women's ratings do not change as the disease fluctuates. 
The only other scale which shows a relationship with change in area of coverage is the 
value of existence subscale, where decrease in psoriasis predicts increase in subscale 
scores for males and females to the same extent. This scale taps issues like " I am glad I 
am who I am", and "It's pretty tough to be me", and as such is perhaps closest to the 
traditional conception of self-esteem as self-evaluation. 
To summarise, there is a clear relationship between change in area of coverage and self-
esteem, which is more apparent for males than for females. 
5.7.4 Sleep quality and psoriasis severity 
The Nottingham Health Profile used in the previous study showed that sleep problems 
are associated with psoriasis. This has also subsequently been found by Finlay et al 
(1990) using the Sickness Impact Profile. Responses to the Patient Knowledge inter-
view reported in Chapter 4 also suggested that sleep is a problem, particularly when the 
condition is severe. The PSQI was used in the present study to discover exactly what the 
sleep problems are and to quantify how they vary as the severity of the condition varies. 
The mean total PSQI score at both assessments was approximately 5.7, which falls 
between a score of 2.7 for "normal controls" and 11.1 for "depressives" reported by the 
originators of the questionnaire (Buysse et al, 1989). As a group, then, psoriasis suffer-
ers have relatively poor sleep. The regression model is interesting because it indicates 
that, while total sleep quality scores at time 2 are predicted by change in area of cover-
age (the better the psoriasis becomes, the better the reported sleep quality), there is a sex 
difference in the effect of time since onset. From the regression coefficients in Table 
5.7, the regression model for males is: 
PSQIj = -2.42 + 0.85xPSQIj + O.OTSxArea^ + 0.24xChange + 0.12xTime since onset 
while for females the model is: 
PSQI^ = 1.62 + 0.85xPSQI, + O.OTSxArea^ + 0.24xChange - O.OlxTime since onset 
and it can be seen that the parameter estimate for time since onset for females has little 
effect while the estimate for time since onset in males is quite high. 
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It is interesting that there was no relationship between change in disease severity and 
any of the PSQI subscales. Scores on these subscales were generally on the low side, 
suggesting that the majority of subjects did not have specific sleep problems which 
could be identified as a group trait. The relatively high global PSQI score must therefore 
be interpreted as a general poor sleep quality, rather than poor sleep quality due to some 
disease-specific factor. 
5.7.5 Pain and psoriasis severity 
Pain is not usually associated with psoriasis, but studies have often used pruritus as part 
of an assessment of disease severity (Chapter 2). The purpose of including the MPQ in 
the present study was to examine further the pain or discomfort that psoriasis sufferers 
experience from their condition and to ascertain whether this changes as the disease 
changes. The instructions for the MPQ were worded such that only pain (or discomfort) 
from psoriasis was reported, not pain from any other condifion that the respondent 
might have. 
Given the generally low scores on the PPI, which measures the degree of pain on a five 
point scale, it is perhaps not surprising that change on this scale showed no relationship 
with change in area of coverage for either males or females. However, change on three 
of the four sub pain-rating indexes was significantly associated with change in area of 
coverage. These scales are designed to tap the qualitative nature of the pain experience 
and as such can provide a useful means of describing the type of pain experienced for 
any condition. 
Table 5.12 PRI-S descriptions of psoriasis pain. Percentages of subjects who chose 
various words on two assessments 
Descriptor Percentage of subjects 
who chose this word 
at assessment I 
Percentage of subjects 
who chose this word 
at assessment 2 
Itchy 
Sore 
Tender 
Burning 
Pricking 
Hot 
Stinging 
74.3 
25.7 
22.9 
20.0 
14.3 
11.4 
2.9 
44.1 
20.6 
23.5 
8.8 
5.9 
8.8 
11.8 
The sensory scale is concerned with how the pain actually feels and produces scores in 
the range 0 to 42, although this range is somewhat artificial since the aim is to describe 
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pain, and the words in each category ought not to apply to all conditions. Examination 
of the actual words chosen in the sensory category provide a more precise description of 
the sensory pain experience of psoriasis than has hitherto been available. Table 5.12 
lists those words which were chosen by more than 10% of the sample at one assess-
ment. The most frequently used word to describe the sensory component of psoriasis 
pain is "itchy", but over 20% of respondents also described it as "sore" and "tender" at 
both assessments, and as "burning" at the first assessment. Of course, it is not clear 
whether these descriptors refer to actual psoriasis or to the effects on the skin of treat-
ment. PUVA treatment, for example, can sometimes result in generalised skin burning, 
and dithranol-based topical treatments tend to irritate unaffected skin with bum-like 
effects. 
While the numbers in individual cells of the contingency tables 5.9 to 5.11 are relatively 
small, the y} values confirms that these distribution was unlikely to have occurred by 
chance. By far the biggest influences on this are the high number of subjects in the 
group whose psoriasis worsened between assessments whose PRI-S score also worsened, 
and the low numbers in the group whose psoriasis worsened but PRi-S improved. This 
suggests that the sensory pain rating index of the McGill Pain Questionnaire is quite 
sensitive to fluctuations in psoriasis severity. 
This pattern is reflected in the evaluative pain rating index, which suggests that that 
subscale is also sensitive to psoriasis change. It is interesting that 17 subjects at the fu-st 
assessment and 11 at the second elected to tick a word in this category, and that the 
strength of evaluation was so intense. Two subjects at the first assessment even ticked 
the word 'unbearable' which represents the highest rank on this subscale (see Table 
5.13), while the full range of 0-5 was also used at the second assessment. This suggests 
that pain may be of major importance to at least some psoriasis patients. 
Table 5.13 PRI-E descriptions of psoriasis pain. Numbers of subjects who chose 
various words on two assessments. These words represent the complete 
'evaluative' scale 
Descriptor Number of subjects Number of subjects 
who chose this word who chose this word 
at assessment 1 at assessment 2 
Annoying 6 7 
Troublesome 6 1 
Miserable 3 1 
Intense 0 1 
Unbearable 2 1 
127 
Chapter Five: Prospective Investigation 
The affective subcategory is concerned with how sufferers/ee/ about their pain or irrita-
tion, and there was a significant relationship between change in area of coverage and 
change on this subscale. The only word that was chosen by more than 10% of respond-
ents was "tiring" (14.3% at the first assessment, 5.9% at the second). The evaluative 
subscale is based on one category only. Twenty percent of respondents chose "trouble-
some" at the first assessment and 17.1% chose "annoying", while only 2.9% chose 
"troublesome" at the second and 20.6% chose "annoying". It would appear therefore 
that decrease in area of coverage results in a more favourable evaluation of pain. 
The simple measurement of pruritus sometimes employed to describe irritation from 
psoriasis is not an adequate descripfion of the type of pain experienced by psoriasis 
sufferers, and more extensive inquiries into the nature of sensory pain may provide a 
fuller description than has hitherto been available. 
When all these scales are combined into the total pain rating index score, there is a 
highly significant relationship with change in area of coverage and time since onset, 
with significant differences between males and females. From the regression coeffi-
cients in Table 5.8, the model for males is: 
PRI-T^ = 0.66 + 0.20xPRI-T| + 0.24xAreaj + 0.87xChange + 0.091 xTime since onset 
while for females the model is: 
PRI-T^ = 8.00 + 0.20xPRI-T, + 0.24xAreaj + 0.87xChange - 2.909xTime since onset 
The effect of time since onset is in opposite directions for men and women, and the 
coefficient for females is quite large. 
The total pain experience, then, has been shown to comprise more than simply pruritus, 
and when taken as an overall descripfion of change in the quality of pain, there is a 
significant decrease for both men and women as area of coverage recedes. 
5.8 Summary and conclusions 
The most striking finding to emerge from this investigation is that there are significant 
differences between males and females in the relationship of psoriasis severity to 
psychological factors. Roenigk & Roenigk (1978) examined this idea in the late seven-
ties and reported that females are more psychologically affected by psoriasis than 
males, which they interpreted as a reaction to sex-role conditioning: "a girl [is] on the 
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look-out for the male to depend upon" (p.531). Times, and gender-role stereotypes, 
have changed, and in the nineties it is no longer tenable to attribute higher psychologi-
cal distress over visible deformity in women to reduced chances of catching a mate! 
Previous investigations into the relationship between depression, anxiety and psoriasis 
have produced conflicting results, and most have been concerned with hospitalised 
patients. The present study has shown a significant relationship between change in 
disease severity and change in depression and anxiety levels. Thus, while psoriasis 
sufferers may be only marginally more depressed and more anxious than non-sufferers, 
when the starting levels of these variables are taken into account, they can be signifi-
cantly predicted by change in area of coverage. Time since onset is an influencing 
factor in depression levels for males where the longer the patient has been suffering, the 
greater the influence on depression. 
Self-esteem improves significantly as the psoriasis improves, more so for men than for 
women, and when the individual components of self-esteem are examined, competence, 
resilience and control, attractiveness, and value of existence show significant improve-
ments as psoriasis ameliorates. The most striking factor with self-esteem is that change 
seems to be much more apparent in men than women. Change in subjective sleep quali-
ty is also related to change in area of coverage, and descriptions of the quality of pain 
experienced also show significant improvement with psoriasis improvement. 
This study has shown that by using a within-subjects design, changes in psychological 
variables can be related to changes in the severity of psoriasis. This has not previously 
been demonstrated in the cross-sectional studies reviewed in Chapter 1, and the data 
reported here support the hypothesis that the psychological state of psoriasis sufferers is 
directly related to the state of their psoriasis. 
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6.1 Overview of the research 
The literature review in Chapter 1 led to some general hypotheses concerning a link 
between certain psychological variables and psoriasis. First, both Hughes et al (1983) 
and Wessely & Lewis (1989) had found high prevalence of psychiatric "cases" in 
general dermatology patients. They did not provide figures for the prevalence of cases 
in psoriasis sufferers specifically. The first hypothesis therefore was that the prevalence 
of psychiatric cases in a group of psoriasis sufferers would be greater than in a group of 
matched controls. 
Second, a number of studies had found levels of depression in hospitalised psoriasis 
sufferers significantly higher than other in-patients (e.g. Fava et al, 1980, Lyketsos et 
al, 1985). Relatively little work, however, has been done to assess levels of depression 
in groups of psoriasis sufferers whose disease was not severe enough to warrant hospi-
talisation, but who represent the majority of psoriasis sufferers. What evidence there is 
is inconclusive. Hardy & Cotterill (1982) had found a small group of out-patient psoria-
sis sufferers (predominantly female) scoring borderline on the Beck Depression Inven-
tory, but Price, Mottahedin & Mayo (1991) had found levels in out-patients well below 
the cutoff point of >8 on the HADS. 
Since hospitalisation for therapy implies quite severe psoriasis, from these results the 
second hypothesis was that psoriasis out-patients would have higher levels of depres-
sion symptoms than matched non-sufferers, and probably also that the level of depres-
sion symptoms would tend be correlated with the severity of the psoriasis. Thus, for 
those psoriasis sufferers whose disease was in a relatively clear phase, levels of depres-
sion symptoms would approximate those of controls, while levels in sufferers whose 
disease was more active would be raised. 
The third, related hypothesis concerned levels of anxiety in psoriasis sufferers. Both 
Fava et al (1980) and Lyketsos et al (1985) had found anxiety in hospitalised patients 
higher than hospitalised controls, but as with depression, little research had examined 
levels of anxiety in out-patient populations. Price etal(\991) found outpatients' mean 
scores above the HADS cutoff point and also provided some evidence that levels of 
anxiety tended to fluctuate with psoriasis severity, but their measure of severity was 
inadequate to draw any firm conclusions. Similarly, the study reported by Gaston et al 
(1987) found a significant relationship between aruiety and psoriasis severity, but those 
authors measured psoriasis on the scalp only. The specific hypothesis regarding anxiety 
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therefore was that psoriasis outpatients would have higher levels of anxiety than 
matched controls, and that levels of anxiety in psoriasis sufferers would tend to be 
correlated with psoriasis severity. 
Self-esteem in psoriasis sufferers, has been touched on indirectly by Ginsburg & Link 
(1989) in their study of feelings of stigmatisation associated with psoriasis, but most of 
the evidence for low self-esteem is anecdotal (e.g. Jobling, 1976; Stankler, 1981). 
Ginsburg & Link found age at onset of psoriasis positively related to some of their 
stigma factors, and time since onset of psoriasis negatively related. They also found 
extent of bleeding of the psoriasis to be the best predictor of feelings of stigmatisation. 
The third specific hypothesis therefore was that self-esteem in psoriasis sufferers would 
be lower than in matched controls, but that this would be moderated by the age at onset 
(the younger the age at onset the lower the self-esteem), the time since onset (the longer 
the time since onset the higher the self-esteem), and the severity of the condition (the 
worse the psoriasis, the lower the self-esteem). Individual components of self-esteem 
were examined on an exploratory basis. 
The next area of study was derived from an overview of the literature regarding psoria-
sis and psychological variables, which had suggested that patients were acutely aware 
of their symptoms. Thus, it was suggested that psoriasis sufferers would report lower 
perceived health status than matched controls. Individual elements of subjective health 
status were to be examined also, but on an exploratory basis. 
Two further areas were examined in detail, both of which arose as a result of findings 
while the research was under way. It became quite clear from informal conversations 
with psoriasis sufferers in the first study that there was a wide range of lay beliefs and 
knowledge about psoriasis which had not been examined in any detail. Savin (1970) 
and Burton & Thompson (1976) had made broad attempts to tap this data but no de-
tailed study had examined lay beliefs and knowledge about psoriasis. Lay beliefs are 
important determinants of health behaviour (e.g. Rosenstock, 1974) and form an impor-
tant part of understanding any disease. The study reported in Chapter 4 was therefore 
undertaken to explore these beliefs and knowledge in detail. 
Finally, while reviewing the available means of measuring psoriasis severity, it became 
clear that no valid and reliable method existed for measuring the area of skin affected 
that did not require expensive equipment and specialised training. A computer program 
was therefore designed to aid in the assessment of dermatological disease severity, and 
its development and validation were reported in Chapter 2. 
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6.2 Performance of SKINMAP 
The first task was to evaluate the validity and reliability of existing means of measuring 
psoriasis severity, and this was reported in Chapter 2. The concept of "severity" in 
psoriasis is defined by the purpose of the research, and while it was noted that typical 
clinical signs such as thickening and erythema are often recorded as part of a measure 
of severity, all assessment techniques include some estimate of the area of coverage in 
one form or another. Area of coverage in psoriasis is most often visually assessed, but it 
was shown in Chapter 2 that research into area perception showed that visual area 
estimation was likely to be inaccurate and inconsistent when applied to the area of disks 
(as in psoriasis), and that this had been confirmed in a clinical setting by comparing 
dermatologists' estimations of area of coverage with planimetrically assessed area. 
Other means of directly measuring area of coverage were discussed, but they all in-
volved either specialised and expensive equipment, or required the subject to be in a 
standardised environment. 
However, while estimating area is unreliable, evaluating the equivalence of two disks is 
much less so. When asked to provide an area estimation subjects fare poorly, but when 
asked to match one disk to another, subjects fare well. A computer program, called 
SKINMAP, was therefore developed which allowed psoriasis to be mapped onto standard 
body shapes by matching lesions drawn on the computer with those on the patient's 
body. The area of coverage is then calculated by SKINMAP. A study of the validity of 
SKINMAP showed it to provide significantly more accurate and consistent estimates of 
area of coverage than visual estimation, and accordingly it was used throughout the 
research presented in this thesis. 
During the course of this research SKINMAP has been used with over 100 psoriasis 
sufferers and no adverse reactions to it were noted at all. It is slightly more time con-
suming than simple visual estimation, but none of the sufferers reported this to be a 
problem: indeed many of them seemed to welcome the opportunity to show their pso-
riasis and talk about it in great detail. Often subjects would spontaneously give an 
account of the vicissitudes of a particular patch while I mapped the body region. Sever-
al also actually seemed pleased that more notice was being taken of their skin than a 
cursory visual inspection. 
Regular use of SKINMAP revealed some minor problems and suggested some possible 
refinements. For example, when SKINMAP saves patch location and size information to 
a temporary file after each body region, it saves all the data from the current session. 
Thus, for a patient with many psoriasis patches on several areas of the body, as the 
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session progresses so disk access time increases. In a few patients this was quite notice-
able, and it would be better to have data from each region stored independently. This 
will be taken into account in future versions of SKINMAP. One problem that also became 
apparent in regular use was that the strategy of presenting all body regions for all pa-
tients was perhaps over-cautious. This strategy had been followed so as to avoid the 
problem of missing certain body regions, but in practice it meant that all body regions 
had to be drawn, even i f the subject only had psoriasis on their face, for example, which 
was the last body region, or in order to produce a record of no psoriasis involvement at 
all. This was quite time-consuming and selection of body regions from a menu will 
therefore be incorporated as an option into later versions. Finally, while output of the 
f u l l database file in pre-defined format for direct entry into SPSSx worked well, the 
output routines proved to be inadequate i f only selected cases needed to be accessed. 
These output routines will therefore be enhanced in future versions. 
To summarise, the SKINMAP computer program overcomes problems with visual area 
estimation and provides a means of measuring psoriasis which is both accurate and 
consistent, and which is acceptable to the patient. It worked well in practice, but some 
minor refinements will be made for future versions. 
6.3 Generalisability of results 
There would be little point examining psychological factors associated with psoriasis in 
groups of subjects which were not representative of the wider psoriatic population. The 
procedure used to select subjects for the studies reported in this thesis involved contact-
ing patients who were currently being treated, or who had previously been treated for 
their condition in a hospital outpatient department. The rationale for this approach was 
that patients hospitalised for their condition would be more likely to be experiencing 
higher levels of depression and anxiety than those not hospitalised, and as such may not 
accurately reflect the psychological state of the majority of sufferers, who treat their 
condition at home, or on an outpatient basis. Also, psoriasis sufferers presenting at CP's 
surgeries were not chosen as a sampling frame, first because suspected cases of psoria-
sis are generally referred to a hospital dermatologist for confirmation of diagnosis, and 
second because the logistical considerations of extracting data from a large number of 
GPs records would have been prohibitive, whereas the catchment area of the dermatolo-
gy department was large and the identification of patients was facilitated by existing 
procedures. 
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The question then arises whether the characteristics of the groups reported in this thesis 
match those of the whole psoriatic population. The most extensive study on the charac-
teristics of psoriasis patients in the general population comes from Hellgren's (1967) 
survey of psoriasis in Sweden. In Hellgren's study prevalence in males was consistently 
higher than in females in all geographical areas, when age had been taken into account. 
There were more females than males in both the studies reported here, which may have 
influenced the results - particularly with psychological factors where sex is an important 
predictor of prevalence (e.g. depression). To counter this, results were calculated for 
males and females separately, as well as the whole group, and these figures have been 
reported where appropriate. Hellgren reports mean age at onset for males between 25.2 
(SD 18.6) and 34.3 (20.8), depending on geographical area, which compares with 31.0 
(17.1) in the first study and 23.8 (13,8) in the second. For females, Hellgren reports 
mean age at onset between 20.4 (15.6) and 32.7 (21.9) which compares with 24.6 (16.1) 
in the first study and 22.5 (17.1) in the second. Therefore the patients used in the 
present research are representative of the general psoriatic population with regards to 
age at onset. Since the mean age at time of study in Hellgren's groups is similar to the 
mean ages in the present studies, the mean time since onset will also be similar. 
The areas of coverage in the present studies is considerably higher than the mean area 
of coverage in Hellgren's sample. Hellgren reported only estimates of absolute area of 
coverage and not percentage of total body coverage. The mean coverage was 78.2cm^. 
Without any indication of the total skin area of the individual sufferers it is not possible 
to convert this figure accurately into percent body coverage, but an approximation can 
be calculated by dividing by an average body area of 19355cm2 (Tortora & Anagnosta-
kos, 1987). This gives an estimated mean area of coverage of 0.4%, compared with the 
median in the first study of 1.4% and in the second study 2.5% (first assessment) and 
1.6% (second assessment). This difference is almost certainly because of the sampling 
frame used. Hellgren examined a representative sample of the complete Swedish popu-
lation including psoriasis sufferers whose condition was either not severe enough for 
outpatient treatment, who were self-medicating, or may not have been previously 
diagnosed. 
Thus, the subjects used in the studies reported in this thesis have similar age at onset 
and length of suffering to those in Hellgren's epidemiological study, but the sex ratio is 
reversed and the area of coverage greater than what would be expected in the full psori-
atic population. Sex differences were allowed for by using sex as an independent varia-
ble in the analyses. The difference in mean areas of coverage can be explained by the 
very large sample size in Hellgren's study. 
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The questionnaires were selected for each variable from what was often a wide avail-
able range. The criteria for selection have been discussed in the appropriate chapters. 
The main concern for the prospective investigation reported in chapter five was a possi-
ble re-test artifact (Jorm, Duncan-Jones & Scott, 1989) that tends to occur with some 
measures used in longitudinal research. The re-test artifact that Jorm et al and others 
(e.g. Bromet et al, 1986) have reported concerns the tendency for scores on some ques-
tionnaires to be consecutively lower on repeated administration. Jorm and his col-
leagues point out that this must be artifactual otherwise psychiatric disorders would 
tend to decrease in prevalence over time, and they note that i f a re-test artifact occurs, 
interpretation of results becomes problematic. Jorm's paper was therefore concerned 
with isolating those aspects of questionnaires which are associated with the re-test arti-
fact. Jorm et al suggest fi-om examining responses to an epidemiological study that two 
factors must be present for the re-test artifact to occur: oral administration of the test 
and a test that measures negative self-characteristics. While some of the measures used 
in the research reported here necessarily involved measurement of negative self-charac-
teristics (the measurement of self-esteem for example), all were presented as pen-and-
paper tests, and all were completed anonymously by respondents. It is not likely there-
fore that a re-test artifact wil l be a problem with the current data. 
6.4 Discussion of the main findings and suggestions for future research 
6.4.1 Psychiatric morbidity 
Two studies reviewed in Chapter 1 found a high rate of probable "cases" on the GHQ 
among dermatology patients. Hughes, Barraclough, Hamblin & White (1983) found 
30% of their outpatients scoring above the GHQ cutoff point while Wessely & Lewis 
(1989) reported 43%. This compares with 24% in the psoriasis group reported in Chap-
ter 3 and 24% in the control group. There were no differences between the psoriasis and 
control groups on the total GHQ or on any of the subscales. This discrepancy is almost 
certainly because both Hughes' and Wessely & Lewis's samples comprised a range of 
dermatological conditions including psoriasis, some of which are more likely to be 
associated with psychiatric morbidity (e.g. dermatitis artefacta), and which fall higher 
on Rook's (1972) hierarchy of psychosomatic involvement discussed in Chapter 1. 
Thus, while dermatology outpatients in general (including psoriasis patients) show 
higher prevalence of cases than controls, taken as a group on their own, psoriasis outpa-
tients show psychiatric morbidity levels comparable to non-dermatology controls. 
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6.4.2 Depression. 
While there is some evidence that hospitalised psoriasis patients are more depressed 
than controls (e.g. Goldsmith, Fisher & Wacks, 1969; Fava et al, 1980; Lyketsos et al, 
1985), there is sparse evidence that this is also the case with non-hospitalised patients. 
Hardy & Cotterill (1982) found a small group of psoriasis outpatients to have a mean 
BDI score of 9.1, which is just below the cutoff point of 10 for minimal/mild depression, 
while Price, Mottahedin & Mayo (1991) found mean depression scores on the HADS of 
between 3.1 and 4.8 (depending on group), which is well below the cutoff point of 9. In 
the present research, the mean scores on the HADS at both assessments in the prospec-
tive study (3.3 and 3.5) correspond to those found by Price et al, and suggest that as a 
whole, the groups were not clinically depressed. The results from the cross-sectional 
study reported in Chapter 3 however, did show psoriasis sufferers reporting significant-
ly more depressive symptoms than controls with a mean CES-D score of 11.2. While this 
is higher than the mean score for controls (8.6), it is below the cutoff point of 16 for 
possible depression. Nevertheless, more psoriasis sufferers (26%) scored above the 
cutoff point than controls (16%). 
Taking these results together, psoriasis sufferers not hospitalised for their condition 
have higher levels of depression symptoms than non-sufferers, but these do not general-
ly reach the level of clinical significance. 
Studies which relate depression levels or the prevalence of depression symptoms to pso-
riasis severity are also sparse. Only Gupta etal{\99\) has attempted to relate the start-
ing levels and change in psoriasis severity to depression scores, and while they did 
show improvement in depression scores with improvement in psoriasis, no information 
was given about how area of coverage was assessed, and their sample comprised inpa-
tients only. Patients hospitalised for any reason are likely to be more depressed than 
those not hospitalised for the same condition (Chapter 1), so Gupta's results should be 
interpreted with caution. 
There was no relationship between area of coverage and depression in the cross-sec-
tional study reported in Chapter 3, but this may have been because the psoriasis was 
generally quite clear. In the prospective study however, there was a clear relationship 
between disease severity and depression levels. Depression at the second assessment 
was evaluated once levels at the first assessment had been taken into account - that is, 
there was a significant relationship between change in area of coverage and change in 
depression scores. 
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However, there was a also significant difference between males and females in the 
extent to which this relationship held: the coefficient for change in area of coverage for 
males was 0.86 while for females it was 0.10, suggesting that change in area of cover-
age is more strongly associated with depression scores for males. On the other hand, 
absolute area of coverage at the second assessment was a significant predictor of change 
in depression scores for females but not for males. So for men, i f psoriasis fluctuated 
(regardless of the amount of body involvement), then depression tended to fluctuate as 
well, but for women, the amount of psoriasis on the body determined the depression 
levels regardless of how much their psoriasis had changed since the first assessment. 
This sex difference was interpreted in terms of levels of depression: i.e. it was suggest-
ed that there may be a qualitative difference in the relationship between psoriasis severi-
ty and depression levels which is dependent upon the level of depression in general. 
That is, depression varies as a function of psoriasis change only when levels of depres-
sion are quite low to begin with, and varies as a function of absolute area of coverage 
when starting levels of depression are higher. It is not possible to test this hypothesis 
with Gupta's data since he neither distinguishes males and females nor reports individ-
ual areas of coverage. However, he did show that change in psoriasis severity is related 
to change in depression and that the greater the change in severity, the greater the 
change in depression. 
It was suggested in Chapter 1 that a possible model of the link between depression and 
psoriasis severity could be drawn from social reinforcement theory (e.g. Lewinsohn, 
1974). To elaborate, it has been established that individuals with overt stigmatising 
characteristics have poorer interpersonal relationships (e.g. Kleck et al, 1966), and in 
the case of psoriasis, based on sufferers reports (e.g. Jobling, 1976; Stankler, 1981; 
Jowett & Ryan, 1985) increase in disease severity may restrict interpersonal contact 
firstly through the simple necessity to spend so much time treating the condition, and 
secondly because of the anticipation of real or imagined negative reactions to the condi-
tion. 
Behavioural explanations of depression are not the only framework in which these 
results can be interpreted. An alternative explanation of the relationship between de-
pression and psoriasis is that depression levels may be influenced by more cognitive 
processes: the lack of control over the course of psoriasis may result in feelings of 
helplessness. It was shown in Chapter 4 that sufferers try many types of treatment on 
their psoriasis, but that they generally rate the effectiveness of those treatments quite 
poorly, and think that all treatments prescribed by doctors are simply different strengths 
of the same thing. This suggests feelings of helplessness about controlling psoriasis. It 
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is possible therefore that worsening of psoriasis may cause depression levels to rise 
through a learned helplessness mechanism related to previous experience with flares 
and remissions, and to the anticipation that treatment will have little or no effect when 
the disease is in an active phase. I f this were the case, one would expect that the longer 
the patient had been suffering from psoriasis, the more likely they would be to antici-
pate negative results from treatment at this stage, and this conforms to the results of the 
regression analyses. 
Conversely, patients who had long experience of psoriasis would also be more likely to 
recognise signs of clearing, to which they could attribute a sense of personal control. In 
the cross-sectional study, absolute depression scores were not related to time since 
onset. As already discussed, this may have been because the psoriasis was not particu-
larly severe. Data from the second study however, shows there is a strong relationship 
between depression scores and the time since onset of psoriasis, where larger depression 
scores are associated with longer suffering. 
To summarise, psoriasis outpatients have levels of depression higher than non-sufferers, 
but below the level usually considered to be clinically significant. Depression levels 
change as the disease progresses, with exacerbation of psoriasis corresponding to in-
crease in depression level, and amelioration of psoriasis corresponding to decrease in 
depression level. This relationship is influenced by length of suffering. This has been 
explained with reference to both social learning theory and the learned helplessness 
hypothesis. 
It was not possible with the study designs reported in this thesis to ascertain at what 
point the direction of change in depression levels is reversed. If changing area of cover-
age is associated with changing levels of depression, at some point the depression level 
must peak then begin to decline. It would be useful to follow a group of patients more 
closely and over a more protracted period to establish at what relative level depression 
stabilises (even though psoriasis severity may continue to increase), and to discover 
what time-lag, i f any, is present between shift in disease phase and shift in rate of 
change of depression. It would also help to clarify the reported difference between 
males and females i f a group could be found whose disease in both sexes fluctuated to 
the same degree, although that would be difficult. 
6.4.3 Anxiety 
While some authors (e.g. Fava et al, 1980; Baughman & Sobel, 1977) have found raised 
levels of anxiety in hospitalised psoriasis patients, others (e.g. Price et al, 1991; Gaston 
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et al, 1987) have shown that sufferers not hospitalised for their condition may also 
experience raised levels of anxiety, and the latter two authors have suggested that these 
levels may be related to disease severity. However, Price et al acknowledged that their 
measure of severity was unreliable, and Gaston et al measured severity on the scalp 
only. The purpose on studying anxiety in the present research therefore was first to 
confirm that psoriasis sufferers are more anxious than non-sufferers, and second to 
ascertain whether levels of anxiety change systematically as the disease progresses. 
In the cross-sectional study reported in Chapter 3 the psoriasis group showed a small 
but statistically significant elevation of trait anxiety scores, with a mean approximately 
three points above controls, who in turn scored close to the cultural norm. There were 
no differences between state anxiety scores. This supports the hypotheses that psoriasis 
sufferers have raised levels of anxiety and is an important finding, especially given the 
relatively low level of psoriasis in that group. It suggests that psoriasis sufferers are 
more predisposed to experience anxiety whatever the current state of their condition. In 
the prospective study, the mean scores on the HADS were moderately elevated at both 
assessments but broadly corresponded with those found by Price et al using the same 
instrument. Thus, psoriasis sufferers are more predisposed to experience anxiety than 
non-sufferers, but the levels of anxiety reported do not reach clinical significance. Price 
found 26% of his sample of outpatients could be categorised as "anxious" on the HADS, 
which corresponds to 35% in the study reported in Chapter 5. 
Area of coverage in the first study did not account for any of the variance in trait anxie-
ty scores. This may have been because the levels of severity were low, but may also 
have been because individual base levels of anxiety were not considered. In the second 
study reported in Chapter 5, anxiety scores were significantly related to change in area 
of coverage scores, arid absolute area for both sexes. This relationship was mediated by 
the length of time the patient had had psoriasis, with longer length of suffering being 
associated with greater change. 
J 
Several authors have found that psoriasis sufferers report considerable worry over the 
course of their condition (e.g. Jobling, 1976; Jowett & Ryan, 1985), which may give 
rise to a generalised heightening of feelings of anxiety not related to the current state of 
psoriasis. Furthermore, anxiety is commonly associated with many chronic illnesses, 
not only in the early stages after diagnosis, but also intermittently throughout the course 
of the illness (Taylor & Aspinwall, 1990). Particularly, anxiety levels tend to rise when 
experiencing adverse side effects from treatment (Taylor & Aspinwall, 1990) and when 
patients are concerned about recurrence of their condition (e.g. Welch-McCaffrey, 
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1985). The treatments used in psoriasis do sometimes have unpleasant side effects (skin 
burning and carcinoma in P U V A treatment, staining with dithranol, dehydration with 
retinoids) which may contribute to anxiety reactions. The cyclic nature of the condition 
means that individuals may experience raised anxiety even in relatively clear phases in 
the anticipation of relapse, and the longer that patient has had psoriasis, the more rein-
forcement the cyclic changes will receive. 
The type of anxiety reaction was examined by the Cognitive Somatic Anxiety Ques-
tionnaire. This examines symptoms experienced by the respondent when they are feel-
ing anxious, and as such is not a measure of anxiety levels per se. Scores on the cogni-
tive or somatic subscales can be compared across groups, or the ratio of cognitive to 
somatic symptoms can be compared. It was hypothesised in Chapter 1 that psoriasis 
sufferers would exhibit a distinctive individual response stereotypy that would distin-
guish them from controls. In the first study, the psoriasis group reported significantly 
more symptoms on both scales than controls. Thus, while the ratio of cognitive to 
somatic symptoms in psoriasis sufferers and controls was the same, psoriasis sufferers 
were more aware of (or experienced more) symptoms in both categories than controls. 
That the ratio did not change between assessments when area of coverage did change 
supports the hypothesis that anxiety reactions conform to Lacey & Lacey's (1959) 
theory of individual response stereotype which is relatively stable over time. Further, 
this response appears to be a group trait which characterises psoriasis sufferers in any 
phase of the condition and distinguishes them from non-sufferers. 
Part of the impetus behind research into the cognitive-somatic anxiety distinction was to 
evaluate appropriate means of treating anxiety or advising on appropriate anxiety-
controlling strategies (e.g. Schwartz, Davidson & Goleman, 1978). The results of the 
present research has shown that psoriasis sufferers do no react to anxiety with predomi-
nantly cognitive or predominantly somatic symptoms. Rather, levels of both cognitive 
and somatic symptoms are raised above those reported by controls. This suggests that 
more general anxiety-reduction techniques may be most appropriate, such as the group 
counselling sessions reported by Price et al (1991), and helps explain why anxiety in 
their experimental group did indeed decline between sessions. 
To summarise, psoriasis patients show higher levels of trait anxiety than controls, and 
levels of current anxiety when measured over the last week tend to change as area of 
coverage changes: the older the individual, the more the change. The ratio of cognitive 
to somatic symptoms reported in anxious situations is not different from controls, but 
psoriasis sufferers report more cognitive and somatic symptoms than controls, which 
141 
Chapter Six: General Discussion 
has been interpreted as a response stereotype. This is relatively resistant to change, 
since neither the ratio nor the absolute levels of cognitive and somatic anxiety changed 
between assessments. 
6.4.4 Self-Esteem 
Only one study had previously examined self-esteem in psoriasis sufferers, and then 
only indirectly through feelings of stigmatisation (Ginsburg & Link, 1989). Those 
authors found longer time since onset to be associated with lower scores on their guilt 
and shame subscales, but neither total area of coverage nor visibility of lesions was 
related to scores on their questionnaire. In the cross-sectional study reported here, it was 
hypothesised that global self-esteem in the psoriatic group would be lower than global 
self-esteem in the control group. This hypothesis was not supported: there was no sig-
nificant difference on the global self-esteem measure between the two groups. Similar-
ly, there were no differences on four of the five subscales: contentment, worthiness and 
significance; competence, resilience and control; self-evaluation; and value of exist-
ence. The only difference was on the attractiveness subscale, where females psoriatics 
scored higher than controls; yet this score was not related to any psoriasis-specific 
variable. In the second study, however, change in the global self-esteem score, the 
competence, resilience and control subscale, and the attractiveness and value of exist-
ence subscales was significantly predicted by change in area of coverage. The differ-
ence in magnitude of the regression line slopes between males and females may be 
another reflection of the lower range of area of coverage scores in females, but it is also 
possible that self-esteem was generally more stable in the females studied. The very 
large differences between slopes in all the above scales would tend to support this inter-
pretation, particularly since the slopes for women were close to zero. 
Self-esteem scores in the second study generally were higher than in the first, (higher 
than for both the psoriasis group and controls), suggesting that the group in the second 
study had quite elevated levels of self-esteem. This was contrary to expectations and 
requires some explanation. Most conceptions of self-esteem involve some sort of evalu-
ation of interaction with other people (e.g. Cooley, 1956; Mead, 1934; Marsh, 1986; 
Robson, 1989). That is, self-esteem is acquired and maintained through interpretation of 
others' opinions, or through comparison with others' abilities. Individuals with stigma-
tising marks (e.g.psoriasis) experience negative reactions from others. In the case of 
psoriasis this was apparent in the study reported in Chapter 4 but also clearly present in 
other data, e.g. Jowett & Ryan, 1985; Savin 1970, and Ginsburg & Link (1989) have 
demonstrated that psoriasis sufferers feel part of a stigmatised group. In theory this 
should lead to lowered self-esteem. 
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However, there is considerable evidence that membership of a stigmatised group does 
not in itself lead to lowered self-esteem (e.g. Major, Carrington & Camevale, 1984; 
Burden & Parrish, 1983). In explanation of this, Crocker & Major (1989) proposed that 
stigma may give rise to the development of self-protective strategies, which in turn will 
lead to raised self-esteem. Since this would in some part explain the findings of the two 
studies reported here it is worthwhile examining these hypothesised self-protective 
strategies in more detail. Crocker & Major examined three possible self-protective 
strategies, all of which may apply to psoriasis sufferers. 
The first was attributing negative feedback to prejudice against the group or condition. 
Negative feedback, for example, revulsion reactions from the public, are attributed to 
prejudice or ignorance rather than accepting that the appearance of the condition may in 
reality be quite distressing to some people who are not used to seeing it. There is some 
evidence that psoriasis sufferers are aware of other peoples' reactions (e.g. Jobling, 
1976; Stankler, 1981), but no research has attempted to ascertain what attributions 
sufferers make for these reactions: that is, whether it is attributed to prejudice against 
the condition. However, informal discussion with patients in the present studies (Chap-
ter 4) suggested that psoriasis sufferers feel others' reactions are based on ignorance of 
the condition. This may be indicative of a self-protective strategy when in the presence 
of others, but may also lead to avoidance of situations where these reactions are likely 
to occur. 
The second was selectively comparing outcomes with ingroup members. This strategy 
involves comparing what happens to you with what happens to other people with a 
similar stigma, rather than comparing with those without stigma. Thus, it can be hy-
pothesised that psoriasis sufferers who employ self-protective strategies should identily 
more closely with other skin sufferers than with non-sufferers. This may have been 
reflected in the knowledge interviews where, when questioned about what other illness-
es were in the same 'family' as psoriasis, out of 34 responses, 20 were of other skin 
diseases (see Table 4.7). It may also have been reflected in the over-estimations of 
prevalence of psoriasis. 
The third was selectively devaluing attributes on which the group fares poorly and 
valuing attributes on which it fares well. This would suggest that as a self-protective 
strategy, psoriasis sufferers should devalue areas from which they are, or they feel, 
excluded, for example sports, sunbathing in public, swimming. It is certainly the case 
that psoriasis sufferers tend to avoid these activities (Jowett & Ryan, 1985; Dooley & 
Finlay, 1990). 
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Crocker & Major (1989) also propose certain factors moderating their hypothesised 
self-protective strategies. 
The first is token (or solo) status of the sufferer, that is, whether there are many or few 
other people with the same stigma. This should result in initial lowering of self-esteem 
(Pettigrew & Martin 1987), and may in part explain the overrating of the prevalence of 
psoriasis found in the knowledge study. It can be hypothesised that inflating the number 
of sufferers operates as a self-protective strategy by diminishing the token status of the 
individual. The true prevalence in Britain is between 1 and 2%, but 60% of respondents 
estimated the prevalence to be over 10%. 
Secondly, time since acquiring the stigmatising feature, Crocker and Major suggest, is 
important because it takes time to acquire self-protective strategies. However, this is not 
supported by the current data because self-esteem would be expected to vary with 
length of suffering, yet it does not. 
These strategies, it should be stressed, are hypothetical, but the data collected in this 
research does fit their general framework, and it would be instructive in future research 
to examine self-protective strategies for self-esteem in psoriasis. 
To summarise, in the first study there was no difference between psoriasis sufferers and 
controls on total self-esteem, and the only difference was on the attractiveness subscale, 
where female psoriatics rated themselves as more attractive than controls. In the second 
study, where psoriasis involvement was more widespread, self-esteem levels were 
generally raised. This may be because the psoriasis sufferers were employing strategies 
to protect their self esteem, and may in part explain some of the results of the patient 
knowledge interview. Some subscales of the self-esteem scale vary with area of cover-
age, more so for men than for women. 
6.4.5 Sleep and Pain. 
While sleep disturbance is not generally examined in relation to psoriasis, two recent 
findings prompted its inclusion in the prospective study reported here. First, the Not-
tingham Health Profile used in the cross-sectional study to examine perceived health 
status found a significant difference between psoriasis sufferers and controls on the 
sleep subscale, which assesses sleep disturbance. The N H P is a rather coarse measure 
and does not give any detailed information on the nature of sleep problems. These 
findings were supported in the patient knowledge interview, with 51% of respondents 
stating that they thought psoriasis affected the way people sleep, and indicating that 
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they thought this problem would be most apparent when the psoriasis was severe. 
Subsequent to that study, Finlay et al (1990) found psoriasis sufferers scoring consider-
ably higher on the SIP sleep scale, which again measures sleep disturbance. 
The results of the prospective investigation found psoriasis sufferers general sleep quali-
ty related to disease severity: that is, as psoriasis changed, so sleep quality changed, but 
this was found only as a general measure and was not reflected in any of the subscales. 
The NHP subscale that measures pain also showed a difference between controls and 
psoriasis sufferers. This was interesting because pain is not generally thought to be a 
feature of cutaneous psoriasis. Since the NHP was not designed to assess pain in detail, 
the MPQ was used in the second study to examine the nature of this reported pain. The 
pain quality scales provided some useful information on the nature of pain associated 
with psoriasis, and suggests that psoriatic pain can best be described as itchy, sore, or 
tender, and annoying. These descriptions of pain quality tend to decline as the psoriasis 
improves, which suggests that pain and irritation qualitatively change with the state of 
the condition. 
6.5 Significance of the regression models 
In Chapter 5 psychological variables and disease severity in psoriasis were modelled by 
linear regression. A number of equations were generated which it was shown fitted the 
data well, with values ranging from 0.44 to 0.79. These equations are not just an 
exercise in statistical modelling: they offer real insight into the link between psoriasis 
and psychological variables. By using these models, it is now possible, with a high 
degree of confidence, to predict the likely effects of change in psoriasis severity on 
depression, anxiety, and self-esteem, and to predict also how sleep disturbance and the 
quality of pain will change as psoriasis progresses. At a practical level, this has implica-
tions for management of psoriasis patients. 
Consider two hypothetical patients presenting with psoriasis assessed as moderately 
severe, say, 10% body coverage: one a male of 20 years, the other a female of 40, and 
both having developed psoriasis at the age of 12. Assume that both have the same levels 
of depression and anxiety (say, a score of 10 on the HADS) and a global self-esteem 
score of 130 on the SEQ. What effects might a change in area of coverage of 5% entail 
for each of these patients? Using these figures in the regression equations presented in 
Chapter 5, predictions made from that same change in area of coverage of 5% would be 
that for the man, self-esteem would be expected to rise to 164, anxiety fall to 6.6, and 
depression would be expected to fall to a HADS score of less than 1. For the woman, on 
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the other hand, self-esteem would only be expected to rise marginally to 136, anxiety 
fall from 10 to 8, and depression fall only to 8.6: a decrease of only just over 1 point on 
the HADS. Assume also relatively poor sleep quality (say a score of 10 on the PSQI). For 
the same change in area of coverage, the young man's score would drop to 6, but the 
older woman's score would be expected to fall only to a score of 9. 
These are, of course, hypothetical figures and the models only predict changes in 
scores. The psychological state of each individual patient wil l be influenced by a variety 
of different factors which must also be taken into account. Domestic or employment 
problems, for example, could be expected to influence depression and anxiety scores, 
and sleep quality may vary for a number of reasons quite apart from psoriasis severity. 
However, given the high values, these predictions are likely to be quite accurate in a 
large number of cases, and could form the basis for formulating treatment regimens and 
guiding decisions about possible referral to psychiatric or psychological support agen-
cies. Predictive models such as these can also be used to identify individuals who are 
not responding in ways that the models predict and can thus be useful for picking up 
people whose depression is getting worse, for example, while their psoriasis is getting 
better, so that appropriate further investigation can be initiated. 
One immediate application is to the SKINMAP program developed as part of this re-
search. As already noted, SKINMAP already has the facility to run external programs and 
combine the data collected with its own estimates of disease severity. Incorporating 
simple measures of depression, anxiety and self-esteem into the computer assessment 
procedure would allow the program to monitor disease progress and psychological state 
and, based on the linear models generated in Chapter 5, identify cases where further 
psychological assessment would be appropriate. This is not to suggest, of course, that 
clinical decisions about patient care should be compromised. Rather, it would offer an 
immediate assessment and permanent record of both the physical and psychological 
state of psoriasis sufferers, together with a preliminary evaluation of their interrelation-
ships, upon which clinicians could choose to act appropriately. 
To summarise, regression models have been fitted to the data collected from psoriasis 
sufferers over time, and allow prediction of levels of psychological variables with a 
high degree of confidence. Application of hypothetical case data to those models high-
lights the importance of sex and time since onset of psoriasis, as well as absolute area of 
coverage and change in area of coverage. These models will be incorporated as part of 
general extensions to the SKINMAP program. 
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6.6 Implications of ttie research findings for the treatment of psoriasis 
While it has been quite well established that psoriasis sufferers hospitalised for their 
condition tend to have quite high levels of anxiety and depression, it has not until now 
been demonstrated that psoriasis out-patients also exhibit higher levels of depression 
and anxiety than a suitably matched control group of non-sufferers. The findings of this 
research show that higher levels of depression and anxiety are associated with relatively 
mild psoriasis and should be considered as part of the general treatment of the psoriasis 
patient. It should also be kept in mind that depression and anxiety fluctuate as the dis-
ease progresses, so regular monitoring should also be a feature of psoriasis manage-
ment. 
Sleep disturbance in psoriasis patients has not previously been examined in any detail 
and the monitoring of sleep quality has not been considered part of the therapy process. 
The results of this research have shown a generalised decline in sleep quality as the 
disease worsens, and those responsible for maintaining psoriasis patients should be 
aware that sleep quality and disease state tend to co-vary, so that appropriate assistance 
can be offered when required. 
Apart from the measurement of pruritus in psoriasis, pain and discomfort are not usual-
ly considered major symptoms. This research has shown that the quality of pain experi-
enced from psoriasis tends to change as the disease progresses, and the more wide-
spread the psoriasis, the worse the pain-descriptor words used, Anti-histamines are 
sometimes prescribed for itch, but no real pain management strategies are taught or 
offered as part of psoriasis treatment. Careful monitoring of pain description by patients 
would identify times when pain starts to become a problem and allow intervention 
before pain rises to the "unbearable" level that was found in the present research. 
Levels of knowledge about psoriasis were found to be quite high, but some gaps in 
patients' knowledge should be filled and some misconceptions rectified. Almost all the 
respondents to the interview described in Chapter 4 said they thought it would help 
them control their psoriasis i f they knew more about the condition. This would seem to 
be particularly pertinent to knowledge about treatment, where respondents showed a 
high level of misunderstanding, evidenced both by 54% thinking that all treatments 
prescribed by doctors are really just different strengths of the same thing, and also by 
the number of respondents who incorrectly named treatments that they thought were 
"non-medical", which in fact were standard medical treatment options. 
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6.7 Conclusions 
This thesis has been concerned with levels of depression, anxiety and self-esteem, with 
the evaluation of sleep quality and the qualitative investigation of pain associated with 
psoriasis, and with discovering the lay beliefs and knowledge about psoriasis in those 
who suffer from the condition. It has also involved developing and validating a new 
means of assessing psoriasis severity. 
The most important conclusions are that psoriasis sufferers whose disease is not severe 
enough to warrant hospitalisation nevertheless experience psychological effects that do 
not afflict non-sufferers to the same degree. Furthermore, the extent of psychological 
disturbance is related to the area of the body covered by the disease, to the length of 
time the individual has had the disease and, most importantly, to the sex of the individ-
ual sufferer. This research has shown that change in psychological disturbance can be 
predicted by regression models, and thus enables clinicians to be more aware of those 
cases who may require psychological intervention. 
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Appendix One: Area of coverage data 
TABLE A2.1. Area of coverage of psoriasis on transparencies of 10 subjects assessed 
by planimetry, and assessed by four clinicians (A, B, C & D) for three body 
areas. (From IMarks etal, 1989) 
Trunk Arm Leg 
Rater Rater Rater 
Subject 1 2 3 4 Plan 1 2 3 4 Plan 1 2 3 4 Plan 
1 0 0 0 0 0 2 5 2 3 1.8 2 5 2 2 1.6 
2 <1 5 2 3 0.4 3 10 4 4 1.9 2 5 3 2 1.2 
3 21 50 12 16 14.6 12 30 5 12 12.1 0 0 0 0 0 
4 70 80 60 65 69.0 50 55 25 50 35.0 35 45 10 28 21.9 
5 14 25 6 11 7.9 0 0 0 0 0 16 30 12 18 17.3 
6 5 20 6 5 4.9 0 0 0 0 0 0 0 0 0 0 
7 6 10 1 4 1.1 3 15 2 5 1.5 9 20 3 7 4.9 
8 4 10 2 3 0.9 6 20 5 7 5.9 25 25 6 10 10.2 
9 40 50 25 30 34.5 40 40 30 30 30.4 15 10 9 10 24.8 
10 7 15 5 8 7.2 5 15 7 13 9.5 4 10 3 5 5.0 
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Appendix Two: SKINMAP Operation 
Procedure for using SKINMAP 
Skin lesions are recorded by the observer (not the patient) by mapping them onto the 
body regions presented by SKINMAP. The program enforces a rigid order of operations 
and precludes progression to the next without satisfactory completion of the current 
operation. 
1) Select DRAW from the main menu. 
2) Basic demographic and personal information about the patient must be entered. 
Blank fields are not accepted. 
3) Patches in SKINMAP are ellipses of variable size which, under normal operation, 
are moved around the screen with a mouse or using the cursor keys. The intial 
size of the patch is determined by the aspect ratio of the screen. Pressing the 
Escape key toggles the mouse (or cursor) movements between patch movement 
and patch size control. Vertical motion increases or decreases the vertical size, 
horizontal motion alters the horizontal size. Patches are fixed on the body region 
by pressing the left mouse button, or by pressing the Enter key on the keyboard, 
and irregular shaped lesions can be built up using multiple, overlapping patches. 
4) Representations of seven body regions are presented successively, onto which 
patches are mapped using a mouse or the cursor keys (front and rear views of 
torso and arms, legs, and hands, and a front view of the head). The patient is 
asked to show each body region in turn as SKINMAP progresses through the 
displays and the observer locates a representation of each psoriasis patch on the 
screen. 
5) For each region, once mapping has been completed, the observer is prompted to 
estimate reddening, thickening and scaling on three point scales. 
6) Once all regions have been mapped, the data are saved to disk and the program 
exits. 
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DECLARATION 
It has been explained to me that everything I say in the course of this interview will 
remain strictly confidential. 
I understand that the interview wil l be tape recorded, but that after the interview the 
tape wil l be transcribed, when any references that might identify me will be removed. 
Once transcribed, I understand that the tape will be wiped clean. 
I give my permission for anything I say to be used for research purposes, in the knowl-
edge that I shall not be identified personally in any way whatsoever. 
Date: 
Name: 
Signature: 
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Date: ' ' ' 
Thank you for agreeing to help us further with this research. I 'd like to talk to you today 
about your thoughts and opinions of psoriasis, and if you have no objections, I 'd prefer 
to tape our conversation. This is to make sure that I don't miss any of your ideas or 
misunderstand anything you say. Once I have transcribed the tape, and removed any 
references that would identify you, the tape will be wiped clean. 
[TURN ON TAPE] 
Although I do have a series of questions that I want to ask you, I don't want you to feel 
as though you should restrict yourself to short answers. I want to know what you think 
about psoriasis, so feel free to volunteer any information you think is appropriate. 
Of course, anything you say to me is in the strictest confidence. 
The first area that I ' d like to look at is how widespread you think psoriasis might be, 
and I 'd like to start by showing you some figures. 
[GIVE CARD ONE] 
1. What proportion of people in Britain would you estimate are current-
ly suffering from psoriasis? 
CARD ONE 
0 Don't know 
1 Less than 1 in 100. 
2 About 2 in 100. 
3 About 5 in 100. 
4 About 10 in 100. 
5 About 15 in 100. 
6 About 20 in 100. 
7 More than 20 in 100. 
[ T A K E BACK CARD ONE] 
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2. Do you think psoriasis affects equal numbers of men and women, or 
do you think one sex is affected in greater numbers than the other? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.4 
1 Men and women are affected in about the same numbers. 
GO TO Q.4 
2 More men are affected than women. 
3 More women are affected than men. 
3. Why do you think that is? 
4. Do you think children are any more or less likely to develop psoriasis 
i f one of their parents already has it? 
0 Don't know. [Probe: No ideas at all?] G 0 T 0 Q . 6 
1 Children are MORE likely to develop psoriasis i f one parent 
already has it. GO TO Q.5(A) 
2 Children are LESS likely to develop psoriasis i f one parent already 
has it. GO TO Q.5(B) 
3 Children are neither more nor less likely to develop psoriasis i f 
one parent already has it. Go to Q.6 
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5A. Can you tell me why you think children are MORE likely to get 
psoriasis i f one parent has it? 
5B. Can you tell me why you think children are LESS likely to get pso-
riasis i f one parent has it? 
6. Do you think there are any particular groups of people who get pso-
riasis more frequently than others? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.8 
1 No. GO TO Q.8 
2 Yes. 
7. What groups? 
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8. Do you think psoriasis can be affected by how clean a person is? 
0 Don't know. [Probe: No ideas at ail?] GO TP Q.IO 
1 No. GO TO Q.IO 
2 Yes. 
9. In what way? 
10. Do you think it's possible for psoriasis to be infectious - that is, under 
certain circumstances can someone else catch psoriasis from you? 
0 Don't know. [Probe: No ideas at ali?] GO TO Q.12 
1 No. GO TO Q.12 
2 Yes. 
11. Under what circumstances? 
12. In people who already suffer from psoriasis, do you think it is some-
times possible for psoriasis to develop at the site of cuts or scratches? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.14 
1 No. GO TO Q.14 
2 Yes. 
13. Can you tell me why diat should happen? 
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14. Do you think pregnancy can affect psoriasis at all? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.16 
1 No. GO TO Q.16 
2 Yes: Makes it worse. 
3. Yes: makes it better. 
15. Why do you think that is? 
16. In general, do you think having psoriasis affects the way people 
sleep? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.18 
1 No. GO TO Q.18 
2 Yes. 
17. Why do you think that should be? 
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18. Can you tell me what actually happens to the skin in psoriasis? 
0 Don't know. [Probe: No ideas at all?] 
1 Skin cells grow too quickly. 
2 Other: 
19. Do you think psoriasis may be an early form of any other disease? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.21 
1 No. GO TO Q.21 
2 Yes. 
20. What disease? 
21. In your opinion, is psoriasis a member of a 'family' of illnesses. 
0 Don't know. [Probe: No ideas at all?] GO TO Q.23 
1 No. GO TO Q.23 
2 Yes. 
22. What other illnesses would you put in the same family as psoriasis? 
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23. Once a person has psoriasis, do you think it is possible that it will 
ever clear away and not come back? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.25 
1 No. GO TO Q.25 
2 Yes. 
24. Under what circumstances? 
25. Are there any sorts of diet that are particularly good for psoriasis? 
0 Don't know. [Probe: No ideas at all?] GO TO Q.27 
1 No. GO TO Q.27 
2 Yes. 
26. What sort of diet? 
27. Are all the ointments prescribed by the doctor for psoriasis really just 
different strengths of the same thing? 
0 Don't know. [Probe: No ideas at all?] 
1 No. 
2 Yes. 
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28. I 'd like you to try and name as many treatments as you can that you 
can get from a doctor or from the hospital for psoriasis? It doesn't 
matter whether or not you have used them personally. 
TREATMENT 
1. 
USED EFFECTIVE 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
Now I 'd like you to try and assess how effective you think those treatments 
might be. Please choose your answers from one of these options. 
[GIVE CARD TWO] 
Have you ever used <TREATMENT>? 
0 Don't know 
1 No 
2 Yes 
(Although you have never used <TREATMENT>), how effective do 
you think it is?. 
CARD TWO 
0 Don't know. 
1 Doesn't work at all. 
2 Works a little. 
3 Works a moderate amount. 
4 Works quite well. 
5 Works very well. 
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29. Now I 'd like you to try and name as many treatments as you can that 
you can NOT get from a doctor or from the hospital for psoriasis? 
Once again, it doesn't matter whether or not you have used them 
personally. 
TREATMENT USED EFFECTIVE 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
Now I 'd like you to try and assess how effective you think those treatments 
might be. Please choose your answers from one of these options. 
[GIVE CARD TWO] 
Have you ever used <TREATMENT>? 
0 Don't know 
1 No 
2 Yes 
(Although you have never used <TREATMENT>), how effective do 
you think it is?. 
0 Don't know. 
1 Doesn't work at all. 
2 Works a little. 
3 Works a moderate amount. 
4 Works quite well. 
5 Works very well. 
[TAKE B A C K CARD TWO. G I V E CARD T H R E E ] 
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30. People find out about psoriasis from all sorts of places. Which of 
these sources do you think has provided you with most information 
about psoriasis? [Probe: And which would be next? etc.] 
Doctors 
Newspapers 
Magazines 
Television 
Radio 
Family and friends 
Other psoriasis sufferers 
[TAKE BACK CARD T H R E E ] 
31. Have you had any information about psoriasis from anywhere else? 
32. Do you think it would help you to control your condition if you knew 
more about psoriasis? 
0 Don't know. 
1 No. 
2 Yes. 
33. Why do you think that is? 
179 
Appendix Four 
SEQ Subscale Scores and NHP scores for Cross-Sectional Study 
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TABLE A3.1 Summary of SEQ subscale scores from cross-sectional study for matched 
samples (n=114) of psoriasis sufferers and controls 
Scunple Group Mean SD Range t Sig 
Contentment, worthiness & Personal Significance 
A l l Controls 3.9 1.3 1.6-6.4 -0.9 
Psoriasis 3.7 1.4 1.1-6.7 
Male Controls 4.2 1.1 2.3-6.4 -0.4 -
Psoriasis 4.1 1.2 1.4-6.6 
Female Controls 3.7 1.4 1.6-6.3 -0.4 -
Psoriasis 3.4 1.4 1.1-6.7 
Competence, resilience and control 
A l l Controls 5.0 0.9 3.0-6.9 1.4 -
Psoriasis 5.2 0.7 3.9-7.0 
Male Controls 5.1 0.8 3.6-6.6 0.7 -
Psoriasis 5.5 0.6 4.0-6.5 
Female Controls 5.0 1.0 3.0-6.9 1.2 -
Psoriasis 5.2 0.8 3.9-7.0 
Attractiveness 
AU Controls 4.8 1.1 2.4-6.6 1.5 
Psoriasis 5.1 0.8 3.9-7.0 
Male Controls 5.2 1.0 3.4-6.6 -0.5 -
Psoriasis 5.0 0.8 3.6-6.6 
Female Controls 4.3 1.1 2.4-6.4 2.5 0.02 
Psoriasis 5.2 0.8 3.8-7.0 
Value of existence 
A l l Controls 4.8 1.2 1.3-6.8 -0.2 -
Psoriasis 4.8 1.2 1.8-6.7 
Male Controls 4.7 1.1 2.2-6.3 1.3 -
Psoriasis 5.1 1.0 2.8-6.7 
Female Controls 4.9 1.3 1.3-6.8 -1.6 -
Psoriasis 4.6 1.2 1.8-6.7 
Self evaluation 
AU Controls 5.0 1.4 1.5-7.0 -0.4 -
Psoriasis 4.9 1.4 0.0-7.0 
Male Controls 5.5 1.2 3.0-7.0 -0.9 -
Psoriasis 5.2 1.3 2.0-7.0 
Female Controls 4.7 1.4 1.5-7.0 0.0 -
Psoriasis 4.7 1.4 0.0-7.0 
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TABLE A3.2 Summary of NHP scale scores from cross-sectional study for matched 
samples (n=114) of psoriasis sufferers and controls 
Scale 
Energy 
Pain 
Sleep 
Social Isolation 
Physical Mobility 
Sample Group Median SIR 
A l l Psoriasis 0 12.0 
Controls 0 19.6 
Male Psoriasis 0 12.0 
Control 0 6.0 
Female Psoriasis 0 27.7 
Control 30.4 31.6 
A l l Psoriasis 0 6.9 
Controls 0 0 
Male Psoriasis 0 2.5 
Control 0 0 
Female Psoriasis 0 17.8 
Control 0 0 
A l l Psoriasis 12.6 21.3 
Controls 0 6.0 
Male Psoriasis 12.6 21.3 
Control 0 3.2 
Female Psoriasis 6.3 22.5 
Control 0 6.3 
A l l Psoriasis 9.8 10.5 
Controls 9.3 9.2 
Male Psoriasis 0 8.5 
Control 0 6.7 
Female Psoriasis 11.9 13.7 
Control 9.8 13.7 
A l l Psoriasis 0 0 
Controls 0 0 
Male Psoriasis 0 4.8 
Control 0 0 
Female Psoriasis 0 0 
Control 0 10.0 
A l l Psoriasis 0 5.3 
Controls 0 2.6 
Male Psoriasis 0 5.3 
Control 0 5.3 
Female Psoriasis 0 5.4 
Control 0 0 
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